data_2kq1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kq1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.915 0.388 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.975 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.872 ' HB2' HG12 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 HD23 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.847 ' HG ' ' HG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.813 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.427 ' HA ' HG23 ' A' ' 62' ' ' THR . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.847 ' HG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.518 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.975 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 42' ' ' ARG . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.436 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CE1' HD23 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.813 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 20' ' ' TYR . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB3' HD11 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.42 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.583 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB2' HG11 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.456 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.93 HG11 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.773 HG11 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.93 ' HD3' HG11 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.44 ' HE3' ' O ' ' A' ' 70' ' ' THR . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 40' ' ' GLY . 40.4 m80 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 1.017 HG12 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.957 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HA ' HD11 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.729 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.729 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 1.017 ' HD3' HG12 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.585 ' HB3' HG23 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.582 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.388 0.613 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.801 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.541 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG12 HD13 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.442 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.564 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 HG12 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.637 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB1' HD13 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.449 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.495 ' O ' ' HD2' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.509 ' HB3' HG23 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.57 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.627 HD13 ' HB1' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG11 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.82 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.82 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.747 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.496 ' HA3' HD23 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.593 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.593 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.527 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD12 HG11 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.645 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD23 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.747 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.619 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.564 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.503 0.668 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB2' HD21 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.669 ' HB2' HG12 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.512 HD13 ' HZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.583 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.583 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.727 HG23 HE21 ' A' ' 30' ' ' GLN . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.727 HE21 HG23 ' A' ' 27' ' ' ILE . 6.9 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 11.3 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.636 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.452 HG23 ' HE3' ' A' ' 90' ' ' MET . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.964 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.964 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.452 ' HE3' HG23 ' A' ' 70' ' ' THR . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.458 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.504 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.433 HG12 HG23 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.653 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.879 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.544 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.879 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.89 HD13 HG13 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.596 ' HB3' HG23 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.89 HG13 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.781 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.781 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 27.6 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.877 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.877 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.52 ' HE3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.949 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.553 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.718 HG11 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 HG11 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.949 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.466 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.632 HG23 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.625 HD21 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.718 ' HG3' HG11 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.498 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 24.4 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' C ' HD21 ' A' ' 8' ' ' ASN . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.8 OUTLIER -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 HD13 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.905 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' HG2' ' ND2' ' A' ' 8' ' ' ASN . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.729 HD13 HG12 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.533 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 44' ' ' VAL . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 41' ' ' PRO . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.538 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.547 ' HB3' HG11 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB2' ' H ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.529 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.563 ' HB3' HG22 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.484 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.883 HG12 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 HG23 HG12 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.672 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.883 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.514 ' HB3' HG21 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.608 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 HD11 ' HD3' ' A' ' 49' ' ' ARG . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.577 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD3' HD11 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HD22 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.587 HD12 ' HE2' ' A' ' 69' ' ' HIS . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.587 ' HE2' HD12 ' A' ' 61' ' ' LEU . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.577 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.499 ' HB3' HG23 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.562 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.804 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' HD21 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.719 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.51 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.561 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.804 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.548 ' HB3' HG22 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.608 HD13 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.471 HD11 HG13 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG13 HD11 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.532 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.608 HH21 HD13 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.539 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.555 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.422 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.696 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.558 HG21 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.555 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' CG ' HG13 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' HG21 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 121.428 0.633 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.648 ' HB2' HG12 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.459 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.438 HG12 HD22 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' HD23 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.412 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.525 ' HB3' HG21 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.471 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.595 0.236 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.694 HD13 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' NE2' HG23 ' A' ' 27' ' ' ILE . 10.9 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 31' ' ' THR . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.694 HG23 HD13 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.622 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.504 HG12 HD22 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.59 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HG3' HG11 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.559 ' HG2' HG23 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.605 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG23 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 10.9 m120 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.706 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.663 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.596 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.827 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.26 158.17 26.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.64 2.227 . . . . 0.0 111.538 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m -143.63 144.25 31.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 110.779 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -131.9 141.2 49.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.734 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.46 69.47 0.75 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.173 0.511 . . . . 0.0 109.869 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 62.97 -164.75 0.25 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.272 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.975 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.872 ' HB2' HG12 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 HD23 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.847 ' HG ' ' HG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.813 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.427 ' HA ' HG23 ' A' ' 62' ' ' THR . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.59 ' CB ' ' HA ' ' A' ' 98' ' ' ARG . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.847 ' HG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.518 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.975 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 42' ' ' ARG . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.436 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CE1' HD23 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.813 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 20' ' ' TYR . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HB3' HD11 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.42 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.06 129.38 2.19 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -52.74 148.2 7.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -163.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.491 ' O ' HG22 ' A' ' 100' ' ' THR . 63.7 tt0 -129.84 -81.49 0.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 99' ' ' GLN . 0.6 OUTLIER -171.47 93.46 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.313 0.645 . . . . 0.0 110.269 176.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.68 146.26 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 0.0 111.003 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 59.3 p -119.4 147.29 44.53 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.67 109.89 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.493 0.663 . . . . 0.0 111.846 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 102' ' ' SER . 37.8 Cg_endo -95.97 63.25 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.608 2.872 . . . . 0.0 111.184 175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -88.49 116.02 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.575 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -103.27 104.34 14.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.298 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.86 -60.8 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 68.79 146.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.007 0.817 . . . . 0.0 111.311 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.3 ttm -135.47 138.79 43.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.444 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 pt -97.43 166.24 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -133.36 133.33 42.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.912 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 tp -89.57 94.63 9.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 111.275 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 142.09 29.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.281 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -176.5 -32.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.602 0.564 . . . . 0.0 110.102 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -59.78 109.87 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.762 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -86.54 77.3 9.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 179.39 71.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.764 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -85.05 -25.3 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.993 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--O 1.243 0.739 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.549 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.7 ptt? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 8.4 Cg_exo -71.03 91.18 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.768 2.312 . . . . 0.0 112.435 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -95.11 103.26 15.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 110.873 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.17 177.54 4.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.952 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -88.8 50.97 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.607 0.718 . . . . 0.0 109.673 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.37 146.35 24.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.757 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.583 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB2' HG11 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.456 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.93 HG11 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.773 HG11 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.93 ' HD3' HG11 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.44 ' HE3' ' O ' ' A' ' 70' ' ' THR . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.85 77.35 0.21 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 100' ' ' THR . 37.1 ttp-105 39.78 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.769 ' HG3' ' H ' ' A' ' 101' ' ' VAL . 6.3 tp60 48.17 -65.44 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.143 -2.299 . . . . 0.0 115.847 173.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 98' ' ' ARG . 12.6 m 84.4 -2.63 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.036 0.934 . . . . 0.0 111.219 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.769 ' H ' ' HG3' ' A' ' 99' ' ' GLN . 61.0 t -123.75 116.48 48.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.635 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.0 m -77.8 85.45 4.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.271 0.558 . . . . 0.0 110.48 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.27 124.68 48.32 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.908 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.46 145.42 26.61 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.632 2.221 . . . . 0.0 112.068 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.07 154.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.842 0.354 . . . . 0.0 110.632 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -142.24 143.89 33.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.94 138.77 51.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.563 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.73 86.77 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.3 ttp -79.59 105.33 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.215 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.6 tt -108.83 98.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.621 0.724 . . . . 0.0 111.835 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -102.94 90.62 3.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.03 79.92 1.56 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.666 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 115' ' ' HIS . 33.7 mt-10 -112.89 -47.68 3.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.099 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 71.78 -27.77 0.18 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.361 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.442 ' H ' ' C ' ' A' ' 113' ' ' GLU . 48.7 t60 -74.63 78.22 2.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -163.78 108.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.288 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -123.43 137.02 54.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.136 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -121.08 143.07 49.27 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.925 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.32 124.46 12.55 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.731 2.288 . . . . 0.0 113.426 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 p -84.11 101.86 12.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.397 0.618 . . . . 0.0 109.405 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -83.03 -178.72 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.842 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 37.0 t70 -151.5 106.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 40.4 m80 75.88 -172.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.583 1.177 . . . . 0.0 109.515 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.669 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 1.017 HG12 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.957 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HA ' HD11 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.729 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.729 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 1.017 ' HD3' HG12 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.585 ' HB3' HG23 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.582 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 -71.06 131.22 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 28.3 ttm180 75.99 137.61 0.06 Allowed 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 124.182 0.926 . . . . 0.0 110.611 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -90.91 116.36 28.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.798 -168.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 m -92.54 -22.61 19.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.853 0.835 . . . . 0.0 110.383 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 162.25 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.03 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -128.65 117.81 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.74 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.53 115.38 64.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.908 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.64 104.52 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.939 2.426 . . . . 0.0 111.111 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.425 ' C ' ' HG1' ' A' ' 106' ' ' THR . 20.4 m -71.1 123.39 25.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.254 0.55 . . . . 0.0 111.017 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 105' ' ' VAL . 88.2 m -157.67 134.96 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.182 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.01 119.77 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.189 0.518 . . . . 0.0 110.059 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.35 135.47 33.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.96 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.9 ttm -75.75 -59.93 2.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.815 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.503 HG22 ' HG ' ' A' ' 112' ' ' LEU . 44.3 mt 57.13 73.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.12 82.25 6.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.665 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 110' ' ' ILE . 94.9 mt -85.31 84.03 7.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.235 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.94 89.85 1.11 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.761 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -98.56 92.65 5.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.356 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -95.67 106.59 18.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.92 137.05 41.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.656 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -106.05 178.22 4.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -120.31 93.88 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 110.378 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.0 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 177.636 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 75.5 mtm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.691 0.281 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 97.5 Cg_endo -95.68 -5.72 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.234 2.623 . . . . 0.0 113.746 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.92 16.03 2.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 112.316 -171.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -74.59 143.12 44.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.918 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -132.46 92.41 3.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.83 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 71.59 -173.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.801 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.541 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG12 HD13 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.442 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.564 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 HG12 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.637 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB1' HD13 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.449 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.495 ' O ' ' HD2' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.509 ' HB3' HG23 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.57 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.627 HD13 ' HB1' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 67.72 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 98' ' ' ARG . 1.4 tpp85 -151.62 170.86 18.65 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -103.31 154.24 19.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 120.297 0.094 . . . . 0.0 111.167 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.8 m 72.31 119.05 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 98.8 t -63.15 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.987 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 p -119.87 96.77 5.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.474 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.31 123.78 47.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.758 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.82 172.12 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.69 2.26 . . . . 0.0 111.858 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.18 104.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.4 p -72.59 141.61 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.301 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.669 HG23 ' HG3' ' A' ' 109' ' ' MET . 12.4 p -128.9 137.52 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.646 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 -69.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.669 ' HG3' HG23 ' A' ' 107' ' ' VAL . 84.5 mtp 65.08 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 125.7 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.363 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.5 127.84 34.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.226 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.44 120.31 7.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -162.49 101.24 1.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.497 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -117.65 84.39 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -112.65 29.41 7.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.909 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -71.25 110.04 5.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.92 0.39 . . . . 0.0 110.35 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -131.58 115.89 16.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -98.95 170.71 8.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.68 178.731 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.615 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.8 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.437 0.16 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 25.2 Cg_endo -89.95 35.59 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.441 2.761 . . . . 0.0 112.238 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 m -151.3 169.72 21.28 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 6' ' ' HIS . 89.1 m-85 -48.49 134.19 15.64 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.183 0.302 . . . . 0.0 110.545 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 7.8 p-10 -80.76 36.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.704 0.764 . . . . 0.0 111.565 -173.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 4' ' ' PHE . 33.2 m170 -102.82 107.47 18.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.931 174.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG11 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.82 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.82 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.747 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.496 ' HA3' HD23 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.596 ' CG ' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.593 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.527 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD12 HG11 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.645 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD23 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.747 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.619 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.564 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.64 62.13 5.35 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 64.9 151.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.954 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.76 130.74 47.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.206 174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 95.5 m -65.76 106.64 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.012 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.706 HG22 ' H ' ' A' ' 103' ' ' VAL . 10.4 p -108.87 134.67 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.078 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 m -96.27 8.9 42.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 110.903 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.706 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.5 t -117.24 125.93 27.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 60.48 2.68 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.992 2.461 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 103' ' ' VAL . 20.1 m -91.82 -23.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.181 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 108' ' ' GLU . 32.5 m -98.36 111.77 24.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.941 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.98 -36.4 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.404 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.567 ' HG3' HG23 ' A' ' 106' ' ' THR . 42.4 mt-10 66.58 108.69 0.04 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.91 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.29 99.4 9.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.79 160.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.971 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.33 118.65 22.81 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.43 65.87 3.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.687 -171.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -89.33 -49.57 6.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -87.57 122.57 31.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -113.43 128.8 56.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.29 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -82.4 118.74 23.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.983 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -74.3 168.25 20.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.551 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -115.85 -81.48 0.61 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.643 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' C ' ' HG1' ' A' ' 3' ' ' THR . 64.5 Cg_endo -73.47 60.91 4.23 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.068 2.512 . . . . 0.0 113.542 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.462 ' HG1' ' C ' ' A' ' 2' ' ' PRO . 63.8 p 52.08 -164.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.716 0.806 . . . . 0.0 112.598 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.767 ' HB3' ' HG2' ' A' ' 42' ' ' ARG . 49.8 t80 -159.9 148.94 17.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.55 84.72 4.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.512 0.672 . . . . 0.0 110.598 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 75.73 152.56 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.707 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB2' HD21 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.669 ' HB2' HG12 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 HD13 ' HZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.583 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.583 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.727 HG23 HE21 ' A' ' 30' ' ' GLN . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.727 HE21 HG23 ' A' ' 27' ' ' ILE . 6.9 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.714 ' HB2' ' HG2' ' A' ' 109' ' ' MET . 11.3 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.767 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.636 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.452 HG23 ' HE3' ' A' ' 90' ' ' MET . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.964 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.964 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.452 ' HE3' HG23 ' A' ' 70' ' ' THR . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 41.3 tt0 -55.03 132.34 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.548 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 42.8 ttp180 75.05 140.8 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 124.273 0.983 . . . . 0.0 111.489 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -111.13 156.78 20.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.124 -168.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 t -158.21 93.63 1.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.337 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.662 HG11 HG23 ' A' ' 103' ' ' VAL . 95.8 t -132.53 105.75 9.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.584 -173.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -119.01 19.56 12.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.82 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.662 HG23 HG11 ' A' ' 101' ' ' VAL . 27.1 m -79.49 145.99 64.73 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.562 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.08 167.7 12.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.611 2.207 . . . . 0.0 112.126 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HB ' ' A' ' 106' ' ' THR . 35.2 t -103.92 143.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 105' ' ' VAL . 93.6 m 79.81 125.31 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.737 0.648 . . . . 0.0 111.141 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.05 -14.44 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.818 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 75.04 91.16 0.08 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.192 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.714 ' HG2' ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -90.94 -175.91 4.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.38 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.75 134.89 25.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.377 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.38 129.47 55.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.1 tp -150.52 119.74 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.183 0.516 . . . . 0.0 112.019 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.57 97.23 4.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -132.5 60.38 1.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 0.0 110.868 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -105.96 154.72 20.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.336 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -132.6 120.93 22.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -68.54 108.0 3.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.783 0.325 . . . . 0.0 110.389 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.52 151.9 48.91 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.043 -177.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.6 ttt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.6 Cg_exo -69.21 -173.1 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.127 2.551 . . . . 0.0 112.239 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -76.59 -167.56 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.127 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -61.22 145.76 50.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.209 0.528 . . . . 0.0 111.455 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.64 101.08 3.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.441 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.4 111.99 1.78 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.339 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.458 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 100' ' ' THR . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.504 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.433 HG12 HG23 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.653 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.08 43.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.466 ' H ' ' C ' ' A' ' 96' ' ' GLU . 18.4 tpp180 -138.44 136.91 36.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -78.77 131.67 36.63 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.434 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 7.9 m -127.2 8.54 6.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.367 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t 77.48 -43.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.182 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 31.8 t 72.65 143.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.075 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.93 92.34 1.37 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.753 0.787 . . . . 0.0 109.904 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.82 15.63 1.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.022 2.481 . . . . 0.0 113.478 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.6 132.41 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 m -152.09 42.11 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.48 0.657 . . . . 0.0 109.338 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 4.1 p -51.58 100.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.575 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 8.0 mm-40 162.31 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.514 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ptm -78.52 113.15 16.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.762 0.792 . . . . 0.0 110.524 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.63 -27.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.605 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.91 110.49 7.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.63 168.27 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.977 0.418 . . . . 0.0 111.071 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.77 140.74 33.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.929 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -114.86 82.72 1.78 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.151 0.976 . . . . 0.0 109.199 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -143.42 91.89 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.561 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -94.58 144.9 25.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -139.77 129.12 24.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.687 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -71.99 149.62 44.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.078 175.684 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.894 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.894 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 5.4 Cg_exo -78.81 123.01 5.62 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.219 1.946 . . . . 0.0 112.101 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m -128.83 144.66 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.146 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -120.27 169.87 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.361 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 11.8 m-20 -78.79 34.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.584 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -117.09 107.74 14.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.879 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.544 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.879 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.89 HD13 HG13 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.596 ' HB3' HG23 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.89 HG13 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 -72.74 81.85 1.15 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.14 141.59 50.67 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.461 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -86.32 94.83 9.45 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.112 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.1 m -119.62 103.4 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 86.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.698 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 m -82.19 -173.97 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.195 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.5 150.88 37.15 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.809 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 159.54 52.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.575 2.184 . . . . 0.0 111.545 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.665 HG13 HD22 ' A' ' 19' ' ' LEU . 26.9 m -115.94 147.3 19.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 111.971 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 m -135.57 94.78 3.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.214 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.55 138.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 159.05 17.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.106 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.5 mtp -111.43 149.74 30.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.42 164.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.53 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -154.64 128.72 8.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.978 0.418 . . . . 0.0 111.373 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.4 tp -158.69 87.38 0.88 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.947 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.11 -43.35 10.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.876 -173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -90.49 99.67 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.701 0.762 . . . . 0.0 111.048 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 116' ' ' HIS . 3.6 p80 -156.57 150.86 25.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.671 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 15.9 m-70 73.83 140.96 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.836 0.71 . . . . 0.0 109.626 -166.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -148.28 154.19 39.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.3 168.47 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.919 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.247 0.924 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.97 120.19 7.11 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.666 2.244 . . . . 0.0 112.292 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -99.61 11.96 37.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.611 1.196 . . . . 0.0 109.207 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -83.32 -166.12 1.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.543 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 63.66 46.98 3.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.619 0.723 . . . . 0.0 110.333 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.44 101.01 5.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.781 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.781 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 27.6 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.877 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.877 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.52 ' HE3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 -74.87 81.33 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -136.07 157.26 47.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.958 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.28 85.47 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.539 ' O ' HG22 ' A' ' 101' ' ' VAL . 5.2 m -97.58 -63.61 1.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 100' ' ' THR . 3.2 m 59.1 -20.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.046 1.739 . . . . 0.0 114.621 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 100' ' ' THR . 23.1 t -118.36 101.95 8.57 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.36 94.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.556 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.89 139.15 39.07 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.711 2.274 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 p -140.87 114.16 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.333 0.587 . . . . 0.0 111.715 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 108' ' ' GLU . 15.0 t -178.31 177.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.449 174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 107' ' ' VAL . 10.8 p -92.18 28.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 122.158 0.98 . . . . 0.0 109.783 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 106' ' ' THR . 9.8 tp10 -137.24 131.58 32.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.403 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 57.2 ttp -122.03 94.49 4.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.507 HG23 ' HG3' ' A' ' 108' ' ' GLU . 9.1 tp -152.81 135.52 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -141.61 87.11 2.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 tp -89.6 117.22 28.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.578 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 14.5 pt-20 -72.45 99.97 2.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.192 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -140.59 32.99 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.961 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -63.78 117.7 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.33 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -125.05 137.17 54.22 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.64 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -83.44 107.83 16.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.636 0.731 . . . . 0.0 110.566 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -90.36 136.38 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.781 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.068 179.083 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.9 mtt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 4.8 Cg_exo -78.98 10.86 2.77 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.479 2.786 . . . . 0.0 112.402 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.6 p -79.23 158.82 27.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.41 141.63 58.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.938 0.399 . . . . 0.0 110.489 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -140.47 98.29 3.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 75.7 141.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.0 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.949 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 98' ' ' ARG . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.553 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.718 HG11 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 HG11 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.949 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.466 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.632 HG23 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.625 HD21 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.718 ' HG3' HG11 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.498 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 24.4 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 134.14 56.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.434 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 8.9 ptp180 -71.49 179.08 3.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -57.16 -47.65 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.895 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 100' ' ' THR . 9.8 t -165.41 108.05 0.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.562 0.696 . . . . 0.0 111.688 174.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.19 97.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.76 . . . . 0.0 110.495 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -113.73 16.44 18.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.276 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 p -112.13 111.42 53.15 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.88 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.54 131.39 29.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.77 2.313 . . . . 0.0 111.475 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -99.15 105.14 16.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.898 0.38 . . . . 0.0 111.028 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.0 m -91.21 108.37 19.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.752 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.17 144.14 12.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.445 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.76 34.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttt -76.71 134.09 39.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.9 77.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.543 0.687 . . . . 0.0 111.043 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -121.72 2.74 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.635 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 113' ' ' GLU . 6.4 tt -144.71 108.39 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.135 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 9.3 tp10 -76.13 160.94 29.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.494 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.537 ' HB2' ' O ' ' A' ' 113' ' ' GLU . 30.0 m80 75.39 26.82 1.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.795 0.685 . . . . 0.0 110.552 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -78.07 -25.21 47.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.197 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.16 134.38 42.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.574 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -146.9 -55.61 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.584 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -168.77 -175.83 2.53 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.411 ' H ' ' CD2' ' A' ' 118' ' ' HIS . 87.6 m-70 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.567 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.1 mtt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.617 0.246 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -75.93 179.23 6.49 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.66 2.24 . . . . 0.0 111.357 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -90.16 11.32 21.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.718 1.247 . . . . 0.0 109.66 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -92.38 -164.31 1.16 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.695 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.4 t70 65.76 55.38 0.98 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -57.45 112.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.177 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' C ' HD21 ' A' ' 8' ' ' ASN . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.8 OUTLIER -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.729 HG12 HD13 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.905 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' HG2' ' ND2' ' A' ' 8' ' ' ASN . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.729 HD13 HG12 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.533 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.16 78.74 2.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.96 153.79 32.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.724 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 88.86 5.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.236 0.541 . . . . 0.0 109.992 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -107.44 142.97 36.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.923 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 m -52.32 115.86 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.623 0.725 . . . . 0.0 111.507 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -86.28 82.32 8.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 26.7 m -103.58 144.87 29.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.445 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 17.2 Cg_exo -67.29 97.75 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.723 2.282 . . . . 0.0 112.427 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.32 88.04 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -92.34 -17.67 24.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.808 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.5 109.07 16.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -93.1 123.44 36.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.154 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.43 149.64 44.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.2 tt -130.39 92.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.72 0.771 . . . . 0.0 110.179 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.39 143.85 45.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.12 4.27 3.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.84 4.72 52.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.361 0.601 . . . . 0.0 110.177 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -66.31 90.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.231 0.539 . . . . 0.0 109.7 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -120.71 137.74 54.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.839 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.83 116.56 29.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.947 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -150.28 130.49 13.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -158.21 148.39 20.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.962 0.41 . . . . 0.0 110.983 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.2 p80 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.38 114.02 2.18 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.472 2.115 . . . . 0.0 111.132 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.57 HG22 ' HA3' ' A' ' 43' ' ' GLY . 25.5 p -68.27 135.51 52.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.45 0.643 . . . . 0.0 111.69 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.88 -165.06 1.25 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.227 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.86 101.51 0.04 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.848 0.717 . . . . 0.0 111.127 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 -77.45 99.47 5.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.209 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 102' ' ' SER . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 44' ' ' VAL . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 3' ' ' THR . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 41' ' ' PRO . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.538 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.578 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.547 ' HB3' HG11 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB2' ' H ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.529 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.563 ' HB3' HG22 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 24.9 tt0 -58.33 130.8 48.41 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 23.3 ttp85 83.24 140.35 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.602 1.189 . . . . 0.0 111.955 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.09 119.81 17.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.052 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.6 m -138.08 96.0 3.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.067 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.85 118.18 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.247 0.546 . . . . 0.0 110.469 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 18.3 m -96.07 137.75 34.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.0 p -113.27 110.11 51.05 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 6.0 Cg_exo -79.62 98.25 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.935 2.424 . . . . 0.0 111.119 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.54 -36.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 m 67.01 109.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.825 0.703 . . . . 0.0 111.352 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.59 133.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.808 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.95 124.3 27.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.833 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -103.71 143.36 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.949 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.99 -172.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -136.85 152.15 49.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.47 157.09 47.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.08 139.21 53.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -103.61 130.55 51.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.825 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -96.66 139.58 32.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -105.54 121.35 43.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.207 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -99.49 140.65 33.36 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.215 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -92.16 173.49 7.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.8 t60 . . . . . 0 C--O 1.245 0.849 0 CA-C-O 117.951 -1.023 . . . . 0.0 108.822 175.098 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.071 0.462 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -91.49 28.23 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.285 2.657 . . . . 0.0 110.823 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 p -71.23 117.75 13.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.203 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -66.04 126.33 28.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.76 98.23 3.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.16 0.505 . . . . 0.0 110.019 -170.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -86.29 157.77 19.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.484 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.883 HG12 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 HG23 HG12 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.672 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.883 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.514 ' HB3' HG21 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.608 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.22 121.98 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 69.38 145.18 0.05 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.366 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.99 127.75 22.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.254 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.5 p -91.93 -166.25 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.398 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.81 130.5 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.913 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 m -83.29 83.58 7.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.034 0.445 . . . . 0.0 110.88 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 p -117.31 106.3 47.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.524 0.678 . . . . 0.0 110.823 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 1.7 Cg_endo -82.31 96.64 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.142 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 HG13 ' A' ' 107' ' ' VAL . 4.9 p -133.9 114.33 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -100.32 90.79 4.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 0.0 110.337 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG13 HG23 ' A' ' 105' ' ' VAL . 4.8 m -92.55 90.43 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.143 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.66 93.66 4.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -162.61 85.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.426 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.85 105.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.605 0.717 . . . . 0.0 110.817 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -131.37 109.4 10.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -101.74 148.47 25.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.274 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -112.2 141.63 45.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.1 75.59 0.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 110.304 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -116.44 113.96 23.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.048 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -154.12 132.17 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.212 0.529 . . . . 0.0 111.937 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -176.69 114.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.227 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -142.66 90.13 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.348 0.594 . . . . 0.0 110.975 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t60 . . . . . 0 C--O 1.242 0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.844 177.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.35 116.31 3.16 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.431 2.088 . . . . 0.0 111.178 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -131.65 151.49 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -89.59 138.56 31.36 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.752 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 12.1 t70 -100.37 72.23 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -131.23 126.99 36.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.317 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 HD11 ' HD3' ' A' ' 49' ' ' ARG . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HG2' HG12 ' A' ' 105' ' ' VAL . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.577 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD3' HD11 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HD22 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.587 HD12 ' HE2' ' A' ' 69' ' ' HIS . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.587 ' HE2' HD12 ' A' ' 61' ' ' LEU . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.577 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.499 ' HB3' HG23 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.08 74.2 5.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.422 ' CG ' ' H ' ' A' ' 99' ' ' GLN . 9.1 ttp180 -94.32 176.13 6.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.956 -174.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.422 ' H ' ' CG ' ' A' ' 98' ' ' ARG . 35.3 tt0 -76.78 0.19 21.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.207 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 p -108.63 96.92 6.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.48 15.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 6.0 p -95.85 37.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.962 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -93.83 108.0 31.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.552 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 102' ' ' SER . 73.1 Cg_endo -93.36 133.49 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.034 2.489 . . . . 0.0 112.628 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 23' ' ' GLU . 28.8 m -82.22 -18.91 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.143 0.497 . . . . 0.0 110.622 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 m -81.32 62.39 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.75 0.786 . . . . 0.0 110.329 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.13 -43.11 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.082 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.87 129.08 11.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.001 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.7 mtp -76.62 73.42 3.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 0.0 110.828 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.599 ' O ' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -115.42 1.5 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -77.04 125.91 30.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.808 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.0 mt -93.18 -175.3 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.413 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.87 99.49 6.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.429 0.633 . . . . 0.0 110.893 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -134.37 104.5 6.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.35 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.72 108.37 5.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.0 98.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -65.61 138.27 57.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 69.54 70.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.471 179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 44.1 t-80 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.909 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.02 -9.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.739 2.292 . . . . 0.0 112.688 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 140.79 35.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -100.91 142.77 31.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 111.478 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -141.98 93.17 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.296 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -75.48 143.59 42.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.307 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.562 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.804 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' HD21 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.719 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.51 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.561 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.804 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.548 ' HB3' HG22 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.79 110.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 98' ' ' ARG . 42.6 ttp-105 68.73 164.0 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.663 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -55.61 131.38 46.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.039 0.536 . . . . 0.0 111.997 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.9 m -125.14 141.53 52.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.2 90.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.439 0.638 . . . . 0.0 111.407 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -151.64 21.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.292 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.55 115.65 47.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.268 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.95 143.58 10.5 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.2 m -77.49 118.69 24.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -65.65 111.13 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.591 0.71 . . . . 0.0 111.693 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 m -141.16 154.58 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.717 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.03 147.15 28.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -79.82 90.35 5.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.123 0.487 . . . . 0.0 110.099 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.66 112.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.47 175.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -179.42 135.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.559 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 -1.51 58.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 73.11 103.87 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.662 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -142.74 125.77 16.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.93 92.92 4.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.273 0.559 . . . . 0.0 110.514 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -104.04 130.95 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.931 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -136.0 113.38 10.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.752 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -118.75 138.48 52.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.476 177.229 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.72 -53.59 4.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.753 2.302 . . . . 0.0 111.795 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -98.73 -166.35 1.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -99.28 128.33 45.39 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.378 0.609 . . . . 0.0 111.536 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 17.9 t70 -101.22 74.7 1.59 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 38.5 m170 72.07 178.08 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.925 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD13 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.471 HD11 HG13 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG23 ' HG3' ' A' ' 99' ' ' GLN . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.628 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG13 HD11 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.532 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.608 HH21 HD13 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.539 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.555 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.422 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.696 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.558 HG21 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.555 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.638 HG21 ' CE1' ' A' ' 116' ' ' HIS . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' CG ' HG13 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' HG21 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.86 91.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 21.6 tpp180 56.26 125.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.479 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.736 ' HG3' HG23 ' A' ' 28' ' ' VAL . 4.3 mm-40 -120.88 -80.06 0.62 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.81 -1.541 . . . . 0.0 107.874 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 9.4 t 171.23 76.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.017 0.823 . . . . 0.0 111.285 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.1 t -83.44 74.36 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 122.0 0.905 . . . . 0.0 108.783 169.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 p -112.84 6.91 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.954 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.76 132.61 21.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.01 131.71 26.13 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.351 2.034 . . . . 0.0 111.509 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.61 141.38 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.3 t -108.19 107.54 18.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.995 0.902 . . . . 0.0 109.496 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.9 96.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.448 -172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.41 136.27 41.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.363 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -82.18 97.96 8.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.13 0.49 . . . . 0.0 110.945 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 11.1 pt -77.13 106.26 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.757 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -78.51 88.59 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.839 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.23 107.25 18.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.437 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.867 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.67 120.29 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 111.511 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -105.6 93.71 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.638 ' CE1' HG21 ' A' ' 85' ' ' THR . 1.4 t60 -73.13 155.37 39.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.704 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.512 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 6.1 t-80 75.4 102.6 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.751 0.657 . . . . 0.0 110.696 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -102.97 -18.37 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 110.459 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.941 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.781 0.324 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.57 135.04 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.163 2.575 . . . . 0.0 111.502 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -72.49 176.42 5.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -80.73 130.79 35.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.468 0.652 . . . . 0.0 111.542 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 31.0 t70 -117.42 87.61 2.74 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 5' ' ' ASP . 2.0 p-80 65.71 157.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 125.016 1.448 . . . . 0.0 110.112 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.648 ' HB2' HG12 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 HG12 HD22 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' HD23 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.412 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.525 ' HB3' HG21 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.16 140.13 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 98' ' ' ARG . 41.8 ttp180 -78.07 139.79 39.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.831 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -72.77 -46.58 52.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 p -89.77 79.27 6.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.924 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' SER . 43.0 t -64.21 -68.85 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.209 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 9.1 t 171.0 177.7 0.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.105 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.19 97.21 12.91 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.12 -165.66 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.061 2.508 . . . . 0.0 113.458 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 HG21 ' CG ' ' A' ' 113' ' ' GLU . 21.6 t 69.05 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.548 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -65.11 -53.9 38.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.239 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.25 127.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.914 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.24 107.75 18.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.331 0.586 . . . . 0.0 110.327 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 38.6 ttm -170.48 -71.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.428 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -88.14 -21.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.492 173.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -114.52 127.48 55.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.198 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.0 97.89 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.449 ' CG ' HG21 ' A' ' 105' ' ' VAL . 6.2 tp10 -98.56 157.67 16.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.553 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -105.5 117.63 34.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.223 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.62 98.91 4.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -84.6 124.43 31.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.08 0.467 . . . . 0.0 110.411 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -165.78 108.69 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.76 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 23.5 p-80 -115.57 132.38 56.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.506 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 15.5 t-80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.676 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.852 0.358 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.83 139.35 39.74 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.553 2.168 . . . . 0.0 112.801 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.5 p 54.89 101.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 113.286 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -136.39 151.68 49.81 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.477 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 t0 64.26 90.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.471 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 -161.5 110.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 -50.1 125.3 11.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.02 138.54 58.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.387 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -56.82 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -166.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' H ' ' HG2' ' A' ' 99' ' ' GLN . 3.6 m -147.63 9.54 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.764 0.792 . . . . 0.0 110.106 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.5 t -133.55 118.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.528 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -79.92 -168.85 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.319 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 m -59.56 130.92 88.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.44 . . . . 0.0 111.051 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.12 25.61 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.109 2.539 . . . . 0.0 112.855 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.51 100.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.944 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -83.65 133.57 34.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.606 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.84 137.13 21.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.721 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 71.7 -76.44 0.06 Allowed 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.954 0.784 . . . . 0.0 111.663 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.4 ttp -134.35 130.57 37.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.769 0.319 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.3 tp -60.03 132.08 25.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 17.5 t-20 -80.98 132.02 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.945 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' OD1' ' A' ' 111' ' ' ASN . 94.5 mt 63.99 -164.37 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.671 0.607 . . . . 0.0 110.812 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.18 127.08 52.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -115.13 108.94 17.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -86.1 93.71 9.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.198 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -137.16 94.87 3.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.633 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -128.51 140.99 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -142.39 115.34 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.906 0.384 . . . . 0.0 110.625 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.641 172.095 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.41 0.148 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.69 114.96 2.15 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.592 2.195 . . . . 0.0 110.938 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 140.82 29.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -99.4 134.35 42.39 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.11 84.56 0.06 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.708 0.63 . . . . 0.0 110.835 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 74.1 145.09 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.627 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.694 HD13 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' NE2' HG23 ' A' ' 27' ' ' ILE . 10.9 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 31' ' ' THR . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.694 HG23 HD13 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.622 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.504 HG12 HD22 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.59 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HG3' HG11 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.559 ' HG2' HG23 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.605 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG23 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.59 93.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HG3' ' H ' ' A' ' 99' ' ' GLN . 3.0 tpp180 -163.18 178.03 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 98' ' ' ARG . 44.2 tt0 -143.7 120.6 11.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -108.09 -167.29 1.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.083 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.55 94.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 0.0 109.954 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -76.51 111.85 12.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 58.3 t -97.64 115.46 65.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.374 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 12.2 Cg_exo -70.62 104.3 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.893 2.395 . . . . 0.0 111.782 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.59 113.37 44.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.354 0.597 . . . . 0.0 110.078 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -163.61 147.81 10.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.198 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.5 m -135.47 144.3 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.037 174.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.3 115.41 27.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.685 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.9 mtt -99.75 104.23 15.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.184 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.7 tt -122.43 131.18 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.236 0.541 . . . . 0.0 110.44 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.62 132.75 13.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.311 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.3 -2.11 19.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' A' ' 114' ' ' HIS . 17.1 mm-40 54.58 -156.97 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 111.908 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.434 ' H ' ' HB3' ' A' ' 113' ' ' GLU . 52.3 m170 -103.82 135.62 45.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -67.64 150.33 48.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 74.68 6.11 4.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.933 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -116.94 96.11 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.863 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -166.38 141.98 4.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.107 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.818 175.203 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.757 ' H2 ' ' HD2' ' A' ' 2' ' ' PRO . 1.3 mpt? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.757 ' HD2' ' H2 ' ' A' ' 1' ' ' MET . 9.9 Cg_endo -53.77 -68.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.205 1.937 . . . . 0.0 113.308 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 p 54.13 117.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.317 1.047 . . . . 0.0 113.188 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.16 124.05 17.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.587 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.36 55.65 3.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.576 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -141.31 123.14 15.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.86 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 10.9 m120 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.706 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.663 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.596 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.827 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.99 36.14 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 96' ' ' GLU . 41.5 ttp180 -142.11 142.67 32.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.968 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -97.52 132.26 43.37 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.414 HG23 HG12 ' A' ' 101' ' ' VAL . 13.0 m -102.49 -74.46 0.63 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.245 0.545 . . . . 0.0 110.074 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 HG23 ' A' ' 100' ' ' THR . 13.8 p 172.69 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.948 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -135.95 115.53 12.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.47 105.45 36.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.451 0.643 . . . . 0.0 111.279 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -93.37 104.82 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.416 2.744 . . . . 0.0 112.037 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.0 119.06 50.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.323 0.582 . . . . 0.0 110.018 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 46.5 m -85.71 106.1 16.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 0.0 110.804 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.85 140.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.689 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -86.85 124.72 33.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 0.0 110.727 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttt -105.1 116.35 31.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.014 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.2 pt -85.8 171.5 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.14 100.85 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.5 OUTLIER -102.22 -59.34 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 112' ' ' LEU . 44.2 tt0 70.84 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.674 0.75 . . . . 0.0 112.722 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -127.64 96.55 4.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.318 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -97.25 86.12 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.871 0.843 . . . . 0.0 110.36 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -84.84 -72.45 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.961 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -151.42 148.91 28.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -162.14 117.11 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.559 175.299 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.915 0.388 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.997 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.896 ' HB2' HG13 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HG ' ' OG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.447 ' OG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.896 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.997 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 82' ' ' LEU . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' HD21 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.794 ' HB2' HG13 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 23' ' ' GLU . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.978 HG13 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.978 ' HD3' HG13 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 40' ' ' GLY . 40.4 m80 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.98 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.02 HG13 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' VAL . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.98 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 15' ' ' GLU . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.717 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 HD21 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 38' ' ' LEU . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 1.02 ' HD3' HG13 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.627 ' HB3' HG22 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.664 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.388 0.613 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.806 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 84' ' ' VAL . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.579 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.645 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 38' ' ' LEU . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.544 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.829 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.829 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.64 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.502 HD22 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.478 ' HB3' HG22 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.694 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.503 0.668 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' GLU . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.592 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 11.3 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.634 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.567 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.992 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.992 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.709 ' HB3' HG21 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 16' ' ' LEU . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 94' ' ' GLN . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.414 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.67 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.466 HG12 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.728 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.66 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.542 ' HB3' HG22 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HB3' ' H ' ' A' ' 29' ' ' GLU . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.881 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.881 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.886 HD13 HG11 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 89' ' ' ARG . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.666 ' HB3' HG22 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.886 HG11 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 9' ' ' LEU . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.8 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.916 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.965 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.569 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.965 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.657 ' HD2' HD22 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.657 HD22 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.673 ' HG3' HG12 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 3.3 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.766 HG13 HD12 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.912 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.753 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.766 HD12 HG13 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.619 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 55' ' ' TYR . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.563 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.568 ' HB3' HG12 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.596 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.464 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' LEU . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.86 HG11 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.686 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HD3' HG11 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.549 ' HB3' HG22 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HD2' ' H ' ' A' ' 22' ' ' GLU . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' ' HD2' ' A' ' 20' ' ' TYR . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 22' ' ' GLU . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 89' ' ' ARG . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.52 ' HB3' HG22 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 6.8 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.72 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.644 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.573 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG21 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.72 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG2' HG22 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.57 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.83 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.63 HD11 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.65 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.65 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 32' ' ' GLU . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.63 HH21 HD11 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.574 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 91.7 m-70 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' CG ' HG12 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 121.428 0.633 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 82' ' ' LEU . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.498 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.457 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 76' ' ' ARG . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB3' HG22 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.47 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.595 0.236 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 14' ' ' LEU . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 11' ' ' LEU . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.72 HD11 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.604 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.438 HG23 HD22 ' A' ' 16' ' ' LEU . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.625 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.674 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.635 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.69 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.672 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.26 158.17 26.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.64 2.227 . . . . 0.0 111.538 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m -143.63 144.25 31.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 110.779 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -131.9 141.2 49.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.734 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.46 69.47 0.75 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.173 0.511 . . . . 0.0 109.869 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 62.97 -164.75 0.25 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.272 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.997 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.896 ' HB2' HG13 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HG ' ' OG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.447 ' OG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.896 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.997 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 82' ' ' LEU . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' HD21 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.06 129.38 2.19 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.601 ' HA ' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -52.74 148.2 7.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -163.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 100' ' ' THR . 63.7 tt0 -129.84 -81.49 0.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 99' ' ' GLN . 0.6 OUTLIER -171.47 93.46 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.313 0.645 . . . . 0.0 110.269 176.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.68 146.26 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 0.0 111.003 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 59.3 p -119.4 147.29 44.53 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.67 109.89 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.493 0.663 . . . . 0.0 111.846 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 102' ' ' SER . 37.8 Cg_endo -95.97 63.25 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.608 2.872 . . . . 0.0 111.184 175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -88.49 116.02 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.575 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -103.27 104.34 14.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.298 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.86 -60.8 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 68.79 146.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.007 0.817 . . . . 0.0 111.311 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.3 ttm -135.47 138.79 43.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.444 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 pt -97.43 166.24 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -133.36 133.33 42.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.912 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 tp -89.57 94.63 9.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 111.275 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 142.09 29.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.281 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -176.5 -32.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.602 0.564 . . . . 0.0 110.102 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -59.78 109.87 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.762 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -86.54 77.3 9.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 179.39 71.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.764 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -85.05 -25.3 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.993 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--O 1.243 0.739 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.549 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.7 ptt? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 8.4 Cg_exo -71.03 91.18 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.768 2.312 . . . . 0.0 112.435 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -95.11 103.26 15.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 110.873 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.17 177.54 4.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.952 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -88.8 50.97 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.607 0.718 . . . . 0.0 109.673 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.37 146.35 24.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.757 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.794 ' HB2' HG13 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 23' ' ' GLU . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.978 HG13 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.978 ' HD3' HG13 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.85 77.35 0.21 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 100' ' ' THR . 37.1 ttp-105 39.78 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.86 ' HG3' ' H ' ' A' ' 101' ' ' VAL . 6.3 tp60 48.17 -65.44 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.143 -2.299 . . . . 0.0 115.847 173.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 98' ' ' ARG . 12.6 m 84.4 -2.63 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.036 0.934 . . . . 0.0 111.219 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.86 ' H ' ' HG3' ' A' ' 99' ' ' GLN . 61.0 t -123.75 116.48 48.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.635 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.0 m -77.8 85.45 4.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.271 0.558 . . . . 0.0 110.48 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.27 124.68 48.32 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.908 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.46 145.42 26.61 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.632 2.221 . . . . 0.0 112.068 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.07 154.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.842 0.354 . . . . 0.0 110.632 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -142.24 143.89 33.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.94 138.77 51.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.563 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.73 86.77 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.3 ttp -79.59 105.33 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.215 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.6 tt -108.83 98.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.621 0.724 . . . . 0.0 111.835 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -102.94 90.62 3.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.03 79.92 1.56 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.666 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 115' ' ' HIS . 33.7 mt-10 -112.89 -47.68 3.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.099 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 71.78 -27.77 0.18 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.361 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 113' ' ' GLU . 48.7 t60 -74.63 78.22 2.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -163.78 108.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.288 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -123.43 137.02 54.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.136 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -121.08 143.07 49.27 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.925 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.32 124.46 12.55 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.731 2.288 . . . . 0.0 113.426 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 p -84.11 101.86 12.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.397 0.618 . . . . 0.0 109.405 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -83.03 -178.72 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.842 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 37.0 t70 -151.5 106.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 40.4 m80 75.88 -172.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.583 1.177 . . . . 0.0 109.515 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.98 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.02 HG13 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' VAL . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.98 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 15' ' ' GLU . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.717 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 HD21 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 38' ' ' LEU . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 1.02 ' HD3' HG13 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.627 ' HB3' HG22 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.664 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 -71.06 131.22 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 28.3 ttm180 75.99 137.61 0.06 Allowed 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 124.182 0.926 . . . . 0.0 110.611 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -90.91 116.36 28.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.798 -168.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 m -92.54 -22.61 19.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.853 0.835 . . . . 0.0 110.383 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 162.25 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.03 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -128.65 117.81 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.74 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 51.3 t -93.53 115.38 64.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.908 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 6.1 Cg_exo -78.64 104.52 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.939 2.426 . . . . 0.0 111.111 174.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 m -71.1 123.39 25.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.254 0.55 . . . . 0.0 111.017 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.2 m -157.67 134.96 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.182 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.01 119.77 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.189 0.518 . . . . 0.0 110.059 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.35 135.47 33.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.96 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.9 ttm -75.75 -59.93 2.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.815 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG22 ' HG ' ' A' ' 112' ' ' LEU . 44.3 mt 57.13 73.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.12 82.25 6.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.665 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.501 ' HG ' HG22 ' A' ' 110' ' ' ILE . 94.9 mt -85.31 84.03 7.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.235 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.94 89.85 1.11 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.761 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -98.56 92.65 5.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.356 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -95.67 106.59 18.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.92 137.05 41.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.656 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -106.05 178.22 4.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -120.31 93.88 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 110.378 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.0 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 177.636 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 75.5 mtm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.691 0.281 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 97.5 Cg_endo -95.68 -5.72 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.234 2.623 . . . . 0.0 113.746 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.92 16.03 2.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 112.316 -171.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -74.59 143.12 44.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.918 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -132.46 92.41 3.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.83 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 71.59 -173.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.806 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 84' ' ' VAL . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.579 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.645 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 38' ' ' LEU . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.544 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 67.72 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 98' ' ' ARG . 1.4 tpp85 -151.62 170.86 18.65 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -103.31 154.24 19.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 120.297 0.094 . . . . 0.0 111.167 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.8 m 72.31 119.05 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 98.8 t -63.15 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.987 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 p -119.87 96.77 5.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.474 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.31 123.78 47.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.758 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.82 172.12 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.69 2.26 . . . . 0.0 111.858 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.18 104.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.4 p -72.59 141.61 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.301 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 109' ' ' MET . 12.4 p -128.9 137.52 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.646 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 -69.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 107' ' ' VAL . 84.5 mtp 65.08 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 125.7 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.363 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.5 127.84 34.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.226 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.44 120.31 7.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -162.49 101.24 1.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.497 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -117.65 84.39 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -112.65 29.41 7.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.909 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -71.25 110.04 5.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.92 0.39 . . . . 0.0 110.35 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -131.58 115.89 16.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -98.95 170.71 8.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.68 178.731 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.8 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.437 0.16 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 25.2 Cg_endo -89.95 35.59 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.441 2.761 . . . . 0.0 112.238 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 4' ' ' PHE . 12.7 m -151.3 169.72 21.28 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' N ' HG22 ' A' ' 3' ' ' THR . 89.1 m-85 -48.49 134.19 15.64 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.183 0.302 . . . . 0.0 110.545 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.626 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 7.8 p-10 -80.76 36.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.704 0.764 . . . . 0.0 111.565 -173.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -102.82 107.47 18.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.931 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.829 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.829 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.613 ' CG ' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.64 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.502 HD22 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.478 ' HB3' HG22 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.694 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.64 62.13 5.35 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 64.9 151.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.954 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.76 130.74 47.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.206 174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 95.5 m -65.76 106.64 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.012 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 103' ' ' VAL . 10.4 p -108.87 134.67 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.078 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 m -96.27 8.9 42.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 110.903 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.8 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.5 t -117.24 125.93 27.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 60.48 2.68 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.992 2.461 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 103' ' ' VAL . 20.1 m -91.82 -23.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.181 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 108' ' ' GLU . 32.5 m -98.36 111.77 24.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.941 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.98 -36.4 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.404 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 106' ' ' THR . 42.4 mt-10 66.58 108.69 0.04 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.91 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.29 99.4 9.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.79 160.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.971 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.33 118.65 22.81 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.43 65.87 3.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.687 -171.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -89.33 -49.57 6.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -87.57 122.57 31.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -113.43 128.8 56.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.29 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -82.4 118.74 23.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.983 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -74.3 168.25 20.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.551 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -115.85 -81.48 0.61 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.643 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.47 60.91 4.23 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.068 2.512 . . . . 0.0 113.542 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.8 p 52.08 -164.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.716 0.806 . . . . 0.0 112.598 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.811 ' HB3' ' HG2' ' A' ' 42' ' ' ARG . 49.8 t80 -159.9 148.94 17.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.55 84.72 4.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.512 0.672 . . . . 0.0 110.598 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 75.73 152.56 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.707 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' GLU . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.592 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.721 ' HB2' ' HG2' ' A' ' 109' ' ' MET . 20.6 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.634 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.567 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.992 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.992 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.709 ' HB3' HG21 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 41.3 tt0 -55.03 132.34 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 42.8 ttp180 75.05 140.8 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 124.273 0.983 . . . . 0.0 111.489 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -111.13 156.78 20.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.124 -168.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 t -158.21 93.63 1.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.337 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.661 HG13 HG22 ' A' ' 103' ' ' VAL . 95.8 t -132.53 105.75 9.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.584 -173.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -119.01 19.56 12.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.82 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.661 HG22 HG13 ' A' ' 101' ' ' VAL . 27.1 m -79.49 145.99 64.73 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.562 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.08 167.7 12.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.611 2.207 . . . . 0.0 112.126 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 106' ' ' THR . 35.2 t -103.92 143.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 105' ' ' VAL . 93.6 m 79.81 125.31 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.737 0.648 . . . . 0.0 111.141 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.05 -14.44 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.818 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 75.04 91.16 0.08 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.192 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.721 ' HG2' ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -90.94 -175.91 4.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.38 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.75 134.89 25.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.377 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.38 129.47 55.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.1 tp -150.52 119.74 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.183 0.516 . . . . 0.0 112.019 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.57 97.23 4.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -132.5 60.38 1.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 0.0 110.868 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -105.96 154.72 20.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.336 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -132.6 120.93 22.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -68.54 108.0 3.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.783 0.325 . . . . 0.0 110.389 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.52 151.9 48.91 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.043 -177.741 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.6 ttt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.6 Cg_exo -69.21 -173.1 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.127 2.551 . . . . 0.0 112.239 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -76.59 -167.56 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.127 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -61.22 145.76 50.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.209 0.528 . . . . 0.0 111.455 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.64 101.08 3.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.441 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.4 111.99 1.78 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.339 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 16' ' ' LEU . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 100' ' ' THR . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 94' ' ' GLN . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.414 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.67 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG12 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.728 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.66 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.542 ' HB3' HG22 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HB3' ' H ' ' A' ' 29' ' ' GLU . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.08 43.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 96' ' ' GLU . 18.4 tpp180 -138.44 136.91 36.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -78.77 131.67 36.63 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 7.9 m -127.2 8.54 6.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.367 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t 77.48 -43.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.182 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 31.8 t 72.65 143.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.075 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.93 92.34 1.37 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.753 0.787 . . . . 0.0 109.904 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.82 15.63 1.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.022 2.481 . . . . 0.0 113.478 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.6 132.41 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 m -152.09 42.11 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.48 0.657 . . . . 0.0 109.338 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 4.1 p -51.58 100.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.575 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 8.0 mm-40 162.31 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.514 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ptm -78.52 113.15 16.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.762 0.792 . . . . 0.0 110.524 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.63 -27.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.605 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.91 110.49 7.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.63 168.27 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.977 0.418 . . . . 0.0 111.071 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.77 140.74 33.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.929 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -114.86 82.72 1.78 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.151 0.976 . . . . 0.0 109.199 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -143.42 91.89 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.561 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -94.58 144.9 25.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -139.77 129.12 24.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.687 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -71.99 149.62 44.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.078 175.684 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.884 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.884 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 5.4 Cg_exo -78.81 123.01 5.62 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.219 1.946 . . . . 0.0 112.101 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m -128.83 144.66 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.146 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -120.27 169.87 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.361 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 11.8 m-20 -78.79 34.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.584 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -117.09 107.74 14.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.881 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.881 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.886 HD13 HG11 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 89' ' ' ARG . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.666 ' HB3' HG22 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.886 HG11 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 -72.74 81.85 1.15 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.14 141.59 50.67 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.461 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -86.32 94.83 9.45 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.112 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.1 m -119.62 103.4 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 86.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.698 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 m -82.19 -173.97 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.195 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.5 150.88 37.15 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.809 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 159.54 52.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.575 2.184 . . . . 0.0 111.545 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 19' ' ' LEU . 26.9 m -115.94 147.3 19.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 111.971 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 m -135.57 94.78 3.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.214 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.55 138.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 159.05 17.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.106 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.5 mtp -111.43 149.74 30.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.42 164.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.53 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -154.64 128.72 8.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.978 0.418 . . . . 0.0 111.373 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.4 tp -158.69 87.38 0.88 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.947 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -90.11 -43.35 10.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.876 -173.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -90.49 99.67 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.701 0.762 . . . . 0.0 111.048 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 116' ' ' HIS . 3.6 p80 -156.57 150.86 25.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.671 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 15.9 m-70 73.83 140.96 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.836 0.71 . . . . 0.0 109.626 -166.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -148.28 154.19 39.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.3 168.47 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.919 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.247 0.924 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.667 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.97 120.19 7.11 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.666 2.244 . . . . 0.0 112.292 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -99.61 11.96 37.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.611 1.196 . . . . 0.0 109.207 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -83.32 -166.12 1.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.543 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 63.66 46.98 3.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.619 0.723 . . . . 0.0 110.333 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.44 101.01 5.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 9' ' ' LEU . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.8 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.916 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 -74.87 81.33 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -136.07 157.26 47.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.958 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -101.28 85.47 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' HG22 ' A' ' 101' ' ' VAL . 5.2 m -97.58 -63.61 1.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 100' ' ' THR . 3.2 m 59.1 -20.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.046 1.739 . . . . 0.0 114.621 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 100' ' ' THR . 23.1 t -118.36 101.95 8.57 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.36 94.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.556 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.89 139.15 39.07 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.711 2.274 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 p -140.87 114.16 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.333 0.587 . . . . 0.0 111.715 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.663 HG23 ' H ' ' A' ' 108' ' ' GLU . 15.0 t -178.31 177.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.449 174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 107' ' ' VAL . 10.8 p -92.18 28.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 122.158 0.98 . . . . 0.0 109.783 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.663 ' H ' HG23 ' A' ' 106' ' ' THR . 9.8 tp10 -137.24 131.58 32.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.403 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 57.2 ttp -122.03 94.49 4.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 108' ' ' GLU . 9.1 tp -152.81 135.52 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -141.61 87.11 2.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 tp -89.6 117.22 28.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.578 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 14.5 pt-20 -72.45 99.97 2.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.192 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -140.59 32.99 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.961 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -63.78 117.7 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.33 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -125.05 137.17 54.22 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.64 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -83.44 107.83 16.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.636 0.731 . . . . 0.0 110.566 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -90.36 136.38 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.781 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.068 179.083 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.9 mtt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 4.8 Cg_exo -78.98 10.86 2.77 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.479 2.786 . . . . 0.0 112.402 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.6 p -79.23 158.82 27.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.41 141.63 58.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.938 0.399 . . . . 0.0 110.489 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -140.47 98.29 3.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 75.7 141.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.0 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.965 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 98' ' ' ARG . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.569 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.965 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.657 ' HD2' HD22 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.657 HD22 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.673 ' HG3' HG12 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 3.3 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 134.14 56.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 8.9 ptp180 -71.49 179.08 3.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -57.16 -47.65 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.895 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.8 t -165.41 108.05 0.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.562 0.696 . . . . 0.0 111.688 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.19 97.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.76 . . . . 0.0 110.495 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -113.73 16.44 18.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.276 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 p -112.13 111.42 53.15 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.88 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.54 131.39 29.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.77 2.313 . . . . 0.0 111.475 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -99.15 105.14 16.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.898 0.38 . . . . 0.0 111.028 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.0 m -91.21 108.37 19.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.752 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.17 144.14 12.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.445 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.76 34.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttt -76.71 134.09 39.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.9 77.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.543 0.687 . . . . 0.0 111.043 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.72 2.74 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.635 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 113' ' ' GLU . 6.4 tt -144.71 108.39 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.135 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 9.3 tp10 -76.13 160.94 29.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.494 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 113' ' ' GLU . 30.0 m80 75.39 26.82 1.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.795 0.685 . . . . 0.0 110.552 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -78.07 -25.21 47.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.197 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.16 134.38 42.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.574 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -146.9 -55.61 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.584 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -168.77 -175.83 2.53 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.567 177.209 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.1 mtt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.617 0.246 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -75.93 179.23 6.49 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.66 2.24 . . . . 0.0 111.357 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -90.16 11.32 21.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.718 1.247 . . . . 0.0 109.66 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -92.38 -164.31 1.16 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.695 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.4 t70 65.76 55.38 0.98 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -57.45 112.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.177 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.766 HG13 HD12 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.912 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.753 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.766 HD12 HG13 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.619 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.16 78.74 2.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.96 153.79 32.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.724 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 88.86 5.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.236 0.541 . . . . 0.0 109.992 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -107.44 142.97 36.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.923 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 m -52.32 115.86 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.623 0.725 . . . . 0.0 111.507 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -86.28 82.32 8.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 26.7 m -103.58 144.87 29.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.445 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 17.2 Cg_exo -67.29 97.75 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.723 2.282 . . . . 0.0 112.427 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.32 88.04 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -92.34 -17.67 24.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.808 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.5 109.07 16.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -93.1 123.44 36.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.154 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.43 149.64 44.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.2 tt -130.39 92.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.72 0.771 . . . . 0.0 110.179 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.39 143.85 45.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.12 4.27 3.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.84 4.72 52.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.361 0.601 . . . . 0.0 110.177 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -66.31 90.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.231 0.539 . . . . 0.0 109.7 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -120.71 137.74 54.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.839 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.83 116.56 29.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.947 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -150.28 130.49 13.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -158.21 148.39 20.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.962 0.41 . . . . 0.0 110.983 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.2 p80 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.38 114.02 2.18 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.472 2.115 . . . . 0.0 111.132 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.584 HG21 ' HA3' ' A' ' 43' ' ' GLY . 25.5 p -68.27 135.51 52.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.45 0.643 . . . . 0.0 111.69 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.88 -165.06 1.25 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.227 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.86 101.51 0.04 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.848 0.717 . . . . 0.0 111.127 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 -77.45 99.47 5.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.209 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 55' ' ' TYR . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 102' ' ' SER . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' HG21 ' A' ' 3' ' ' THR . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.563 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.568 ' HB3' HG12 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.596 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 24.9 tt0 -58.33 130.8 48.41 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 23.3 ttp85 83.24 140.35 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.602 1.189 . . . . 0.0 111.955 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.09 119.81 17.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.052 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.6 m -138.08 96.0 3.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.067 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.85 118.18 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.247 0.546 . . . . 0.0 110.469 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 18.3 m -96.07 137.75 34.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.0 p -113.27 110.11 51.05 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 6.0 Cg_exo -79.62 98.25 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.935 2.424 . . . . 0.0 111.119 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.54 -36.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 m 67.01 109.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.825 0.703 . . . . 0.0 111.352 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.59 133.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.808 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.95 124.3 27.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.833 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -103.71 143.36 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.949 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.99 -172.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -136.85 152.15 49.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.47 157.09 47.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.08 139.21 53.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -103.61 130.55 51.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.825 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -96.66 139.58 32.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -105.54 121.35 43.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.207 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -99.49 140.65 33.36 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.215 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -92.16 173.49 7.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.8 t60 . . . . . 0 C--O 1.245 0.849 0 CA-C-O 117.951 -1.023 . . . . 0.0 108.822 175.098 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.071 0.462 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -91.49 28.23 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.285 2.657 . . . . 0.0 110.823 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 p -71.23 117.75 13.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.203 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -66.04 126.33 28.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.76 98.23 3.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.16 0.505 . . . . 0.0 110.019 -170.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -86.29 157.77 19.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.464 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' LEU . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.86 HG11 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.686 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HD3' HG11 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.549 ' HB3' HG22 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.22 121.98 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 69.38 145.18 0.05 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.366 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -51.99 127.75 22.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.254 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.5 p -91.93 -166.25 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.398 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.81 130.5 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.913 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 m -83.29 83.58 7.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.034 0.445 . . . . 0.0 110.88 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 p -117.31 106.3 47.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.524 0.678 . . . . 0.0 110.823 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 1.7 Cg_endo -82.31 96.64 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.142 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 107' ' ' VAL . 4.9 p -133.9 114.33 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -100.32 90.79 4.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 0.0 110.337 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 105' ' ' VAL . 4.8 m -92.55 90.43 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.143 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.66 93.66 4.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -162.61 85.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.426 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.85 105.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.605 0.717 . . . . 0.0 110.817 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -131.37 109.4 10.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -101.74 148.47 25.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.274 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -112.2 141.63 45.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.1 75.59 0.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 110.304 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -116.44 113.96 23.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.048 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -154.12 132.17 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.212 0.529 . . . . 0.0 111.937 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -176.69 114.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.227 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -142.66 90.13 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.348 0.594 . . . . 0.0 110.975 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t60 . . . . . 0 C--O 1.242 0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.844 177.742 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.35 116.31 3.16 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.431 2.088 . . . . 0.0 111.178 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -131.65 151.49 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -89.59 138.56 31.36 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.75 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 12.1 t70 -100.37 72.23 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -131.23 126.99 36.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.317 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HD2' ' H ' ' A' ' 22' ' ' GLU . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' ' HD2' ' A' ' 20' ' ' TYR . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' HG2' HG13 ' A' ' 105' ' ' VAL . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 22' ' ' GLU . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 89' ' ' ARG . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.52 ' HB3' HG22 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 6.8 pt-20 -79.08 74.2 5.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -94.32 176.13 6.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.956 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -76.78 0.19 21.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.207 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 p -108.63 96.92 6.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.48 15.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 6.0 p -95.85 37.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.962 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -93.83 108.0 31.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.552 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 102' ' ' SER . 73.1 Cg_endo -93.36 133.49 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.034 2.489 . . . . 0.0 112.628 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 23' ' ' GLU . 28.8 m -82.22 -18.91 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.143 0.497 . . . . 0.0 110.622 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 m -81.32 62.39 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.75 0.786 . . . . 0.0 110.329 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.13 -43.11 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.082 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.87 129.08 11.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.001 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.7 mtp -76.62 73.42 3.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 0.0 110.828 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -115.42 1.5 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.057 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -77.04 125.91 30.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.808 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.0 mt -93.18 -175.3 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.413 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.87 99.49 6.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.429 0.633 . . . . 0.0 110.893 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -134.37 104.5 6.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.35 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.72 108.37 5.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.0 98.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -65.61 138.27 57.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 69.54 70.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.471 179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 83.4 t60 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.909 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.02 -9.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.739 2.292 . . . . 0.0 112.688 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 140.79 35.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -100.91 142.77 31.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 111.478 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -141.98 93.17 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.296 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -75.48 143.59 42.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.307 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.72 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.644 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.573 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG21 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.72 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG2' HG22 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.57 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.83 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.79 110.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 98' ' ' ARG . 42.6 ttp-105 68.73 164.0 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.663 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . 87.2 mm-40 -55.61 131.38 46.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.039 0.536 . . . . 0.0 111.997 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.9 m -125.14 141.53 52.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.2 90.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.439 0.638 . . . . 0.0 111.407 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -151.64 21.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.292 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.55 115.65 47.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.268 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.95 143.58 10.5 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.2 m -77.49 118.69 24.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -65.65 111.13 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.591 0.71 . . . . 0.0 111.693 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 m -141.16 154.58 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.717 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.03 147.15 28.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -79.82 90.35 5.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.123 0.487 . . . . 0.0 110.099 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.414 ' C ' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -144.66 112.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.47 175.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -179.42 135.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.559 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 -1.51 58.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 73.11 103.87 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.662 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -142.74 125.77 16.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.93 92.92 4.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.273 0.559 . . . . 0.0 110.514 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.04 130.95 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.931 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -136.0 113.38 10.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.752 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -118.75 138.48 52.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.476 177.229 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.72 -53.59 4.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.753 2.302 . . . . 0.0 111.795 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -98.73 -166.35 1.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -99.28 128.33 45.39 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.378 0.609 . . . . 0.0 111.536 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 17.9 t70 -101.22 74.7 1.59 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 38.5 m170 72.07 178.08 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.925 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.63 HD11 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.65 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG22 ' HG3' ' A' ' 99' ' ' GLN . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.65 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 32' ' ' GLU . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.63 HH21 HD11 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.574 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 91.7 m-70 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.653 HG21 ' CE1' ' A' ' 116' ' ' HIS . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' CG ' HG12 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.86 91.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 21.6 tpp180 56.26 125.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.479 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 28' ' ' VAL . 4.3 mm-40 -120.88 -80.06 0.62 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.81 -1.541 . . . . 0.0 107.874 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 9.4 t 171.23 76.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.017 0.823 . . . . 0.0 111.285 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.1 t -83.44 74.36 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 122.0 0.905 . . . . 0.0 108.783 169.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 p -112.84 6.91 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.954 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.76 132.61 21.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.01 131.71 26.13 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.351 2.034 . . . . 0.0 111.509 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.61 141.38 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.3 t -108.19 107.54 18.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.995 0.902 . . . . 0.0 109.496 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.9 96.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.448 -172.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.41 136.27 41.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.363 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -82.18 97.96 8.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.13 0.49 . . . . 0.0 110.945 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 11.1 pt -77.13 106.26 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.757 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -78.51 88.59 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.839 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.23 107.25 18.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.437 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.867 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.67 120.29 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 111.511 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -105.6 93.71 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.653 ' CE1' HG21 ' A' ' 85' ' ' THR . 1.4 t60 -73.13 155.37 39.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.704 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.525 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 6.1 t-80 75.4 102.6 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.751 0.657 . . . . 0.0 110.696 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -102.97 -18.37 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 110.459 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.941 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.781 0.324 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.57 135.04 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.163 2.575 . . . . 0.0 111.502 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -72.49 176.42 5.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -80.73 130.79 35.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.468 0.652 . . . . 0.0 111.542 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 31.0 t70 -117.42 87.61 2.74 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 5' ' ' ASP . 2.0 p-80 65.71 157.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 125.016 1.448 . . . . 0.0 110.112 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 82' ' ' LEU . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.498 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.457 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 76' ' ' ARG . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB3' HG22 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.16 140.13 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 98' ' ' ARG . 41.8 ttp180 -78.07 139.79 39.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.831 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -72.77 -46.58 52.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 p -89.77 79.27 6.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.924 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' SER . 43.0 t -64.21 -68.85 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.209 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 9.1 t 171.0 177.7 0.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.105 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.19 97.21 12.91 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.12 -165.66 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.061 2.508 . . . . 0.0 113.458 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG22 ' CG ' ' A' ' 113' ' ' GLU . 21.6 t 69.05 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.548 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -65.11 -53.9 38.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.239 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.25 127.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.914 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 108' ' ' GLU . 7.1 pt-20 -87.24 107.75 18.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.331 0.586 . . . . 0.0 110.327 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 38.6 ttm -170.48 -71.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.428 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -88.14 -21.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.492 173.07 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -114.52 127.48 55.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.198 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.0 97.89 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.451 ' CG ' HG22 ' A' ' 105' ' ' VAL . 6.2 tp10 -98.56 157.67 16.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.553 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -105.5 117.63 34.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.223 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.62 98.91 4.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -84.6 124.43 31.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.08 0.467 . . . . 0.0 110.411 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -165.78 108.69 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.76 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 23.5 p-80 -115.57 132.38 56.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.506 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 15.5 t-80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.676 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.852 0.358 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.83 139.35 39.74 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.553 2.168 . . . . 0.0 112.801 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.5 p 54.89 101.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 113.286 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -136.39 151.68 49.81 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.477 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 t0 64.26 90.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.47 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 -161.5 110.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 14' ' ' LEU . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 11' ' ' LEU . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 -50.1 125.3 11.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.02 138.54 58.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.387 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -56.82 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -166.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.434 ' H ' ' HG2' ' A' ' 99' ' ' GLN . 3.6 m -147.63 9.54 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.764 0.792 . . . . 0.0 110.106 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.5 t -133.55 118.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.528 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -79.92 -168.85 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.319 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 105' ' ' VAL . 11.3 m -59.56 130.92 88.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.44 . . . . 0.0 111.051 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.12 25.61 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.109 2.539 . . . . 0.0 112.855 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 103' ' ' VAL . 47.3 t -59.51 100.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.944 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -83.65 133.57 34.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.606 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.84 137.13 21.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.721 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 71.7 -76.44 0.06 Allowed 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.954 0.784 . . . . 0.0 111.663 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.4 ttp -134.35 130.57 37.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.769 0.319 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.3 tp -60.03 132.08 25.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 17.5 t-20 -80.98 132.02 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.945 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.436 ' HG ' ' OD1' ' A' ' 111' ' ' ASN . 94.5 mt 63.99 -164.37 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.671 0.607 . . . . 0.0 110.812 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.18 127.08 52.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -115.13 108.94 17.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -86.1 93.71 9.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.198 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -137.16 94.87 3.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.633 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -128.51 140.99 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -142.39 115.34 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.906 0.384 . . . . 0.0 110.625 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.641 172.095 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.41 0.148 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.69 114.96 2.15 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.592 2.195 . . . . 0.0 110.938 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 140.82 29.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -99.4 134.35 42.39 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.11 84.56 0.06 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.708 0.63 . . . . 0.0 110.835 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 74.1 145.09 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.627 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.72 HD11 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.604 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.438 HG23 HD22 ' A' ' 16' ' ' LEU . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.625 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.674 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.635 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.69 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.59 93.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' HG3' ' H ' ' A' ' 99' ' ' GLN . 3.0 tpp180 -163.18 178.03 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 98' ' ' ARG . 44.2 tt0 -143.7 120.6 11.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -108.09 -167.29 1.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.083 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.55 94.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 0.0 109.954 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -76.51 111.85 12.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 58.3 t -97.64 115.46 65.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.374 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 12.2 Cg_exo -70.62 104.3 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.893 2.395 . . . . 0.0 111.782 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.59 113.37 44.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.354 0.597 . . . . 0.0 110.078 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -163.61 147.81 10.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.198 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.5 m -135.47 144.3 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.037 174.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.3 115.41 27.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.685 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.9 mtt -99.75 104.23 15.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.184 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.7 tt -122.43 131.18 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.236 0.541 . . . . 0.0 110.44 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.62 132.75 13.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.311 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.3 -2.11 19.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HB3' ' H ' ' A' ' 114' ' ' HIS . 17.1 mm-40 54.58 -156.97 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 111.908 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.489 ' H ' ' HB3' ' A' ' 113' ' ' GLU . 52.3 m170 -103.82 135.62 45.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -67.64 150.33 48.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 74.68 6.11 4.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.933 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' HIS . 70.7 t60 -116.94 96.11 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.863 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -166.38 141.98 4.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.107 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.818 175.203 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.621 ' H2 ' ' HD2' ' A' ' 2' ' ' PRO . 1.3 mpt? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' HD2' ' H2 ' ' A' ' 1' ' ' MET . 9.9 Cg_endo -53.77 -68.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.205 1.937 . . . . 0.0 113.308 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 p 54.13 117.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.317 1.047 . . . . 0.0 113.188 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.16 124.05 17.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.587 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.36 55.65 3.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.576 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -141.31 123.14 15.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.86 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.672 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.99 36.14 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLU . 41.5 ttp180 -142.11 142.67 32.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.968 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -97.52 132.26 43.37 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 101' ' ' VAL . 13.0 m -102.49 -74.46 0.63 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.245 0.545 . . . . 0.0 110.074 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 100' ' ' THR . 13.8 p 172.69 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.948 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -135.95 115.53 12.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.47 105.45 36.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.451 0.643 . . . . 0.0 111.279 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -93.37 104.82 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.416 2.744 . . . . 0.0 112.037 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.0 119.06 50.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.323 0.582 . . . . 0.0 110.018 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 46.5 m -85.71 106.1 16.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 0.0 110.804 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.85 140.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.689 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -86.85 124.72 33.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 0.0 110.727 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttt -105.1 116.35 31.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.014 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.2 pt -85.8 171.5 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.14 100.85 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.5 OUTLIER -102.22 -59.34 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' LEU . 44.2 tt0 70.84 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.674 0.75 . . . . 0.0 112.722 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -127.64 96.55 4.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.318 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -97.25 86.12 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.871 0.843 . . . . 0.0 110.36 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -84.84 -72.45 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.961 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -151.42 148.91 28.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -162.14 117.11 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.559 175.299 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.915 0.388 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.997 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.896 ' HB2' HG13 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HG ' ' OG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.447 ' OG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.896 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.997 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 82' ' ' LEU . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' HD21 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.794 ' HB2' HG13 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 23' ' ' GLU . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.978 HG13 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.978 ' HD3' HG13 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 40' ' ' GLY . 40.4 m80 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.98 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.02 HG13 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' VAL . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.98 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 15' ' ' GLU . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.717 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 HD21 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 38' ' ' LEU . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 1.02 ' HD3' HG13 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.627 ' HB3' HG22 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.664 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.388 0.613 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.806 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 84' ' ' VAL . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.579 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.645 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 38' ' ' LEU . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.544 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.829 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.829 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.64 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.502 HD22 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.478 ' HB3' HG22 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.694 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.503 0.668 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' GLU . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.592 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.783 HG21 HE21 ' A' ' 30' ' ' GLN . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.783 HE21 HG21 ' A' ' 27' ' ' ILE . 6.9 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 11.3 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.634 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.992 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.992 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.709 ' HB3' HG21 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 94' ' ' GLN . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.414 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.67 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.597 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.466 HG12 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.66 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.542 ' HB3' HG22 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HB3' ' H ' ' A' ' 29' ' ' GLU . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.881 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.881 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.886 HD13 HG11 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 89' ' ' ARG . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.666 ' HB3' HG22 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.886 HG11 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.422 HD22 ' HG2' ' A' ' 39' ' ' GLU . 8.0 m120 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 9' ' ' LEU . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 27.6 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.916 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.965 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.569 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.965 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.657 ' HD2' HD22 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.657 HD22 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.673 ' HG3' HG12 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 24.4 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' C ' HD22 ' A' ' 8' ' ' ASN . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 HD22 ' C ' ' A' ' 7' ' ' GLY . 0.8 OUTLIER -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.766 HG13 HD12 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.912 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' ND2' ' A' ' 8' ' ' ASN . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.766 HD12 HG13 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.619 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 55' ' ' TYR . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HE21 ' A' ' 30' ' ' GLN . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.402 HE21 HG21 ' A' ' 27' ' ' ILE . 7.6 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.563 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.568 ' HB3' HG12 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.596 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.464 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' LEU . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.86 HG11 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.686 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HD3' HG11 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.549 ' HB3' HG22 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HD2' ' H ' ' A' ' 22' ' ' GLU . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' ' HD2' ' A' ' 20' ' ' TYR . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 22' ' ' GLU . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 89' ' ' ARG . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.52 ' HB3' HG22 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 6.8 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.72 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.644 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.573 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG21 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.72 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG2' HG22 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.57 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.83 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.63 HD11 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.65 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.65 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 32' ' ' GLU . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.63 HH21 HD11 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.574 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 66.3 m80 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' CG ' HG12 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 121.428 0.633 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 82' ' ' LEU . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.498 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.457 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 76' ' ' ARG . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB3' HG22 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.47 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.595 0.236 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 14' ' ' LEU . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 11' ' ' LEU . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.72 HD11 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.604 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' NE2' HG21 ' A' ' 27' ' ' ILE . 10.9 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.438 HG23 HD22 ' A' ' 16' ' ' LEU . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.625 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.674 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.635 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.69 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 10.9 m120 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.672 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.26 158.17 26.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.64 2.227 . . . . 0.0 111.538 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m -143.63 144.25 31.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 110.779 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -131.9 141.2 49.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.734 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.46 69.47 0.75 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.173 0.511 . . . . 0.0 109.869 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 62.97 -164.75 0.25 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.272 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.9 155.18 26.06 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.361 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.997 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 1.1 p30 -149.96 144.79 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.329 0.585 . . . . 0.0 111.19 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.6 tp -147.92 127.69 13.43 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.77 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 m -80.66 129.17 34.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.0 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.896 ' HB2' HG13 ' A' ' 36' ' ' VAL . 97.6 mt -81.07 -20.7 40.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.21 -173.4 17.17 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.045 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.77 119.67 33.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CE1' ' A' ' 55' ' ' TYR . 75.1 mt -96.61 154.05 17.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.68 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -73.03 134.14 44.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.567 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HG ' ' OG1' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.63 111.29 18.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.7 m -97.09 120.97 38.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.172 0.51 . . . . 0.0 111.266 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 61' ' ' LEU . 60.7 t -105.89 121.3 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.769 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 91.8 mt -91.22 118.73 30.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.9 -179.74 8.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -125.25 151.46 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -84.15 4.53 30.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.69 -7.07 31.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.0 110.13 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -98.39 -79.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.148 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 91.1 m-85 -141.16 175.55 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.437 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 37.5 t0 -123.15 161.37 24.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.429 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.0 mt -86.15 112.95 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.73 -48.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.861 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 57.8 mm-40 -134.68 153.09 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.42 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 11.4 pt20 -170.66 -177.36 2.32 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.86 0.725 . . . . 0.0 109.854 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.447 ' OG1' ' HG ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.26 142.26 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.215 172.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.8 -63.98 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.329 . . . . 0.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 p -141.1 148.96 40.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.206 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -129.37 148.31 33.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.107 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -104.95 139.33 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.41 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.896 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -123.78 124.09 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.612 0.72 . . . . 0.0 110.695 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 5.3 m-20 -116.7 139.81 50.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.281 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -119.79 124.72 46.83 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.924 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.997 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 41.9 mt-10 -116.65 155.18 29.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.56 -153.39 24.73 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.797 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.45 135.16 32.92 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.24 2.627 . . . . 0.0 113.158 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.96 -43.17 63.42 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.66 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.58 -44.48 95.52 Favored Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.242 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 82' ' ' LEU . 25.7 t -65.69 -39.09 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.655 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.21 -35.11 74.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.759 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.8 m -68.85 -43.24 75.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.349 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.5 -48.21 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.029 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -66.1 -14.5 61.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.133 -178.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -77.03 -24.74 52.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.959 0.409 . . . . 0.0 111.203 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.2 132.04 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -68.97 155.06 94.29 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.56 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.91 123.64 12.13 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.248 2.632 . . . . 0.0 113.661 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -141.24 20.2 2.25 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.653 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' HD21 ' A' ' 14' ' ' LEU . 7.6 p90 -95.17 138.03 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.23 148.68 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.34 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 73' ' ' VAL . 15.0 m -115.84 127.85 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' THR . 49.7 p90 -149.35 157.02 42.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.9 136.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.627 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 30.8 t70 -89.39 110.28 21.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 18' ' ' VAL . 95.8 mt -119.08 31.66 6.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.262 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -70.62 -8.13 49.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.555 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.6 -20.86 21.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -78.34 141.33 38.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.244 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.86 -141.85 7.4 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.771 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.1 pt-20 -69.33 149.86 47.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.135 0.493 . . . . 0.0 111.591 -175.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.96 172.59 30.22 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.396 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -93.78 135.75 34.76 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.336 0.588 . . . . 0.0 109.829 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -131.37 139.18 49.43 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.078 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.5 t -106.21 137.21 44.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.161 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 61' ' ' LEU . 16.3 m -139.28 158.33 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.183 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.06 133.55 34.23 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 49.0 t -76.41 128.9 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.216 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.09 153.62 21.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.133 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -118.5 148.13 42.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.07 -174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -159.64 157.33 29.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 102.11 -63.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.416 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 38.9 p90 -87.1 144.22 36.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.3 Cg_exo -68.41 108.53 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.479 2.119 . . . . 0.0 111.315 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.01 49.36 3.49 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.724 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -84.62 -30.57 24.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 110.234 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 4.9 mp -81.54 -176.11 5.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.188 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 113.63 19.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.93 110.56 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.025 0.44 . . . . 0.0 110.274 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 2.6 m -103.88 133.04 49.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.53 143.55 39.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 120.91 0.386 . . . . 0.0 110.364 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 59.4 mm-40 -102.03 149.81 36.89 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 34.2 Cg_exo -8.76 127.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.233 3.289 . . . . 0.0 115.56 -133.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -105.38 -14.98 15.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.504 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 92.9 mmm -105.17 124.96 50.44 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.528 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.83 150.99 38.25 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.074 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 27.4 ptt-85 -105.58 124.48 49.62 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.56 122.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 46.8 tt0 -106.51 118.91 37.9 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 81.3 mt -110.12 128.42 55.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.156 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -149.86 147.1 27.54 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.06 129.38 2.19 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.896 0.748 . . . . 0.0 110.868 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.601 ' HA ' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -52.74 148.2 7.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -163.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 100' ' ' THR . 63.7 tt0 -129.84 -81.49 0.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 99' ' ' GLN . 0.6 OUTLIER -171.47 93.46 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.313 0.645 . . . . 0.0 110.269 176.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.68 146.26 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 0.0 111.003 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 59.3 p -119.4 147.29 44.53 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.67 109.89 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.493 0.663 . . . . 0.0 111.846 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 102' ' ' SER . 37.8 Cg_endo -95.97 63.25 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.608 2.872 . . . . 0.0 111.184 175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -88.49 116.02 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.575 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -103.27 104.34 14.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.298 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.86 -60.8 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 68.79 146.76 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.007 0.817 . . . . 0.0 111.311 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.3 ttm -135.47 138.79 43.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.444 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 pt -97.43 166.24 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -133.36 133.33 42.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.912 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.8 tp -89.57 94.63 9.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 111.275 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 142.09 29.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.281 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -176.5 -32.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.602 0.564 . . . . 0.0 110.102 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -59.78 109.87 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.762 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -86.54 77.3 9.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 179.39 71.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.764 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -85.05 -25.3 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.993 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--O 1.243 0.739 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.549 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.7 ptt? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 8.4 Cg_exo -71.03 91.18 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.768 2.312 . . . . 0.0 112.435 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -95.11 103.26 15.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 110.873 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.17 177.54 4.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.952 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -88.8 50.97 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.607 0.718 . . . . 0.0 109.673 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.37 146.35 24.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.757 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.84 165.9 13.01 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.353 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 14.7 m120 -118.47 159.8 22.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.2 tp -146.31 121.42 10.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.162 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -101.68 113.03 25.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.794 ' HB2' HG13 ' A' ' 36' ' ' VAL . 56.0 mt -78.12 -14.71 59.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.26 -160.63 27.14 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 44.2 mt-10 -91.14 118.9 30.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.077 0.465 . . . . 0.0 110.555 174.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.6 mt -96.31 150.88 20.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -71.58 131.17 42.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 59' ' ' VAL . 2.1 tm? -82.74 113.03 20.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 21.4 m -88.49 123.74 33.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.161 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 93' ' ' VAL . 47.4 t -106.02 114.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.967 0.413 . . . . 0.0 110.443 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.85 118.4 34.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -146.44 -178.17 6.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.465 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 23' ' ' GLU . 18.5 t70 -88.96 107.96 19.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.42 9.38 36.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.949 -173.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.7 mm-40 -67.67 -51.88 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.078 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -53.56 2.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 52.7 m-85 -84.79 160.98 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.141 0.495 . . . . 0.0 111.678 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -134.4 154.63 51.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.471 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.98 112.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.86 -48.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 109.845 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -133.74 153.28 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.339 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -172.34 168.4 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 0.0 110.609 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.1 m -74.97 130.4 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 170.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.05 -66.52 0.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.314 . . . . 0.0 111.526 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 32.3 p -128.77 155.3 45.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.978 HG13 ' HD3' ' A' ' 88' ' ' PRO . 41.2 t -124.54 145.77 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -90.13 121.67 32.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 11' ' ' LEU . 4.3 p -123.26 127.03 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.98 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.3 139.84 48.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.06 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.91 139.5 49.15 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 121.166 -0.214 . . . . 0.0 110.473 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 32.5 mt-10 -116.16 162.54 17.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.258 0.551 . . . . 0.0 109.976 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.61 28.65 Favored Glycine 0 C--N 1.309 -0.923 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.495 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 141.68 19.51 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.008 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.32 -32.03 68.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.757 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.69 70.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.54 -38.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.802 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.47 -35.69 74.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -39.28 87.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.602 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.13 -43.36 98.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.349 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -65.49 -28.08 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.644 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -65.27 -24.81 67.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.071 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -74.92 -35.61 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.285 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.37 134.83 37.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 35.7 mtm180 -72.6 164.68 58.21 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 175.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 52' ' ' ARG . 8.5 Cg_endo -52.63 122.0 10.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.211 1.941 . . . . 0.0 113.521 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -140.04 12.85 2.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.51 173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 2.8 p90 -96.42 121.35 38.14 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.466 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -127.84 147.51 50.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.838 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.42 124.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.063 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -142.56 157.03 45.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.211 0.529 . . . . 0.0 111.748 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 16' ' ' LEU . 43.3 t -129.76 138.34 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.332 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.84 115.47 30.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.636 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 79.7 mt -133.54 65.5 1.58 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.151 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -76.53 -36.4 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.492 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -85.38 -48.28 9.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.431 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 60.83 -167.02 0.19 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.134 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.17 -134.92 1.73 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -90.75 142.56 27.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.92 -125.77 31.24 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-O 121.629 0.572 . . . . 0.0 112.829 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 35.0 t -108.96 143.23 38.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.623 -0.788 . . . . 0.0 109.125 174.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.2 m80 -132.1 141.1 49.05 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.831 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 15.3 t -108.63 133.13 53.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.293 0.568 . . . . 0.0 111.872 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.77 167.04 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.209 175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.36 151.32 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.34 126.91 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.267 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.19 22.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.103 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -137.61 149.97 47.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.519 . . . . 0.0 111.804 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 7.8 tpt180 -133.5 147.83 51.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.73 -177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.51 -87.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.302 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -67.23 144.58 98.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.822 0.344 . . . . 0.0 111.35 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.79 176.37 7.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.009 2.473 . . . . 0.0 112.53 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.84 1.92 85.5 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.226 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.12 -32.96 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 109.951 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.09 162.9 18.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.573 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -87.48 111.85 21.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.17 111.05 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.091 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -109.79 120.63 43.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.468 0.651 . . . . 0.0 109.979 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.69 134.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 177.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -144.48 93.6 5.78 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 113.486 -3.286 . . . . 0.0 117.99 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.978 ' HD3' HG13 ' A' ' 34' ' ' VAL . 20.4 Cg_endo -116.79 127.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.407 0 C-N-CA 124.925 3.75 . . . . 0.0 105.002 100.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -25.86 38.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.699 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 ttt -129.51 122.15 28.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.127 -1.397 . . . . 0.0 107.46 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.03 157.3 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.665 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 18.9 ptt180 -124.92 137.38 54.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.247 0.546 . . . . 0.0 111.937 -170.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.52 HG11 HG11 ' A' ' 18' ' ' VAL . 62.7 t -131.75 138.12 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.247 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 50.4 tt0 -106.54 123.06 47.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.627 0.251 . . . . 0.0 110.963 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 64' ' ' ALA . 82.1 mt -111.79 127.88 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.16 146.45 50.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.85 77.35 0.21 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.663 0.602 . . . . 0.0 111.861 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 100' ' ' THR . 37.1 ttp-105 39.78 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.86 ' HG3' ' H ' ' A' ' 101' ' ' VAL . 6.3 tp60 48.17 -65.44 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.143 -2.299 . . . . 0.0 115.847 173.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 98' ' ' ARG . 12.6 m 84.4 -2.63 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.036 0.934 . . . . 0.0 111.219 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.86 ' H ' ' HG3' ' A' ' 99' ' ' GLN . 61.0 t -123.75 116.48 48.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.635 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.0 m -77.8 85.45 4.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.271 0.558 . . . . 0.0 110.48 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.27 124.68 48.32 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.908 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.46 145.42 26.61 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.632 2.221 . . . . 0.0 112.068 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.07 154.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.842 0.354 . . . . 0.0 110.632 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -142.24 143.89 33.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.94 138.77 51.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.563 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.73 86.77 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.3 ttp -79.59 105.33 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.215 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.6 tt -108.83 98.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.621 0.724 . . . . 0.0 111.835 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -102.94 90.62 3.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.03 79.92 1.56 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.666 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 115' ' ' HIS . 33.7 mt-10 -112.89 -47.68 3.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.099 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 71.78 -27.77 0.18 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.361 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 113' ' ' GLU . 48.7 t60 -74.63 78.22 2.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -163.78 108.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.288 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -123.43 137.02 54.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.136 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -121.08 143.07 49.27 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.925 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.32 124.46 12.55 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.731 2.288 . . . . 0.0 113.426 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 p -84.11 101.86 12.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.397 0.618 . . . . 0.0 109.405 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -83.03 -178.72 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.842 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 37.0 t70 -151.5 106.6 3.29 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 40.4 m80 75.88 -172.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.583 1.177 . . . . 0.0 109.515 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.53 -179.13 15.71 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.066 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.98 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 4.7 p30 -152.38 147.63 26.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.301 0.572 . . . . 0.0 111.073 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.73 128.54 37.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.785 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 p -98.73 116.78 31.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.908 0.385 . . . . 0.0 110.215 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.47 -46.78 65.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.31 -145.42 17.64 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.161 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -79.07 113.31 17.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 36' ' ' VAL . 42.7 mt -105.16 147.54 27.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.523 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 32.5 mt-10 -76.96 128.75 35.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.117 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -87.41 112.0 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.759 0.314 . . . . 0.0 110.202 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 36.4 m -99.67 124.16 44.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -105.32 126.18 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.913 0.387 . . . . 0.0 110.36 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.717 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 84.0 mt -88.65 117.8 27.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -147.74 -179.08 6.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.552 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.27 122.06 45.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.45 16.87 1.2 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.883 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.58 -65.78 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.617 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 1.2 mmp_? -111.19 -44.14 3.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.8 m-85 -97.47 144.1 27.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.71 161.92 34.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.749 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.1 mt -77.39 105.31 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.167 0.508 . . . . 0.0 111.292 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 -49.43 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.402 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.37 153.79 48.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HB3' HG23 ' A' ' 93' ' ' VAL . 7.5 pt20 -169.85 -177.99 2.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 m -94.65 97.61 10.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.47 -52.79 60.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 p -129.9 165.61 21.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.02 HG13 ' HD3' ' A' ' 88' ' ' PRO . 14.8 t -123.71 148.6 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.31 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -89.01 112.71 23.7 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 14' ' ' LEU . 47.9 t -120.06 121.1 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.449 0.642 . . . . 0.0 111.286 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.9 137.03 42.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.942 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' VAL . 86.0 mt -123.17 128.61 50.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.093 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.98 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.7 mt-10 -117.42 165.28 13.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.06 0.457 . . . . 0.0 110.446 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 6' ' ' HIS . . . 132.68 -154.09 20.95 Favored Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.85 121.76 10.56 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.953 2.435 . . . . 0.0 112.633 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.4 ptm180 -57.25 -34.25 68.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.075 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.47 -49.81 70.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.126 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -62.23 -38.98 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 80.6 mt -58.74 -41.42 86.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.321 0.581 . . . . 0.0 110.622 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 m -69.62 -37.92 77.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.943 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' GLY . 73.5 t -55.31 -52.4 46.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 45' ' ' LEU . 19.3 p90 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.935 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -71.22 -18.42 62.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.735 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -81.28 -13.14 58.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.95 173.13 6.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.311 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -83.13 165.19 42.42 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.2 122.84 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.43 1.42 . . . . 0.0 112.041 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -125.73 15.56 8.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.354 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.91 104.56 16.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.329 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -114.24 143.78 44.28 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 15' ' ' GLU . 60.2 t -119.47 124.14 72.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 17' ' ' THR . 45.8 p90 -150.92 149.84 30.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -139.56 138.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.717 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.9 t70 -92.24 117.14 29.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 71' ' ' VAL . 89.7 mt -131.48 34.46 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.7 p -66.46 -23.1 66.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.118 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.07 -41.83 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.24 113.82 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -95.83 -89.89 1.78 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.193 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.35 163.98 21.87 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 112.527 -170.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.12 168.86 14.05 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.166 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -84.34 134.44 34.5 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.34 128.55 39.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.741 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 90' ' ' MET . 5.1 m -104.48 119.96 40.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.401 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 HD21 ' A' ' 61' ' ' LEU . 30.9 m -136.8 168.22 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 111.604 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -68.0 144.87 54.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.481 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.1 117.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.155 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.42 154.79 20.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 110.346 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -138.44 163.43 31.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.228 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 76' ' ' ARG . 32.3 ttt180 -126.9 158.39 36.88 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.91 -83.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 31.5 p90 -88.38 143.51 32.56 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 6.0 Cg_exo -75.08 159.57 40.9 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.94 2.427 . . . . 0.0 112.305 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.2 44.34 3.27 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.161 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.71 -39.4 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.564 0.697 . . . . 0.0 109.425 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.2 176.74 9.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.636 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.54 102.09 10.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 38' ' ' LEU . 64.4 t -94.98 113.72 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.475 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 21.6 m -102.43 125.36 49.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.857 0.837 . . . . 0.0 110.066 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -130.82 128.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -144.52 94.0 5.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 113.393 -3.323 . . . . 0.0 117.243 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 1.02 ' HD3' HG13 ' A' ' 34' ' ' VAL . 12.5 Cg_endo -110.6 129.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.453 0 C-N-CA 124.548 3.499 . . . . 0.0 104.121 101.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -65.55 -47.64 75.18 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.802 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.627 ' HB3' HG22 ' A' ' 70' ' ' THR . 59.9 mtt -123.15 145.88 48.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.856 -1.52 . . . . 0.0 107.103 160.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.67 141.76 48.3 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.653 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.664 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -105.92 134.6 48.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.193 -177.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 30' ' ' GLN . 4.3 p -137.37 137.64 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.347 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -108.72 120.75 43.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.064 0.459 . . . . 0.0 110.683 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 85.0 mt -107.68 124.07 49.45 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.15 142.87 47.57 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 24' ' ' ARG . 34.7 tt0 -71.06 131.22 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 28.3 ttm180 75.99 137.61 0.06 Allowed 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 124.182 0.926 . . . . 0.0 110.611 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -90.91 116.36 28.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.798 -168.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.4 m -92.54 -22.61 19.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.853 0.835 . . . . 0.0 110.383 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 162.25 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.03 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -128.65 117.81 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.74 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 51.3 t -93.53 115.38 64.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.908 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 6.1 Cg_exo -78.64 104.52 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.939 2.426 . . . . 0.0 111.111 174.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 m -71.1 123.39 25.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.254 0.55 . . . . 0.0 111.017 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.2 m -157.67 134.96 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.182 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.01 119.77 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.189 0.518 . . . . 0.0 110.059 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.35 135.47 33.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.96 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.9 ttm -75.75 -59.93 2.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.815 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG22 ' HG ' ' A' ' 112' ' ' LEU . 44.3 mt 57.13 73.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.12 82.25 6.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.665 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.501 ' HG ' HG22 ' A' ' 110' ' ' ILE . 94.9 mt -85.31 84.03 7.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.235 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.94 89.85 1.11 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.761 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -98.56 92.65 5.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.356 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -95.67 106.59 18.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.92 137.05 41.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.656 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -106.05 178.22 4.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -120.31 93.88 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 110.378 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.0 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 177.636 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 75.5 mtm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.691 0.281 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 97.5 Cg_endo -95.68 -5.72 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.234 2.623 . . . . 0.0 113.746 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.92 16.03 2.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 112.316 -171.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -74.59 143.12 44.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.918 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -132.46 92.41 3.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.83 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 71.59 -173.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -152.49 162.44 29.91 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.806 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 5.5 p30 -150.43 150.05 30.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.372 0.586 . . . . 0.0 111.53 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -133.1 138.51 46.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.954 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -99.38 115.98 30.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.643 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.33 -35.52 30.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.201 0.524 . . . . 0.0 109.733 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.8 -154.82 20.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.97 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -89.72 109.51 20.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 110.597 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.34 154.59 17.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.509 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.5 122.9 22.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.884 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 59' ' ' VAL . 64.4 tp -85.83 120.13 26.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 26.3 m -100.99 134.38 44.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.551 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 61' ' ' LEU . 98.5 t -105.57 117.9 52.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -89.33 115.85 27.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 62' ' ' THR . 42.1 t80 -178.88 142.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.125 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 23' ' ' GLU . 22.9 t70 -90.5 153.46 20.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 10.7 pt-20 -77.15 36.56 0.18 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.539 0.685 . . . . 0.0 110.876 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.1 pt-20 -80.1 -26.55 39.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.31 -49.68 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.24 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.4 154.59 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.739 0.304 . . . . 0.0 111.073 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.27 164.0 15.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 59.0 mt -84.8 123.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.9 -47.47 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.343 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 10.0 pt-20 -140.99 154.5 46.06 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.386 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -168.77 171.34 8.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.093 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 16' ' ' LEU . 17.8 m -92.56 132.5 36.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.3 -69.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 7.9 p -129.39 152.32 49.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 11.8 m -124.09 146.84 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.383 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -94.1 115.04 27.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.82 0.343 . . . . 0.0 110.494 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.9 t -109.97 124.3 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.126 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -126.41 137.5 53.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 84' ' ' VAL . 81.6 mt -120.43 132.78 55.39 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.268 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 38.6 mt-10 -119.33 169.93 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.277 0.561 . . . . 0.0 110.299 172.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.43 -154.0 23.3 Favored Glycine 0 C--N 1.309 -0.959 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.976 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 120.07 7.67 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.573 2.182 . . . . 0.0 111.578 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 19.3 ptt180 -61.08 -31.12 70.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.217 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.44 80.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.406 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.63 -51.47 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.729 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.21 -40.09 86.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 m -65.64 -40.9 93.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.994 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 99.0 t -70.94 -36.84 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.08 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -63.01 -34.76 78.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.07 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -65.91 -25.12 67.01 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 47' ' ' VAL . 19.9 m-85 -74.79 -30.69 61.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.29 152.77 20.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.441 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -71.03 155.4 93.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.089 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 11.4 Cg_exo -70.06 123.82 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.725 2.283 . . . . 0.0 113.117 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.0 m -114.19 7.72 16.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.366 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.579 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 10.9 p90 -94.43 153.73 17.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.165 -172.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.99 145.48 32.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.978 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.68 129.52 68.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' THR . 21.3 p90 -153.26 158.63 41.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.974 0.416 . . . . 0.0 111.67 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 16' ' ' LEU . 21.7 t -128.62 137.09 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 18' ' ' VAL . 96.8 mt -124.95 42.56 3.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 110.366 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.645 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 9.6 p -65.2 -24.86 67.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.831 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -99.05 6.11 46.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -80.83 114.27 19.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.123 0.487 . . . . 0.0 111.24 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.65 79.44 0.18 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -176.04 -164.0 0.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.19 -163.44 4.35 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.205 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.5 t -62.72 135.97 57.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.237 0.541 . . . . 0.0 110.694 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 5.5 m-70 -132.05 132.53 43.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.985 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 90' ' ' MET . 26.7 m -98.47 118.05 34.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.453 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 61' ' ' LEU . 27.3 m -130.69 167.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.81 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -82.8 148.35 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.189 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -91.42 133.42 33.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.569 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.78 154.79 18.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.558 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -140.14 148.63 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.511 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG3' ' HE1' ' A' ' 58' ' ' PHE . 30.0 mtm180 -144.82 164.01 32.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.242 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 105.78 -69.97 0.23 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.923 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 12.9 p90 -79.03 145.12 64.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 22.3 Cg_exo -64.66 127.89 19.84 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.182 2.588 . . . . 0.0 113.297 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.37 -2.35 73.6 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.372 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.38 -26.01 67.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.421 0.629 . . . . 0.0 110.014 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 45.5 mt -88.99 176.91 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.067 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.49 101.83 10.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 38' ' ' LEU . 73.9 t -94.35 112.46 27.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.037 -173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.1 m -108.04 122.47 46.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.515 0.674 . . . . 0.0 110.837 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.61 116.36 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 89.32 52.1 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 113.735 -3.186 . . . . 0.0 116.589 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 88' ' ' PRO . 27.5 Cg_endo -116.23 127.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.337 1 C-N-CA 125.634 4.222 . . . . 0.0 105.092 103.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -68.19 -47.36 68.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.467 -1.293 . . . . 0.0 109.563 -171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.544 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.8 mtp -126.56 133.49 51.07 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.533 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.93 146.6 45.64 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 34.0 ptt180 -105.69 127.99 53.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.483 0.659 . . . . 0.0 110.916 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.37 135.6 63.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.511 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 47.7 tt0 -116.49 119.68 36.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 64' ' ' ALA . 94.5 mt -109.77 123.34 49.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.02 145.36 51.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.407 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 67.72 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.265 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 98' ' ' ARG . 1.4 tpp85 -151.62 170.86 18.65 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -103.31 154.24 19.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 120.297 0.094 . . . . 0.0 111.167 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.8 m 72.31 119.05 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 98.8 t -63.15 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.987 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 p -119.87 96.77 5.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.474 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.31 123.78 47.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.758 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.82 172.12 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.69 2.26 . . . . 0.0 111.858 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.18 104.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.4 p -72.59 141.61 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.301 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 109' ' ' MET . 12.4 p -128.9 137.52 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.646 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 -69.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 107' ' ' VAL . 84.5 mtp 65.08 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 125.7 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.363 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.5 127.84 34.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.226 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.44 120.31 7.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -162.49 101.24 1.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.497 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -117.65 84.39 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -112.65 29.41 7.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.909 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -71.25 110.04 5.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.92 0.39 . . . . 0.0 110.35 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -131.58 115.89 16.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -98.95 170.71 8.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.68 178.731 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.8 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.437 0.16 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 25.2 Cg_endo -89.95 35.59 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.441 2.761 . . . . 0.0 112.238 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 4' ' ' PHE . 12.7 m -151.3 169.72 21.28 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' N ' HG22 ' A' ' 3' ' ' THR . 89.1 m-85 -48.49 134.19 15.64 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.183 0.302 . . . . 0.0 110.545 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.626 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 7.8 p-10 -80.76 36.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.704 0.764 . . . . 0.0 111.565 -173.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -102.82 107.47 18.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.931 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.08 -175.35 14.52 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.177 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -118.67 153.91 33.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.11 0.481 . . . . 0.0 110.187 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.49 123.79 10.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.459 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -92.81 138.14 31.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.12 0.74 57.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.844 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.45 -139.84 26.29 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 8.0 pt-20 -103.44 126.59 50.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.2 0.524 . . . . 0.0 110.078 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.62 156.3 17.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.55 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -78.63 120.58 23.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.848 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 31' ' ' THR . 18.4 tp -87.34 111.23 20.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.408 0.623 . . . . 0.0 109.779 174.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -93.67 134.22 36.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 61' ' ' LEU . 60.0 t -106.17 126.17 61.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.409 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.3 117.54 29.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -134.54 -176.24 4.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.949 0.404 . . . . 0.0 111.113 -170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.829 ' HB3' ' HD2' ' A' ' 25' ' ' TYR . 14.3 t70 -100.3 107.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.524 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.5 pm0 -88.62 16.22 6.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.459 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.93 -59.86 2.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.64 -23.33 5.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.829 ' HD2' ' HB3' ' A' ' 21' ' ' ASP . 51.5 m-85 -94.63 130.43 41.09 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.347 -169.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.22 151.0 27.88 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.437 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -92.3 117.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.16 -48.41 19.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.125 0.488 . . . . 0.0 109.701 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 12.5 pt-20 -151.4 153.76 35.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -151.1 -178.66 6.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.973 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 16' ' ' LEU . 38.5 m -99.9 123.95 44.69 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.98 -51.4 5.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 0.0 111.592 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 5.6 p -131.98 150.51 52.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.618 -172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 25.6 t -124.82 147.81 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.646 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -93.19 123.93 36.8 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 t -125.32 130.8 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.794 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.45 130.98 41.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.02 151.71 32.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.833 0.349 . . . . 0.0 111.154 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 34.4 tt0 -130.4 139.88 50.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.849 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 170.26 -171.01 43.36 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.188 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.0 135.31 34.57 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.75 2.3 . . . . 0.0 111.889 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.613 ' CG ' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -55.19 -29.8 58.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -60.31 -44.17 97.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.208 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.6 t -69.72 -41.42 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.087 0.47 . . . . 0.0 110.047 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.8 mt -60.78 -33.21 72.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.114 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.5 m -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.649 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.42 -37.83 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.427 0.632 . . . . 0.0 110.009 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.43 -34.17 77.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.564 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.444 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.61 -23.93 63.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 111.0 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.07 152.27 18.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -83.17 162.65 53.63 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.556 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.01 124.46 14.76 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.136 1.891 . . . . 0.0 111.987 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t -140.48 16.22 2.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.338 1.066 . . . . 0.0 108.593 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 5.2 p90 -113.89 134.99 54.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.323 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.11 148.83 46.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.931 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 16' ' ' LEU . 35.7 t -102.68 142.92 15.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.8 p90 -151.31 153.47 34.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 73' ' ' VAL . 16.8 m -131.31 146.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.148 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -96.68 108.35 20.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 0.0 110.93 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 18' ' ' VAL . 82.9 mt -131.14 28.94 4.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.557 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -74.36 -25.05 59.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.27 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.03 -5.46 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 123.17 24.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.5 65.06 0.41 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.904 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HG2' ' H ' ' A' ' 67' ' ' GLY . 11.2 tt0 -174.06 -166.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 66' ' ' GLU . . . -65.95 -167.4 2.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.832 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 23.0 t -50.65 134.59 24.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.684 0.754 . . . . 0.0 111.52 -173.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -131.11 137.33 49.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.44 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 90' ' ' MET . 9.4 m -102.5 116.95 33.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.415 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -124.65 168.33 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.49 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.15 145.67 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.988 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.64 HG21 ' HG2' ' A' ' 88' ' ' PRO . 30.5 t -97.58 116.45 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.655 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.53 151.56 19.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.323 0.582 . . . . 0.0 110.311 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -142.04 149.21 39.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.529 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -159.54 161.03 35.2 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.268 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 122.51 -59.88 0.58 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.745 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.31 152.65 88.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.02 123.44 13.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 123.154 2.569 . . . . 0.0 112.7 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.91 52.57 3.63 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.956 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -134.78 -27.11 1.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.941 0.401 . . . . 0.0 111.231 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.502 HD22 ' HA3' ' A' ' 40' ' ' GLY . 90.2 mt -77.76 163.79 25.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -81.1 102.52 10.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.98 125.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.869 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -114.55 125.66 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.232 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.61 154.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -147.95 94.59 4.3 Favored Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 114.705 -2.798 . . . . 0.0 115.813 152.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -114.03 129.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.81 0 C-N-CA 124.736 3.624 . . . . 0.0 105.145 110.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -72.17 -42.89 65.38 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.435 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.478 ' HB3' HG22 ' A' ' 70' ' ' THR . 94.1 mtp -140.14 153.01 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.06 166.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.82 140.74 49.46 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.767 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.694 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.77 137.25 46.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.282 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 68' ' ' SER . 91.2 t -134.01 136.77 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.602 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 8.1 tp60 -98.39 120.75 39.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.08 139.33 52.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.652 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.64 62.13 5.35 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 64.9 151.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.954 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.76 130.74 47.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.206 174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 95.5 m -65.76 106.64 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.012 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 103' ' ' VAL . 10.4 p -108.87 134.67 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.078 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 m -96.27 8.9 42.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 110.903 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.8 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.5 t -117.24 125.93 27.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 60.48 2.68 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.992 2.461 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 103' ' ' VAL . 20.1 m -91.82 -23.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.181 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 108' ' ' GLU . 32.5 m -98.36 111.77 24.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.941 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.98 -36.4 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.404 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 106' ' ' THR . 42.4 mt-10 66.58 108.69 0.04 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.91 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.29 99.4 9.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.79 160.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.971 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.33 118.65 22.81 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.43 65.87 3.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.687 -171.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -89.33 -49.57 6.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -87.57 122.57 31.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -113.43 128.8 56.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.29 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -82.4 118.74 23.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.983 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -74.3 168.25 20.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.551 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -115.85 -81.48 0.61 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.643 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.47 60.91 4.23 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.068 2.512 . . . . 0.0 113.542 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.8 p 52.08 -164.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.716 0.806 . . . . 0.0 112.598 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.811 ' HB3' ' HG2' ' A' ' 42' ' ' ARG . 49.8 t80 -159.9 148.94 17.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.55 84.72 4.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.512 0.672 . . . . 0.0 110.598 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 75.73 152.56 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.707 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' GLU . . . -154.5 167.03 32.43 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -125.17 153.12 43.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.528 0.68 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.6 tm? -135.23 124.29 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.019 174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -99.45 106.27 18.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.288 0.566 . . . . 0.0 111.481 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 36' ' ' VAL . 83.5 mt -79.96 -27.1 39.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.9 -151.72 24.11 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.421 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 9.0 pt-20 -99.05 120.87 40.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.133 0.492 . . . . 0.0 110.084 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.89 152.34 20.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.659 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.88 136.52 45.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.924 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.99 121.57 27.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.341 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.2 m -101.74 115.27 30.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.84 132.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.487 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tt -99.92 121.46 41.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' HE2' ' HB2' ' A' ' 25' ' ' TYR . 7.5 t80 -160.13 -176.98 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -119.49 124.71 47.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 111.402 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -64.03 -20.9 66.25 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.86 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.86 -27.16 68.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.981 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -111.88 -64.04 1.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.069 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.592 ' HB2' ' HE2' ' A' ' 20' ' ' TYR . 95.0 m-85 -139.48 150.47 45.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -118.13 163.8 16.09 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.783 HG21 HE21 ' A' ' 30' ' ' GLN . 65.6 mt -77.85 105.72 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.345 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' GLU . 48.3 t -90.6 -29.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 92' ' ' ARG . 5.7 tm-20 -145.76 153.23 40.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.783 HE21 HG21 ' A' ' 27' ' ' ILE . 6.9 tt0 -170.37 150.24 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -75.6 115.56 15.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.88 -66.5 0.51 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 -173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 1.6 p -140.99 145.89 36.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.0 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 3.3 m -124.65 148.64 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.96 0.41 . . . . 0.0 110.905 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.721 ' HB2' ' HG2' ' A' ' 109' ' ' MET . 11.3 tt0 -90.17 131.71 35.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.4 p -128.24 120.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.527 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 14.8 t70 -118.88 142.82 47.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 93.6 mt -113.36 123.42 50.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 1.9 tm-20 -119.05 136.45 54.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.393 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -156.69 28.38 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.764 -1.208 . . . . 0.0 113.054 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.72 115.98 2.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.41 2.74 . . . . 0.0 112.436 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -48.83 -29.73 4.96 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.946 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.634 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -59.35 -49.47 78.12 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.543 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.81 -39.32 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 9' ' ' LEU . 91.5 mt -66.08 -33.19 75.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -66.07 -44.65 83.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.407 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.11 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 0.0 110.33 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -66.55 -28.76 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.914 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmm-85 -70.08 -14.95 62.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.052 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -95.73 -17.72 21.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 111.017 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.62 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.159 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -70.36 155.8 92.88 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.506 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.53 128.51 28.26 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.195 2.597 . . . . 0.0 113.28 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 t -144.26 14.17 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.907 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -98.38 145.53 26.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.626 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.41 159.89 41.27 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.225 0.536 . . . . 0.0 111.283 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.95 124.65 73.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.453 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 19' ' ' LEU . 90.8 t80 -141.44 148.38 39.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 111.543 -172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.08 134.29 27.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.831 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.48 119.25 38.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.1 mt -127.23 37.63 4.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.104 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -69.06 -18.85 64.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.852 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -100.41 5.97 44.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.966 0.412 . . . . 0.0 110.715 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.91 158.15 19.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.03 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -125.25 -137.79 4.83 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.792 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.5 144.31 44.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.325 0.25 . . . . 0.0 110.406 -174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.03 173.81 42.31 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.917 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.3 t -79.52 137.96 37.36 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.401 0.619 . . . . 0.0 110.569 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -126.55 135.32 51.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.164 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -114.37 127.11 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.595 0.236 . . . . 0.0 111.05 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.55 167.39 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.696 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.39 145.12 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.158 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.98 115.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.492 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.66 152.16 19.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.651 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -120.22 149.85 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -136.6 144.81 44.3 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.574 -178.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.13 -54.38 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -98.89 149.39 35.7 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.42 133.1 23.61 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.465 2.11 . . . . 0.0 111.53 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.56 46.26 3.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.4 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.43 -12.94 18.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.696 0.76 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.2 175.58 7.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -86.89 111.31 20.67 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.73 111.05 24.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 6.1 m -92.95 131.37 38.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 35' ' ' GLN . 21.3 t -133.37 142.29 42.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.072 0.463 . . . . 0.0 111.35 -171.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.992 ' HG3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 tp10 -103.34 148.36 35.58 Favored Pre-proline 0 CA--C 1.507 -0.691 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 169.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.992 ' HD2' ' HG3' ' A' ' 87' ' ' GLU . 22.8 Cg_exo -13.93 128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 124.621 3.548 . . . . 0.0 115.23 -138.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -89.86 -13.67 35.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.595 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 87.5 mtp -110.08 135.64 50.58 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.647 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.56 141.13 49.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.323 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -107.57 136.41 47.39 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.746 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -135.4 124.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 51.4 tt0 -98.16 120.97 39.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 87.8 mt -106.48 123.72 48.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.349 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.709 ' HB3' HG21 ' A' ' 28' ' ' VAL . 35.0 tt0 -150.89 144.31 24.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 41.3 tt0 -55.03 132.34 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.698 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 42.8 ttp180 75.05 140.8 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 124.273 0.983 . . . . 0.0 111.489 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -111.13 156.78 20.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.124 -168.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 t -158.21 93.63 1.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.337 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.661 HG13 HG22 ' A' ' 103' ' ' VAL . 95.8 t -132.53 105.75 9.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.584 -173.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -119.01 19.56 12.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.82 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.661 HG22 HG13 ' A' ' 101' ' ' VAL . 27.1 m -79.49 145.99 64.73 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.562 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.08 167.7 12.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.611 2.207 . . . . 0.0 112.126 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 106' ' ' THR . 35.2 t -103.92 143.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 105' ' ' VAL . 93.6 m 79.81 125.31 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.737 0.648 . . . . 0.0 111.141 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.05 -14.44 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.818 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 75.04 91.16 0.08 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.192 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.721 ' HG2' ' HB2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -90.94 -175.91 4.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.38 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.75 134.89 25.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.377 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.38 129.47 55.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.1 tp -150.52 119.74 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.183 0.516 . . . . 0.0 112.019 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.57 97.23 4.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -132.5 60.38 1.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 0.0 110.868 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -105.96 154.72 20.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.336 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -132.6 120.93 22.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -68.54 108.0 3.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.783 0.325 . . . . 0.0 110.389 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.52 151.9 48.91 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.043 -177.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 25.6 ttt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.6 Cg_exo -69.21 -173.1 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.127 2.551 . . . . 0.0 112.239 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -76.59 -167.56 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.127 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -61.22 145.76 50.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.209 0.528 . . . . 0.0 111.455 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.64 101.08 3.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.441 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.4 111.99 1.78 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.339 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.76 177.61 21.97 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -118.64 146.78 44.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.143 0.497 . . . . 0.0 110.3 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -139.33 122.74 17.18 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.033 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -100.77 128.41 46.83 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.982 0.42 . . . . 0.0 111.148 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -84.71 -13.01 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -163.27 29.26 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.093 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 12.8 pt-20 -100.22 109.69 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.594 0.711 . . . . 0.0 109.814 173.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.77 148.95 22.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.225 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.6 131.67 40.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.3 pt? -113.28 145.73 40.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.013 0.435 . . . . 0.0 110.411 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -115.39 138.07 51.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -104.61 128.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -88.17 132.2 34.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.599 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 62' ' ' THR . 10.3 p90 -153.0 156.24 38.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.727 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 9.7 t70 -74.67 118.09 17.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 1.16 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.118 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.02 -33.84 11.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.037 0.446 . . . . 0.0 110.352 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 33.8 mmt180 -80.4 -49.78 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.838 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -133.56 168.02 19.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 100' ' ' THR . 8.8 t0 -136.54 162.53 32.83 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.4 mt -90.33 112.62 25.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -85.93 -49.19 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.675 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 94' ' ' GLN . 31.8 mt-10 -138.73 154.66 48.56 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.96 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 31' ' ' THR . 8.3 tt0 -164.25 153.19 13.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.269 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.414 ' N ' ' HG2' ' A' ' 30' ' ' GLN . 17.9 m -62.32 128.79 37.7 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.59 -67.33 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.568 -172.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -128.51 145.87 50.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 0.0 110.203 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.67 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 16.1 m -124.69 145.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.82 121.88 38.02 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.775 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG22 HG13 ' A' ' 86' ' ' VAL . 17.6 t -120.38 122.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.708 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.07 138.13 53.15 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.8 141.92 46.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.724 0.297 . . . . 0.0 110.874 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 4.7 mt-10 -116.14 149.28 39.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.395 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 158.43 -170.91 35.17 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.723 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.72 127.99 25.43 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.385 2.056 . . . . 0.0 111.382 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -53.06 -32.14 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.57 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -58.83 -49.24 79.98 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.292 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.56 -42.43 95.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.953 0.406 . . . . 0.0 110.364 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.48 -40.06 85.73 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.5 m -69.17 -47.0 66.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.838 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 93.8 t -60.69 -43.09 94.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.81 -36.2 83.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.597 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -72.06 -14.18 61.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.119 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 19.8 m-85 -72.96 -23.96 60.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.869 0.366 . . . . 0.0 110.654 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.98 155.5 18.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.342 0.592 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 33.9 mtt180 -79.55 154.69 76.35 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 123.24 13.32 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.446 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -137.11 23.68 3.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.856 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 13.1 p90 -114.48 129.17 56.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.647 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.01 144.48 43.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.358 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.35 123.37 70.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -156.45 161.39 40.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.81 0.338 . . . . 0.0 110.661 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG12 ' HG ' ' A' ' 61' ' ' LEU . 4.5 t -129.43 134.66 63.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.48 102.86 12.78 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 59' ' ' VAL . 68.0 mt -131.17 38.13 3.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.517 . . . . 0.0 110.667 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 t -73.99 -14.12 60.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.903 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -87.76 -3.64 58.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.965 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.45 139.45 32.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.337 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -138.16 9.98 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.813 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -70.27 144.93 51.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.035 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.12 163.16 30.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.172 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -79.34 139.57 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.328 0.585 . . . . 0.0 109.885 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.99 126.03 44.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.937 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 90' ' ' MET . 7.4 m -117.8 116.63 27.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.904 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.46 166.57 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.11 151.12 35.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 59' ' ' VAL . 42.1 t -93.29 126.11 45.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -88.32 150.83 23.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -122.0 149.17 43.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.081 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -133.0 150.52 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 119.05 -69.51 0.34 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.07 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 15.5 p90 -90.7 143.97 29.75 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.695 0.283 . . . . 0.0 110.458 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -76.64 160.58 34.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.946 2.431 . . . . 0.0 111.933 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.8 40.38 3.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.61 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.12 -42.47 16.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.559 0.695 . . . . 0.0 109.572 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' A' ' 40' ' ' GLY . 81.6 mt -83.67 166.87 17.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.246 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.98 112.13 18.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.34 110.86 23.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.399 0.619 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.66 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -131.17 155.67 42.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.31 85.96 37.09 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 114.965 -2.694 . . . . 0.0 112.952 153.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 66.7 Cg_endo -122.72 131.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.67 1 C-N-CA 126.143 4.562 . . . . 0.0 107.511 112.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -75.62 -42.64 51.17 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.066 -1.453 . . . . 0.0 108.014 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.542 ' HB3' HG22 ' A' ' 70' ' ' THR . 64.8 mtt -132.95 153.49 51.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.371 165.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.65 142.33 48.54 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 92' ' ' ARG . 12.9 ptp180 -110.28 133.62 53.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.869 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.31 138.81 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.382 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HB3' ' H ' ' A' ' 29' ' ' GLU . 7.0 tp60 -105.12 118.64 37.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.66 134.35 54.98 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.934 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -140.3 145.09 36.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.687 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.08 43.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.345 0.593 . . . . 0.0 111.478 175.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 96' ' ' GLU . 18.4 tpp180 -138.44 136.91 36.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -78.77 131.67 36.63 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 7.9 m -127.2 8.54 6.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.367 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t 77.48 -43.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.182 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 31.8 t 72.65 143.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.075 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.93 92.34 1.37 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.753 0.787 . . . . 0.0 109.904 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -91.82 15.63 1.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.022 2.481 . . . . 0.0 113.478 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.6 132.41 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 m -152.09 42.11 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.48 0.657 . . . . 0.0 109.338 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 4.1 p -51.58 100.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.575 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 8.0 mm-40 162.31 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.514 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ptm -78.52 113.15 16.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.762 0.792 . . . . 0.0 110.524 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.63 -27.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.605 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.91 110.49 7.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.63 168.27 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.977 0.418 . . . . 0.0 111.071 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.77 140.74 33.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.929 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -114.86 82.72 1.78 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.151 0.976 . . . . 0.0 109.199 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -143.42 91.89 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.561 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -94.58 144.9 25.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -139.77 129.12 24.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.687 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -71.99 149.62 44.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.078 175.684 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.884 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.884 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 5.4 Cg_exo -78.81 123.01 5.62 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.219 1.946 . . . . 0.0 112.101 -177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m -128.83 144.66 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.146 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -120.27 169.87 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.361 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 11.8 m-20 -78.79 34.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.584 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -117.09 107.74 14.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.98 -174.14 13.71 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.408 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -118.99 157.65 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.823 0.344 . . . . 0.0 110.172 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.63 124.83 9.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.536 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' OD1' ' A' ' 37' ' ' ASP . 50.9 m -92.72 125.39 37.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 87.7 mt -95.5 -41.33 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.64 -162.42 23.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.648 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 35' ' ' GLN . 41.7 mm-40 -72.67 115.5 12.02 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.847 0.459 . . . . 0.0 111.281 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt -118.09 145.78 44.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.191 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' THR . 50.3 mt-10 -72.76 141.18 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 tp -84.58 106.29 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.818 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -88.23 113.0 23.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.286 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 61' ' ' LEU . 95.3 t -119.65 129.13 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.881 ' HG ' ' HE1' ' A' ' 58' ' ' PHE . 65.6 mt -91.21 126.35 36.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -124.0 178.27 5.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.645 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 20.1 t70 -93.01 119.04 31.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.28 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.75 -11.33 60.19 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -65.94 -67.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 65.9 mtp180 -142.42 4.09 1.55 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 99.5 m-85 -103.98 92.83 4.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -113.58 155.65 25.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.462 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.5 115.19 30.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -80.58 -50.01 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 109.868 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -139.19 154.28 48.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.438 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -158.92 175.71 13.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -75.54 100.7 4.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.43 -54.31 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.713 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 15' ' ' GLU . 37.0 p -135.71 150.14 49.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.687 0.28 . . . . 0.0 111.085 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.74 150.42 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.867 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 60.1 tt0 -100.61 127.41 47.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.505 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 6.1 p -127.59 138.75 53.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 10' ' ' SER . 72.6 m-20 -132.04 158.15 42.3 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.91 140.79 51.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.107 0.48 . . . . 0.0 111.455 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 26.0 mt-10 -123.18 165.9 16.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.097 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 -154.13 20.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.817 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 11.9 Cg_endo -55.62 120.1 7.66 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.43 2.753 . . . . 0.0 112.235 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.62 -30.37 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.336 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -56.74 -49.16 72.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.386 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.19 -42.1 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.459 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.14 -36.52 77.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.614 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -68.37 -42.02 79.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' GLY . 93.4 t -63.06 -43.9 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 110.982 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.68 -29.0 69.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.517 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -25.65 65.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.338 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.41 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.16 165.97 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.22 0.533 . . . . 0.0 111.641 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -85.22 161.03 53.36 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.435 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.44 123.08 12.99 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.834 1.689 . . . . 0.0 112.047 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 m -151.64 24.94 0.68 Allowed 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.852 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.3 p90 -118.42 130.93 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.34 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -121.0 152.42 38.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.099 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.66 123.77 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.881 ' HE1' ' HG ' ' A' ' 19' ' ' LEU . 73.1 t80 -139.72 148.17 41.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.054 0.454 . . . . 0.0 112.063 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.5 t -143.1 138.53 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -101.8 118.84 37.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.886 HD13 HG11 ' A' ' 93' ' ' VAL . 73.5 mt -132.92 35.66 3.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 p -63.47 -35.32 80.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.683 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -85.52 -72.35 0.49 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.212 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.1 -154.93 0.31 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.933 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.19 -140.75 3.14 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -109.53 145.99 35.37 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.7 159.38 14.12 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.495 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.4 t -66.02 138.03 57.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -132.2 141.58 49.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.197 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.5 m -111.99 115.8 29.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.45 164.79 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.331 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.14 144.02 57.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.88 132.82 35.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.027 0.442 . . . . 0.0 111.713 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.88 153.09 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.117 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -137.12 150.56 48.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.202 -0.311 . . . . 0.0 111.008 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -152.32 162.89 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 97.26 -59.29 1.13 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 42.0 p90 -99.21 143.53 26.57 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.0 Cg_endo -86.41 146.88 8.61 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.03 22.56 4.98 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -75.79 -30.15 58.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.548 0.69 . . . . 0.0 109.736 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.07 177.73 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -84.0 108.07 16.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.54 122.51 45.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.385 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.6 m -110.79 128.77 55.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' GLU . 6.2 t -130.81 151.79 36.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.945 0.402 . . . . 0.0 110.893 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 24.9 mm-40 -101.54 150.02 36.9 Favored Pre-proline 0 CA--C 1.502 -0.9 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 167.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 35.3 Cg_exo -10.55 128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.864 3.709 . . . . 0.0 115.507 -137.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 89' ' ' ARG . 30.4 ptt180 -81.32 -19.58 42.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.864 -171.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.666 ' HB3' HG22 ' A' ' 70' ' ' THR . 55.1 mtt -110.63 138.92 46.39 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.115 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.93 150.01 40.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 110.037 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -105.76 145.57 30.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.194 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.886 HG11 HD13 ' A' ' 61' ' ' LEU . 10.0 p -137.73 128.27 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.271 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -107.13 119.18 38.68 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.6 126.12 52.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.15 143.02 51.29 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 1.9 mp0 -72.74 81.85 1.15 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.472 0.653 . . . . 0.0 110.63 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.14 141.59 50.67 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.461 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -86.32 94.83 9.45 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.112 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.1 m -119.62 103.4 9.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 86.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.698 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 m -82.19 -173.97 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.195 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.5 150.88 37.15 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.809 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 159.54 52.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.575 2.184 . . . . 0.0 111.545 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 19' ' ' LEU . 26.9 m -115.94 147.3 19.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 111.971 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 m -135.57 94.78 3.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.214 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.55 138.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 159.05 17.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.106 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.5 mtp -111.43 149.74 30.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.42 164.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.53 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -154.64 128.72 8.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.978 0.418 . . . . 0.0 111.373 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.4 tp -158.69 87.38 0.88 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.947 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -90.11 -43.35 10.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.876 -173.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -90.49 99.67 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.701 0.762 . . . . 0.0 111.048 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 116' ' ' HIS . 3.6 p80 -156.57 150.86 25.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.671 175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 15.9 m-70 73.83 140.96 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.836 0.71 . . . . 0.0 109.626 -166.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -148.28 154.19 39.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.3 168.47 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.919 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.247 0.924 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.97 120.19 7.11 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.666 2.244 . . . . 0.0 112.292 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -99.61 11.96 37.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.611 1.196 . . . . 0.0 109.207 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -83.32 -166.12 1.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.543 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 63.66 46.98 3.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.619 0.723 . . . . 0.0 110.333 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.44 101.01 5.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.72 0.771 . . . . 0.0 109.298 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.77 -179.26 46.17 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.151 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.422 HD22 ' HG2' ' A' ' 39' ' ' GLU . 8.0 m120 -118.62 148.03 43.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 9' ' ' LEU . 1.8 tm? -135.04 124.35 24.67 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -108.74 116.04 31.22 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.96 -8.86 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.665 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 74.67 -156.02 49.05 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.576 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 11.6 pt-20 -84.0 114.36 21.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.39 0.614 . . . . 0.0 109.957 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.55 143.13 27.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.065 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -72.34 128.55 35.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.43 113.4 20.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -100.96 128.89 46.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.349 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.507 HG21 HG21 ' A' ' 93' ' ' VAL . 55.5 t -105.53 123.11 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.711 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.8 117.42 30.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.59 170.42 19.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.75 125.92 51.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.5 pt-20 -81.91 40.73 0.62 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.262 0.553 . . . . 0.0 111.041 -175.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.4 -37.31 65.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.668 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -157.71 2.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.072 -172.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -127.3 137.99 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.074 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -110.25 161.87 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.254 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -88.59 109.99 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 0.0 110.235 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.86 -46.64 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -144.37 163.9 32.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 7.9 pt20 -161.33 171.91 17.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.6 m -74.9 126.73 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.06 -76.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.144 0.497 . . . . 0.0 111.189 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 13' ' ' GLU . 10.9 p -143.59 147.2 34.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 m -123.82 148.34 27.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.305 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 27.6 mt-30 -98.46 136.04 39.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.128 0.49 . . . . 0.0 111.265 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 122.98 66.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.337 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 10.1 m-20 -116.07 132.46 56.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.481 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.02 139.22 49.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.668 0.271 . . . . 0.0 110.63 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.3 mt-10 -116.54 145.59 43.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.46 . . . . 0.0 110.879 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.33 177.28 33.29 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.545 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.03 125.5 19.38 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.466 2.111 . . . . 0.0 111.593 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.981 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.31 -39.93 83.72 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.488 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.75 -42.89 80.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.36 -34.46 73.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.03 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.3 m -64.39 -43.38 94.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.629 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 51.1 t -62.77 -39.39 84.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.116 0.484 . . . . 0.0 110.726 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -69.15 -31.93 70.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.85 -15.1 63.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.006 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 35.6 m-85 -77.88 -23.59 48.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.91 133.47 40.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.809 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -66.76 154.53 91.58 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.412 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.58 123.64 12.63 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.779 2.319 . . . . 0.0 113.565 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -127.73 9.47 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.098 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 9.4 p90 -100.78 142.16 32.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.386 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.29 152.93 48.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.181 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.44 124.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.47 150.04 50.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.456 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.63 133.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.493 166.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -111.57 118.0 34.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.8 mt -134.91 36.09 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.33 0.586 . . . . 0.0 110.31 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -69.67 -10.66 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.682 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -103.65 5.34 36.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.628 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 156.99 17.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.785 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.48 -134.74 8.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.83 161.65 24.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.34 165.46 40.38 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.373 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 32.3 t -70.3 140.41 52.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.191 0.519 . . . . 0.0 110.099 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -129.56 139.42 51.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.96 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 24.4 m -114.35 118.57 34.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.671 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.08 166.6 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.28 139.22 42.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.7 t -72.72 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.157 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.0 25.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -122.55 149.41 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 0.0 111.232 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -159.27 144.88 16.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.715 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 121.38 -57.21 0.6 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.433 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 36.1 p90 -94.33 149.86 37.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.615 0.245 . . . . 0.0 110.436 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 14.1 Cg_exo -70.05 145.25 54.9 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.988 2.458 . . . . 0.0 112.297 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.1 63.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.092 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.44 -32.15 66.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.942 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.33 158.09 30.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.239 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.29 117.04 20.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.92 119.49 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.497 . . . . 0.0 111.345 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m -112.95 132.68 55.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 21.7 t -136.64 146.42 28.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.954 0.407 . . . . 0.0 110.76 -173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HG2' ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt0 -102.67 148.22 35.2 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 168.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.916 ' HD2' ' HG2' ' A' ' 87' ' ' GLU . 50.5 Cg_exo -7.03 128.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.525 3.483 . . . . 0.0 115.808 -134.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 66.9 mtt180 -92.1 -23.22 19.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.862 -170.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 70' ' ' THR . 84.2 mtp -106.31 136.74 45.5 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.357 173.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.15 148.01 43.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.963 0.411 . . . . 0.0 111.29 -171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -108.82 125.32 51.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 3.7 p -138.03 138.36 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.176 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 61.4 tt0 -107.08 120.55 42.4 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.111 0.481 . . . . 0.0 111.656 -173.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.74 129.48 53.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.984 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.49 142.27 49.15 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.462 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 36.0 tt0 -74.87 81.33 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -136.07 157.26 47.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.958 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.28 85.47 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' HG22 ' A' ' 101' ' ' VAL . 5.2 m -97.58 -63.61 1.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 100' ' ' THR . 3.2 m 59.1 -20.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.046 1.739 . . . . 0.0 114.621 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 100' ' ' THR . 23.1 t -118.36 101.95 8.57 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.36 94.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.556 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.89 139.15 39.07 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.711 2.274 . . . . 0.0 111.188 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 p -140.87 114.16 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.333 0.587 . . . . 0.0 111.715 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.663 HG23 ' H ' ' A' ' 108' ' ' GLU . 15.0 t -178.31 177.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.449 174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 107' ' ' VAL . 10.8 p -92.18 28.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 122.158 0.98 . . . . 0.0 109.783 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.663 ' H ' HG23 ' A' ' 106' ' ' THR . 9.8 tp10 -137.24 131.58 32.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.403 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 57.2 ttp -122.03 94.49 4.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.615 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 108' ' ' GLU . 9.1 tp -152.81 135.52 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -141.61 87.11 2.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 tp -89.6 117.22 28.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.578 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 14.5 pt-20 -72.45 99.97 2.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.192 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -140.59 32.99 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.961 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -63.78 117.7 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.33 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -125.05 137.17 54.22 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.64 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -83.44 107.83 16.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.636 0.731 . . . . 0.0 110.566 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -90.36 136.38 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.781 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.068 179.083 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.9 mtt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 4.8 Cg_exo -78.98 10.86 2.77 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.479 2.786 . . . . 0.0 112.402 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.6 p -79.23 158.82 27.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.41 141.63 58.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.938 0.399 . . . . 0.0 110.489 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -140.47 98.29 3.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 m170 75.7 141.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.0 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.13 175.45 32.2 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.261 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.965 ' HB3' ' HG2' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -140.18 139.29 35.66 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.021 0.439 . . . . 0.0 110.458 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.31 128.89 38.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -89.77 117.89 28.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.427 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 36' ' ' VAL . 95.7 mt -78.99 -22.15 45.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.36 -156.36 33.58 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.682 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.8 pt-20 -87.48 117.16 26.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 0.0 109.772 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -107.98 150.27 27.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.51 131.89 37.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 59' ' ' VAL . 10.5 tt -94.31 135.24 35.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.9 m -102.51 129.17 48.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.26 124.09 59.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.186 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -98.86 117.86 34.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 22' ' ' GLU . 5.9 p90 -152.01 179.31 8.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 -173.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 10.7 t70 -97.25 105.29 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 35.2 mt-10 -70.7 -28.1 64.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.163 -175.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -73.29 -1.34 17.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.679 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 11.5 mmt180 -108.39 -72.48 0.72 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 31.9 m-85 -123.59 165.59 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.278 . . . . 0.0 111.248 -170.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 98' ' ' ARG . 3.9 m-20 -109.79 160.36 16.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.32 115.87 29.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.683 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.569 ' HB ' ' HG3' ' A' ' 94' ' ' GLN . 44.7 t -87.65 -44.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.855 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 94' ' ' GLN . 45.5 tt0 -143.13 152.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -149.81 156.31 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.185 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.8 m -88.3 99.7 12.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.76 -51.04 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -167.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 p -128.68 150.84 50.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 88' ' ' PRO . 16.5 m -128.59 147.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.897 177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.89 120.55 33.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.038 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 86' ' ' VAL . 22.3 t -123.35 122.5 65.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.058 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.69 130.02 37.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.42 143.57 50.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.18 0.514 . . . . 0.0 112.053 -174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.965 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 51.0 mt-10 -120.66 167.27 12.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.849 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.9 -156.71 26.8 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.657 ' HD2' HD22 ' A' ' 82' ' ' LEU . 47.5 Cg_exo -57.19 119.81 7.31 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.008 2.472 . . . . 0.0 112.275 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -52.58 -31.07 34.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.12 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.14 70.82 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.707 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.9 -42.3 95.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 110.197 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.49 -49.23 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.199 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.2 m -68.67 -43.54 75.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.45 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.05 -43.17 97.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.659 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.08 -34.1 77.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.481 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -19.24 61.89 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.99 -20.81 34.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.72 156.31 17.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.046 0.45 . . . . 0.0 111.046 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -81.26 156.91 71.27 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.08 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.76 123.86 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.289 1.993 . . . . 0.0 113.303 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -121.78 8.39 9.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.785 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 36.2 p90 -95.23 135.83 36.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.48 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.1 154.0 51.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.093 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.86 130.54 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.71 150.57 50.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.389 0.614 . . . . 0.0 112.12 -173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 16' ' ' LEU . 60.5 t -134.24 134.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.753 168.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -99.07 110.22 22.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.11 26.04 4.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -66.36 -28.01 68.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.231 0.539 . . . . 0.0 110.336 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -95.7 5.17 52.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.042 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.99 140.42 34.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 25' ' ' TYR . . . -115.55 -131.47 4.94 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.668 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 42.4 mt-10 -67.88 162.08 24.93 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.953 0.406 . . . . 0.0 111.94 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.79 172.29 47.38 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.75 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -83.07 136.55 34.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.161 0.505 . . . . 0.0 109.647 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -125.45 122.43 36.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 8.4 m -116.25 115.39 25.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.45 167.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.733 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.18 151.09 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 88' ' ' PRO . 57.6 t -99.62 133.55 42.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.094 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -103.46 152.13 22.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.23 149.37 52.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.438 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -143.26 149.68 38.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 113.97 -74.25 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -83.32 143.33 44.74 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.46 160.69 9.56 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 113.026 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.1 37.76 2.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.591 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.14 -42.9 16.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.656 0.741 . . . . 0.0 109.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.657 HD22 ' HD2' ' A' ' 41' ' ' PRO . 40.8 mt -89.94 175.55 7.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.527 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 101.1 12.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.04 123.47 52.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.434 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -108.49 126.29 52.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.457 0.646 . . . . 0.0 110.565 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.21 162.22 15.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -146.08 91.33 5.55 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 115.154 -2.619 . . . . 0.0 114.681 148.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.673 ' HG3' HG12 ' A' ' 34' ' ' VAL . 60.0 Cg_endo -118.82 131.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 125.236 3.957 . . . . 0.0 106.828 111.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -76.97 -37.4 55.28 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.704 -1.599 . . . . 0.0 106.896 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' HG22 ' A' ' 70' ' ' THR . 63.1 mtt -136.48 155.97 49.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.019 165.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.59 142.95 47.13 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -107.22 125.49 51.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.452 0.644 . . . . 0.0 110.698 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.91 123.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 24.4 pt20 -107.94 128.46 54.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.198 0.523 . . . . 0.0 110.749 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 79.2 mt -114.79 139.01 50.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.127 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -131.54 144.28 50.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 134.14 56.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 8.9 ptp180 -71.49 179.08 3.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -57.16 -47.65 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.895 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.8 t -165.41 108.05 0.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.562 0.696 . . . . 0.0 111.688 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.19 97.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.76 . . . . 0.0 110.495 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -113.73 16.44 18.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.276 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 p -112.13 111.42 53.15 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.88 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.54 131.39 29.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.77 2.313 . . . . 0.0 111.475 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -99.15 105.14 16.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.898 0.38 . . . . 0.0 111.028 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.0 m -91.21 108.37 19.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.752 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.17 144.14 12.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.445 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.76 34.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttt -76.71 134.09 39.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.9 77.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.543 0.687 . . . . 0.0 111.043 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -121.72 2.74 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.635 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 113' ' ' GLU . 6.4 tt -144.71 108.39 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.135 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 9.3 tp10 -76.13 160.94 29.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.494 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 113' ' ' GLU . 30.0 m80 75.39 26.82 1.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.795 0.685 . . . . 0.0 110.552 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -78.07 -25.21 47.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.197 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.16 134.38 42.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.574 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -146.9 -55.61 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.584 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' HD2' ' H ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -168.77 -175.83 2.53 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' H ' ' HD2' ' A' ' 118' ' ' HIS . 87.6 m-70 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.567 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 65.1 mtt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.617 0.246 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -75.93 179.23 6.49 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.66 2.24 . . . . 0.0 111.357 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -90.16 11.32 21.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.718 1.247 . . . . 0.0 109.66 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -92.38 -164.31 1.16 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.695 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.4 t70 65.76 55.38 0.98 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -57.45 112.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.177 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' C ' HD22 ' A' ' 8' ' ' ASN . . . -70.17 154.86 52.9 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.489 -171.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 HD22 ' C ' ' A' ' 7' ' ' GLY . 0.8 OUTLIER -117.53 154.54 31.3 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.3 tp -146.81 123.97 11.49 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.246 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.779 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 14' ' ' LEU . 96.0 mt -79.34 -31.0 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.629 . . . . 0.0 109.419 174.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.51 -149.79 27.7 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.862 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 42.8 mt-10 -86.96 116.03 24.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.993 0.425 . . . . 0.0 110.677 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 11' ' ' LEU . 99.0 mt -96.9 147.08 24.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.554 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.24 124.48 25.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.25 112.52 21.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.71 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -93.66 128.7 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.466 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.766 HG13 HD12 ' A' ' 61' ' ' LEU . 79.6 t -106.37 120.91 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 85.3 mt -92.42 117.46 29.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 25.1 p90 -137.75 165.99 25.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.5 99.57 11.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.484 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.72 -6.51 41.81 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.746 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.28 -11.14 47.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.285 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -115.52 -60.43 1.88 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.272 -175.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.29 178.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.235 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 34.9 t70 -140.16 159.08 42.97 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.419 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.0 mt -73.29 120.07 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.573 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.42 -48.02 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 41.8 mt-10 -134.56 153.86 51.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.401 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -171.46 164.82 6.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -78.46 120.4 23.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -79.36 -48.74 13.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.912 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 4.0 p -139.11 147.43 41.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -129.25 149.89 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.221 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.29 122.19 36.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.314 -174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.64 128.61 75.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.121 0.486 . . . . 0.0 111.05 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -117.32 136.8 52.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.561 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.55 131.73 55.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.666 0.269 . . . . 0.0 111.325 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' ND2' ' A' ' 8' ' ' ASN . 34.3 mt-10 -123.86 166.49 15.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.013 0.435 . . . . 0.0 110.85 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.78 -159.29 27.9 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.549 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -58.02 127.97 27.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.859 2.372 . . . . 0.0 112.126 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 42' ' ' ARG . 16.0 ptt180 -52.84 -37.43 60.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.51 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.03 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.413 -175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.24 -38.87 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.597 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.53 -32.5 73.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 m -65.73 -45.59 82.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.172 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.99 -36.68 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.44 -28.81 67.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.415 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -73.58 -34.38 65.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.008 178.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -67.67 -31.71 71.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.308 0.575 . . . . 0.0 110.45 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.32 134.68 49.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.712 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 58.2 ttt180 -71.44 151.57 94.02 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 52' ' ' ARG . 4.2 Cg_endo -51.8 120.61 7.34 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 121.604 1.536 . . . . 0.0 112.582 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -137.53 3.37 2.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.876 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 53' ' ' PRO . 1.2 p90 -96.63 134.35 39.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.237 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.55 152.45 48.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.532 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.18 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.81 150.85 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.95 0.405 . . . . 0.0 111.108 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.41 133.92 61.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.519 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 11.5 t70 -83.14 120.12 25.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.766 HD12 HG13 ' A' ' 18' ' ' VAL . 46.9 mt -132.28 29.27 4.32 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.372 0.606 . . . . 0.0 109.458 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.5 p -65.92 -25.02 66.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.499 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -94.21 6.0 49.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.022 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.03 175.94 5.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.726 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.26 -113.97 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.057 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 144.7 52.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 112.121 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 136.49 0.22 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.656 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 t -71.61 134.24 46.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 28.9 m80 -128.42 137.5 51.88 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.474 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 90' ' ' MET . 1.8 m -111.01 120.94 44.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.021 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.41 157.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.441 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.05 131.75 41.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.01 129.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.309 0.576 . . . . 0.0 111.944 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.35 152.11 22.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.735 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -122.54 149.26 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -149.39 144.47 26.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.135 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 125.04 -72.15 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -76.4 144.74 74.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.36 143.82 78.0 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.719 2.279 . . . . 0.0 112.633 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.01 46.69 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.947 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.4 -19.79 8.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.611 0.72 . . . . 0.0 109.766 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.14 165.71 15.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.872 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -83.7 104.17 13.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.7 122.24 45.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -122.07 134.53 54.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.59 150.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 46.7 mt-10 -102.86 149.99 37.34 Favored Pre-proline 0 CA--C 1.501 -0.912 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 168.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 32.1 Cg_exo -7.22 127.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 124.445 3.43 . . . . 0.0 115.074 -133.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -93.44 -15.87 25.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.867 -168.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.619 ' HB3' HG22 ' A' ' 70' ' ' THR . 82.2 mtp -106.58 132.82 52.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.465 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.95 140.7 50.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 22.9 ptt85 -106.47 138.33 42.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.255 0.55 . . . . 0.0 110.317 -177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 61' ' ' LEU . 14.6 p -116.73 139.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.622 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 6.3 tp60 -117.42 119.08 33.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.83 124.68 45.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.63 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -131.05 143.51 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.16 78.74 2.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.96 153.79 32.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.724 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 88.86 5.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.236 0.541 . . . . 0.0 109.992 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -107.44 142.97 36.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.923 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 m -52.32 115.86 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.623 0.725 . . . . 0.0 111.507 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -86.28 82.32 8.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 26.7 m -103.58 144.87 29.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.445 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 17.2 Cg_exo -67.29 97.75 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.723 2.282 . . . . 0.0 112.427 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.32 88.04 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -92.34 -17.67 24.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.808 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.5 109.07 16.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -93.1 123.44 36.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.154 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.43 149.64 44.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.2 tt -130.39 92.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.72 0.771 . . . . 0.0 110.179 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.39 143.85 45.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.12 4.27 3.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.84 4.72 52.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.361 0.601 . . . . 0.0 110.177 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -66.31 90.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.231 0.539 . . . . 0.0 109.7 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -120.71 137.74 54.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.839 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.83 116.56 29.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.947 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -150.28 130.49 13.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -158.21 148.39 20.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.962 0.41 . . . . 0.0 110.983 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.2 p80 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.38 114.02 2.18 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.472 2.115 . . . . 0.0 111.132 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.584 HG21 ' HA3' ' A' ' 43' ' ' GLY . 25.5 p -68.27 135.51 52.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.45 0.643 . . . . 0.0 111.69 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.88 -165.06 1.25 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.227 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.86 101.51 0.04 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.848 0.717 . . . . 0.0 111.127 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 19.0 m-70 -77.45 99.47 5.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.209 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.94 179.65 26.24 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.0 m120 -124.67 154.08 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.079 0.466 . . . . 0.0 110.204 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -141.38 124.74 16.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.651 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -80.5 128.93 34.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.493 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -91.39 -7.18 51.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.29 -177.4 34.93 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.584 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -86.58 112.73 21.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HE1' ' A' ' 55' ' ' TYR . 89.8 mt -96.53 133.94 40.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.056 -173.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.05 138.26 38.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.47 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 59' ' ' VAL . 30.9 tp -82.53 137.26 34.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 111.281 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 28.6 m -109.88 116.73 32.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.829 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.0 132.45 53.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.106 0.479 . . . . 0.0 111.246 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 77.6 mt -102.2 118.28 36.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.41 -166.58 2.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.214 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -119.52 104.43 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.0 110.607 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.87 -7.01 58.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.646 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.13 -1.4 40.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.614 0.245 . . . . 0.0 111.564 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -137.21 -62.54 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.801 0.334 . . . . 0.0 110.708 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -106.74 157.61 17.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -121.52 162.36 20.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.694 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HE21 ' A' ' 30' ' ' GLN . 64.2 mt -73.97 121.28 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.957 0.408 . . . . 0.0 111.252 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 96' ' ' GLU . 65.1 t -101.09 -47.69 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.346 0.593 . . . . 0.0 110.165 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 102' ' ' SER . 49.0 mt-10 -134.37 153.86 51.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.486 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.402 HE21 HG21 ' A' ' 27' ' ' ILE . 7.6 tt0 -158.11 153.99 26.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -91.78 106.64 18.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.35 -58.96 3.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -129.1 146.57 51.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 112.109 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.4 155.73 41.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.782 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.52 133.9 47.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.865 0.365 . . . . 0.0 110.733 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.02 123.35 66.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 16.5 t70 -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.19 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 90.9 mt -112.79 124.38 52.45 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 2.1 tm-20 -116.91 135.3 53.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . 150.57 -153.51 25.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.497 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 122.76 11.86 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.227 2.618 . . . . 0.0 112.554 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -54.02 -35.34 61.83 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.138 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' HG21 ' A' ' 3' ' ' THR . . . -64.8 -45.38 92.81 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.67 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.1 t -57.33 -43.63 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 109.992 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.54 -42.48 96.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -69.62 -45.12 69.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.6 t -62.55 -44.27 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.027 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -64.37 -29.14 70.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.075 0.464 . . . . 0.0 110.393 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' ARG . 2.1 mmt180 -75.21 -13.95 60.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.948 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 30.0 m-85 -79.89 -21.99 43.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.05 166.19 12.06 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.502 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -84.99 154.16 60.57 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.593 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.25 124.34 12.41 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.194 1.929 . . . . 0.0 112.222 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 m -137.95 34.66 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.096 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.563 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 14.2 p90 -106.76 132.86 52.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.027 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -117.12 144.63 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.949 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 75' ' ' HIS . 15.5 m -120.04 124.13 72.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 17' ' ' THR . 42.3 p90 -143.12 154.21 43.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.269 -171.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 16' ' ' LEU . 39.6 t -124.75 135.65 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.084 174.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 12.9 t70 -113.3 107.13 15.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.767 0.318 . . . . 0.0 110.291 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 91.7 mt -138.07 86.3 2.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.0 p -98.11 -15.39 19.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.728 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.3 -2.4 42.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.905 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -72.7 119.46 16.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.02 -131.71 7.25 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.165 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -75.71 157.51 33.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.183 0.516 . . . . 0.0 111.511 -174.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.69 158.54 19.0 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.054 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 t -74.35 135.0 42.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.351 0.595 . . . . 0.0 109.596 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 35.9 m80 -114.42 121.97 45.21 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.66 -176.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -104.88 115.78 30.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.831 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.6 167.88 24.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.606 0.241 . . . . 0.0 110.707 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.98 144.27 50.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.159 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.28 126.58 50.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.021 0.439 . . . . 0.0 111.102 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 150.81 20.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.655 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.568 ' HB3' HG12 ' A' ' 57' ' ' VAL . 1.7 p80 -147.68 150.73 34.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 111.655 -175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -142.0 164.46 30.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.34 -55.85 0.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -101.7 143.0 25.72 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -92.96 153.92 2.69 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.413 2.075 . . . . 0.0 112.988 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.1 31.09 2.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.746 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.12 -29.24 63.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.54 0.686 . . . . 0.0 109.553 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.59 -164.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.711 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -89.59 113.21 24.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.845 0.355 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.78 125.84 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 25.4 m -109.43 132.1 54.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 89' ' ' ARG . 40.2 t -133.26 140.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.305 -174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 38.4 mt-10 -102.97 150.23 37.61 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 170.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 52.6 Cg_exo -5.8 128.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.638 3.558 . . . . 0.0 115.443 -134.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HG2' ' HB ' ' A' ' 86' ' ' VAL . 69.4 mtt180 -102.0 -27.05 13.17 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.626 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.596 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.0 ttt -105.57 120.56 41.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.359 -1.292 . . . . 0.0 107.683 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.62 146.44 45.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.985 0.421 . . . . 0.0 111.326 -170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 30.2 ptt85 -107.26 135.78 48.2 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.312 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.54 138.08 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.724 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -111.47 121.48 45.3 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.643 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.36 124.05 48.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.844 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 28' ' ' VAL . 9.6 tp10 -150.14 144.14 25.5 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 98' ' ' ARG . 24.9 tt0 -58.33 130.8 48.41 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.351 0.407 . . . . 0.0 110.807 -176.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 23.3 ttp85 83.24 140.35 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.602 1.189 . . . . 0.0 111.955 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.09 119.81 17.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.052 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.6 m -138.08 96.0 3.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.067 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.85 118.18 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.247 0.546 . . . . 0.0 110.469 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 18.3 m -96.07 137.75 34.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.0 p -113.27 110.11 51.05 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 6.0 Cg_exo -79.62 98.25 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.935 2.424 . . . . 0.0 111.119 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.54 -36.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 m 67.01 109.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 123.825 0.703 . . . . 0.0 111.352 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.59 133.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.808 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.95 124.3 27.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.833 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -103.71 143.36 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.949 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.99 -172.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -136.85 152.15 49.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.47 157.09 47.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.08 139.21 53.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -103.61 130.55 51.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.825 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -96.66 139.58 32.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -105.54 121.35 43.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.207 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -99.49 140.65 33.36 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.215 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -92.16 173.49 7.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.8 t60 . . . . . 0 C--O 1.245 0.849 0 CA-C-O 117.951 -1.023 . . . . 0.0 108.822 175.098 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.071 0.462 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -91.49 28.23 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.285 2.657 . . . . 0.0 110.823 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 p -71.23 117.75 13.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.203 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -66.04 126.33 28.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.76 98.23 3.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.16 0.505 . . . . 0.0 110.019 -170.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -86.29 157.77 19.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 42' ' ' ARG . . . -117.1 160.54 13.47 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.362 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.46 146.86 44.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.464 HD11 ' HD3' ' A' ' 49' ' ' ARG . 54.6 tp -148.9 147.41 28.64 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.416 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -125.37 124.0 40.57 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 96.0 mt -77.64 -14.65 59.57 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.9 -162.07 42.5 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 54.3 mt-10 -81.96 115.5 21.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.91 0.386 . . . . 0.0 110.534 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.66 147.41 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -82.59 127.33 33.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tt -91.73 131.1 37.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.101 0.477 . . . . 0.0 110.504 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 31.5 m -108.03 137.28 46.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.7 122.15 60.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.763 0.316 . . . . 0.0 110.916 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.4 mt -92.02 116.93 29.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 170.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.05 -25.38 0.21 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.439 -171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 21.2 t70 69.28 120.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.983 0.802 . . . . 0.0 110.274 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.69 2.68 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.503 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.81 -8.03 24.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.724 0.297 . . . . 0.0 110.45 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 6.4 mmp_? -84.51 -65.57 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 0.0 109.894 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' LEU . 84.5 m-85 -141.59 172.5 12.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.917 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.44 160.81 18.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.3 mt -91.2 123.23 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.993 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -109.19 -32.98 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.298 0.57 . . . . 0.0 110.352 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 3.5 tm-20 -142.36 153.55 43.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -168.33 166.58 12.45 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.491 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.5 m -99.62 108.62 21.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.472 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -77.66 0.05 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 8.9 p -131.55 146.57 52.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.507 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.86 HG11 ' HD3' ' A' ' 88' ' ' PRO . 6.7 t -125.72 148.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.715 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -90.56 135.82 33.46 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.12 0.486 . . . . 0.0 110.305 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 86' ' ' VAL . 26.0 t -127.48 135.45 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.014 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 8.7 m-20 -126.39 153.92 44.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.423 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.79 133.98 42.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.682 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -126.29 146.18 50.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.84 -159.12 27.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.355 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.18 109.75 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.829 2.353 . . . . 0.0 111.863 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.686 ' HB3' ' HA3' ' A' ' 7' ' ' GLY . 3.4 ppt_? -59.68 -26.82 65.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.84 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.58 -39.17 65.49 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.243 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.02 -43.83 78.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.209 0.528 . . . . 0.0 110.288 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.13 -44.49 92.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.661 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m -60.49 -42.79 97.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.498 0.19 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' GLY . 63.7 t -63.59 -38.58 82.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.213 0.53 . . . . 0.0 110.299 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -69.2 -34.36 74.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.162 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' HD11 ' A' ' 9' ' ' LEU . 15.4 mmm180 -75.13 -17.47 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.313 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -70.82 -29.76 66.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 110.545 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.03 160.35 18.65 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.672 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -85.0 156.86 60.47 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.371 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TYR . 3.7 Cg_endo -50.6 122.19 9.21 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.282 1.988 . . . . 0.0 112.943 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -130.92 8.7 4.84 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.495 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 0.4 OUTLIER -91.38 125.99 36.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.42 -178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -130.16 151.42 50.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.475 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.13 124.37 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.3 p90 -150.89 152.78 34.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.68 144.69 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.099 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 19.4 t70 -107.55 104.86 14.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 110.385 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -129.35 111.06 12.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.513 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 p -108.04 -34.48 6.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -110.92 -23.85 10.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.08 115.16 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.7 -82.41 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.472 -172.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -47.33 144.76 2.7 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . 67.63 -125.94 23.79 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -172.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 t -142.08 146.04 34.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.6 122.89 48.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.019 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 27.6 m -106.07 116.64 32.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.672 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.39 165.45 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.634 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -85.2 139.95 31.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.97 130.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.87 151.89 22.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.445 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -121.66 152.15 39.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.738 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -126.11 162.94 24.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.43 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 100.27 -70.61 0.47 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.468 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.44 144.18 27.48 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -88.85 179.38 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.823 2.349 . . . . 0.0 112.194 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.66 29.58 7.74 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.535 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.42 -39.47 62.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.332 0.587 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.82 173.75 7.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.22 107.43 13.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.06 118.99 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 37' ' ' ASP . 3.6 m -114.82 132.83 56.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -139.65 167.18 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' OE2' ' HG3' ' A' ' 89' ' ' ARG . 16.2 tp10 -143.32 86.75 8.85 Favored Pre-proline 0 N--CA 1.436 -1.152 0 C-N-CA 115.279 -2.569 . . . . 0.0 113.191 150.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HD3' HG11 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -124.45 128.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.728 1 C-N-CA 126.198 4.598 . . . . 0.0 107.453 114.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HG3' ' OE2' ' A' ' 87' ' ' GLU . 46.8 mtt180 -89.11 -26.07 21.55 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.437 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.549 ' HB3' HG22 ' A' ' 70' ' ' THR . 89.3 mtp -143.35 146.61 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.433 -2.167 . . . . 0.0 105.958 160.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -117.19 150.99 37.82 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.553 -169.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 92' ' ' ARG . 39.0 ttm180 -113.33 125.64 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.883 -169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.48 131.09 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.168 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 59.0 tt0 -111.36 120.84 43.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.054 0.454 . . . . 0.0 110.882 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . 99.0 mt -115.77 124.63 51.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.465 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.45 143.94 42.06 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.22 121.98 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.24 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 69.38 145.18 0.05 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.366 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.99 127.75 22.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.254 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.5 p -91.93 -166.25 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.398 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.81 130.5 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.913 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 m -83.29 83.58 7.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.034 0.445 . . . . 0.0 110.88 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 p -117.31 106.3 47.17 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.524 0.678 . . . . 0.0 110.823 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 1.7 Cg_endo -82.31 96.64 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.142 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 107' ' ' VAL . 4.9 p -133.9 114.33 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -100.32 90.79 4.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 0.0 110.337 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 105' ' ' VAL . 4.8 m -92.55 90.43 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.143 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.66 93.66 4.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -162.61 85.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.426 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.85 105.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.605 0.717 . . . . 0.0 110.817 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -131.37 109.4 10.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -101.74 148.47 25.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.274 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -112.2 141.63 45.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.1 75.59 0.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 110.304 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -116.44 113.96 23.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.048 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -154.12 132.17 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.212 0.529 . . . . 0.0 111.937 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -176.69 114.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.227 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -142.66 90.13 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.348 0.594 . . . . 0.0 110.975 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t60 . . . . . 0 C--O 1.242 0.707 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.844 177.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.35 116.31 3.16 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.431 2.088 . . . . 0.0 111.178 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -131.65 151.49 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -89.59 138.56 31.36 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.42 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.75 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 12.1 t70 -100.37 72.23 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -131.23 126.99 36.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.317 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.92 -174.37 23.25 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.048 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.57 163.85 25.1 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.3 tp -153.13 122.33 6.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.073 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -96.94 113.25 24.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.13 -37.03 86.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.946 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.29 -154.6 16.4 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.016 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.0 pt-20 -91.97 127.59 37.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.2 135.16 52.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.93 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.15 131.29 38.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.182 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 59' ' ' VAL . 9.7 tt -87.1 132.58 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 12.9 m -107.94 137.01 46.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.357 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 93' ' ' VAL . 66.7 t -106.04 124.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.954 0.407 . . . . 0.0 111.087 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.0 mt -106.86 118.15 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HD2' ' H ' ' A' ' 22' ' ' GLU . 50.3 p90 -144.91 151.35 38.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.364 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -108.72 32.6 4.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.156 0.979 . . . . 0.0 109.056 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' ' HD2' ' A' ' 20' ' ' TYR . 29.6 mm-40 -117.73 69.0 0.77 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.79 -174.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' HG2' HG13 ' A' ' 105' ' ' VAL . 35.3 mt-10 -63.65 -0.55 1.01 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.091 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 24' ' ' ARG . 29.9 mtt85 -83.1 -20.53 34.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.356 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 22' ' ' GLU . 35.1 m-85 -123.48 149.43 45.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.264 -172.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -113.21 162.21 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.24 106.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -84.58 -43.69 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.98 0.419 . . . . 0.0 110.675 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.35 153.41 51.91 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 25.3 pt20 -178.4 166.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 m -79.43 110.21 14.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.88 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.97 -171.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -128.09 145.87 50.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 88' ' ' PRO . 19.0 m -128.22 156.9 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.05 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -111.31 132.68 54.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.692 HG22 HG13 ' A' ' 86' ' ' VAL . 20.9 t -121.64 133.76 67.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.229 0.538 . . . . 0.0 111.271 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 4.5 t70 -127.03 143.82 51.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.066 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.17 123.73 50.31 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -118.04 136.14 53.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.316 -176.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.38 -154.4 25.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.766 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 5' ' ' ASP . 12.1 Cg_endo -57.09 117.57 4.28 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.965 2.443 . . . . 0.0 112.032 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -62.0 -28.36 69.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 -178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -56.46 -48.99 72.03 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -42.99 98.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 42' ' ' ARG . 92.8 mt -58.47 -39.88 81.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.104 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 m -66.11 -38.9 89.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.5 t -66.17 -40.25 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.535 . . . . 0.0 110.365 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.383 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -14.45 62.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.19 -20.69 20.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.017 0.437 . . . . 0.0 111.007 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.9 136.61 34.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 52' ' ' ARG . 52.7 mtt180 -74.39 154.02 87.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.84 121.75 8.64 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.921 1.748 . . . . 0.0 112.574 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.1 m -134.26 18.74 3.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.057 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 32.3 p90 -101.49 139.91 36.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.336 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -127.65 155.24 44.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.84 124.22 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 62.1 m-85 -133.23 156.57 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 111.519 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 16' ' ' LEU . 38.6 t -124.78 134.04 67.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 165.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.56 116.05 31.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.29 40.02 3.81 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.093 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.1 p -81.97 -21.7 37.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.485 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.97 -28.71 13.3 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.15 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.61 153.36 39.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.855 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.93 -138.93 10.31 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.027 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -88.8 -177.9 5.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.597 -172.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 -173.39 29.38 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.49 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 23.1 t -85.01 132.57 34.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.582 0.706 . . . . 0.0 109.295 172.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -133.73 126.2 30.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' HB3' ' A' ' 90' ' ' MET . 13.4 m -98.42 116.97 31.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 -177.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.6 167.28 25.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.1 151.42 25.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.268 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.09 128.76 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.85 152.78 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.954 173.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -151.06 149.44 29.54 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.578 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' ARG . 17.3 mmt180 -147.3 154.25 40.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.169 0.509 . . . . 0.0 111.157 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 132.2 -59.96 0.68 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -87.7 153.16 52.52 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.55 136.71 60.22 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.893 2.396 . . . . 0.0 112.941 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.54 86.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.605 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.11 -55.3 36.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.377 0.608 . . . . 0.0 110.278 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.43 163.03 9.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.939 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -79.78 111.82 16.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.94 112.42 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 1.9 m -101.0 122.78 44.13 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.435 0.636 . . . . 0.0 109.408 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.21 153.57 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.34 87.7 46.42 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 114.633 -2.827 . . . . 0.0 114.022 155.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 58.2 Cg_endo -121.06 128.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.599 1 C-N-CA 125.726 4.284 . . . . 0.0 106.707 110.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 89' ' ' ARG . 37.3 mtt-85 -92.17 -39.56 11.5 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.81 -1.556 . . . . 0.0 107.756 -176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.52 ' HB3' HG22 ' A' ' 70' ' ' THR . 88.4 mtp -130.36 134.08 46.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.691 162.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.95 149.27 41.89 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.002 0.429 . . . . 0.0 110.674 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 3.0 ptp180 -106.5 129.14 54.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.408 HG11 HG11 ' A' ' 18' ' ' VAL . 40.8 t -129.22 120.95 52.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 54.0 tt0 -98.58 119.15 36.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.891 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.34 123.72 47.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -116.47 135.92 53.42 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.016 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 6.8 pt-20 -79.08 74.2 5.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -94.32 176.13 6.42 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.956 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -76.78 0.19 21.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.207 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 p -108.63 96.92 6.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.48 15.31 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 6.0 p -95.85 37.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.962 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -93.83 108.0 31.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.552 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 102' ' ' SER . 73.1 Cg_endo -93.36 133.49 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.034 2.489 . . . . 0.0 112.628 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 23' ' ' GLU . 28.8 m -82.22 -18.91 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.143 0.497 . . . . 0.0 110.622 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 m -81.32 62.39 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.75 0.786 . . . . 0.0 110.329 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.13 -43.11 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.082 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.87 129.08 11.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.001 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.7 mtp -76.62 73.42 3.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 0.0 110.828 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' O ' HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -115.42 1.5 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 174.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -77.04 125.91 30.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.808 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.0 mt -93.18 -175.3 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.413 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.87 99.49 6.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.429 0.633 . . . . 0.0 110.893 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -134.37 104.5 6.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.35 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.72 108.37 5.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.0 98.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -65.61 138.27 57.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 69.54 70.02 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.471 179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 44.1 t-80 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.909 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.02 -9.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.739 2.292 . . . . 0.0 112.688 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 140.79 35.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -100.91 142.77 31.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 111.478 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -141.98 93.17 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.296 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -75.48 143.59 42.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.307 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.08 173.7 15.74 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.853 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -124.02 142.64 51.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.1 tp -154.15 122.92 6.28 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' ASP . 2.7 p -105.69 132.63 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 111.561 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 mt -75.8 -20.74 57.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.576 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -173.99 34.07 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.74 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 4.9 mp0 -72.69 104.73 4.03 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.142 0.496 . . . . 0.0 110.504 175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.6 169.06 9.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.456 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 135.0 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.402 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 31' ' ' THR . 63.4 tp -87.13 113.12 22.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 18.3 m -91.63 137.3 32.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.411 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 27' ' ' ILE . 61.4 t -111.7 120.49 62.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.837 0.351 . . . . 0.0 110.173 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -92.28 117.27 29.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -151.4 178.83 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' ARG . 26.4 t70 -102.16 124.62 48.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -36.52 67.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.496 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.78 7.61 23.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.816 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -104.37 -76.35 0.6 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.565 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 82.9 m-85 -148.4 -178.8 6.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.72 161.52 34.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 ' HB ' ' A' ' 18' ' ' VAL . 18.2 mt -75.64 112.98 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -173.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' GLU . 93.2 t -89.67 -49.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 94' ' ' GLN . 0.3 OUTLIER -142.23 154.15 44.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -171.51 -177.42 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.776 -172.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -87.09 110.22 19.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -61.3 -57.28 13.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.734 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 p -128.85 152.9 48.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.72 ' CG1' ' HD3' ' A' ' 88' ' ' PRO . 42.6 t -124.91 147.46 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.772 177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -103.05 123.42 46.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 19.6 t -117.4 129.29 74.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 28.2 t70 -135.45 144.58 46.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.058 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.81 143.34 51.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 111.338 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 23.6 mt-10 -125.87 138.61 53.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.238 173.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 177.78 -174.99 47.31 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.654 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.08 154.45 74.45 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.85 2.367 . . . . 0.0 112.243 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -59.33 -39.12 82.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.293 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.33 72.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -67.53 -47.1 81.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.828 0.314 . . . . 0.0 111.013 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.2 -43.81 97.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.908 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.3 m -65.44 -43.97 88.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.076 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.644 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 95.2 t -64.78 -40.97 90.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.035 0.445 . . . . 0.0 110.43 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.474 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 49' ' ' ARG . 1.2 mmt180 -74.09 -15.0 61.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.082 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 37.8 m-85 -76.54 -23.3 53.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 110.477 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.94 143.22 26.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.026 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -85.61 161.44 50.95 Favored Pre-proline 0 N--CA 1.445 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.994 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.61 122.81 10.8 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 121.925 1.75 . . . . 0.0 113.164 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 p -128.81 4.76 5.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.15 0.976 . . . . 0.0 109.331 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.573 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 8.1 p90 -86.93 157.39 19.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.326 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -143.54 144.54 32.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.529 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.93 124.12 71.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 17' ' ' THR . 44.6 p90 -150.62 161.76 41.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.184 0.516 . . . . 0.0 111.98 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 m -124.73 139.42 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.768 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.67 109.99 22.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.694 0.283 . . . . 0.0 110.576 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.6 mt -131.27 73.88 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.204 0.526 . . . . 0.0 111.44 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -104.08 -29.98 10.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.431 0.634 . . . . 0.0 109.759 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -74.17 -41.72 61.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.818 173.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.88 40.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.844 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.47 -108.16 1.48 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.908 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -69.62 147.87 50.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.164 0.507 . . . . 0.0 111.084 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.64 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 92' ' ' ARG . 8.9 t -68.5 133.82 49.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.278 0.561 . . . . 0.0 109.54 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 34.9 m80 -119.97 128.38 53.51 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.462 -172.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 90' ' ' MET . 1.8 m -98.8 116.07 30.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.3 168.52 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.306 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.59 29.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG21 ' HG2' ' A' ' 88' ' ' PRO . 46.5 t -89.36 131.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.109 0.481 . . . . 0.0 112.128 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 152.18 19.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.649 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -153.58 149.76 27.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.638 0.256 . . . . 0.0 110.578 -177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 76' ' ' ARG . 5.2 ttm180 -154.22 163.46 40.09 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 106.46 -62.44 0.31 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.706 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 44.8 p90 -89.49 143.94 31.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_exo -76.49 132.3 13.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.016 2.477 . . . . 0.0 112.224 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 84' ' ' VAL . . . -87.9 27.24 6.78 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.022 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.64 -27.48 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.512 0.672 . . . . 0.0 110.174 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' A' ' 40' ' ' GLY . 77.1 mt -88.08 -176.9 5.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.899 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.57 102.16 9.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 80' ' ' GLY . 59.5 t -96.11 128.4 47.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.675 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.3 m -121.36 124.3 44.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.662 0.744 . . . . 0.0 110.255 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.82 156.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.88 94.55 5.0 Favored Pre-proline 0 N--CA 1.436 -1.156 0 C-N-CA 114.224 -2.99 . . . . 0.0 115.869 156.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.72 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 19.1 Cg_endo -114.59 126.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 124.309 3.339 . . . . 0.0 104.929 106.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 89' ' ' ARG . 19.3 mtm180 -85.9 -26.07 25.8 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 117.856 -1.537 . . . . 0.0 107.911 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG2' HG22 ' A' ' 70' ' ' THR . 11.2 ttt -142.88 135.7 27.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.926 -1.943 . . . . 0.0 105.835 163.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.63 129.9 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.265 0.555 . . . . 0.0 111.398 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.57 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 42.0 ttm180 -107.55 131.39 54.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.73 -176.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.3 t -132.45 134.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.17 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.83 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 4.2 tp60 -101.78 121.77 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . 88.7 mt -111.89 123.93 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 28' ' ' VAL . 10.4 tp10 -129.7 145.95 51.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.931 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.79 110.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 98' ' ' ARG . 42.6 ttp-105 68.73 164.0 0.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.663 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . 87.2 mm-40 -55.61 131.38 46.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.039 0.536 . . . . 0.0 111.997 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.9 m -125.14 141.53 52.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.2 90.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.439 0.638 . . . . 0.0 111.407 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -151.64 21.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.292 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.55 115.65 47.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.268 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.95 143.58 10.5 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.2 m -77.49 118.69 24.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 t -65.65 111.13 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.591 0.71 . . . . 0.0 111.693 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 m -141.16 154.58 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.717 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.03 147.15 28.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -79.82 90.35 5.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.123 0.487 . . . . 0.0 110.099 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.414 HD13 ' C ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -144.66 112.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.47 175.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -179.42 135.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.559 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 -1.51 58.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 73.11 103.87 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.662 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -142.74 125.77 16.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.391 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.93 92.92 4.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.273 0.559 . . . . 0.0 110.514 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -104.04 130.95 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.931 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -136.0 113.38 10.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.752 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -118.75 138.48 52.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.476 177.229 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.72 -53.59 4.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.753 2.302 . . . . 0.0 111.795 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -98.73 -166.35 1.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -99.28 128.33 45.39 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.378 0.609 . . . . 0.0 111.536 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 17.9 t70 -101.22 74.7 1.59 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 38.5 m170 72.07 178.08 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.925 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.23 160.76 19.82 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.747 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -121.72 141.2 51.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.118 0.485 . . . . 0.0 109.801 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.63 HD11 HH21 ' A' ' 49' ' ' ARG . 3.0 tm? -145.91 124.55 12.52 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.005 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -106.6 139.5 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.923 0.392 . . . . 0.0 110.478 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 36' ' ' VAL . 90.1 mt -84.39 -9.25 58.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.137 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.76 -170.25 45.65 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 21.5 mm-40 -76.11 108.2 8.85 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 36' ' ' VAL . 87.7 mt -95.72 148.83 22.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.69 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.61 129.06 37.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.65 ' HG ' ' HB ' ' A' ' 31' ' ' THR . 1.8 tm? -83.62 116.55 22.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 32.8 m -91.27 133.49 35.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.609 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.73 127.05 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 87.3 mt -95.54 118.62 32.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -157.63 176.33 12.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.035 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -110.1 108.1 18.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.115 176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.3 -7.68 55.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.844 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -73.96 -36.08 64.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 109.932 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -105.89 -47.08 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.328 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 65' ' ' GLY . 71.5 m-85 -116.77 152.45 34.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.527 0.68 . . . . 0.0 112.54 -169.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 16.3 t70 -125.29 152.55 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.333 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.86 110.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.143 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG22 ' HG3' ' A' ' 99' ' ' GLN . 6.5 t -82.06 -50.24 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.61 156.18 41.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.852 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -157.47 178.84 9.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.65 ' HB ' ' HG ' ' A' ' 16' ' ' LEU . 12.1 m -74.03 127.72 33.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 32' ' ' GLU . 5.6 pt-20 -76.24 -57.86 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.652 0.263 . . . . 0.0 111.082 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 13' ' ' GLU . 36.5 p -136.23 156.04 49.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' CG ' ' A' ' 88' ' ' PRO . 2.0 m -123.22 147.53 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 111.621 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -96.16 114.69 26.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.846 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 11' ' ' LEU . 21.2 t -114.81 119.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.891 0.376 . . . . 0.0 110.272 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -115.85 130.59 56.9 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.98 124.34 51.41 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 44.4 mt-10 -119.66 162.92 18.18 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.285 0.564 . . . . 0.0 110.949 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.19 -153.41 20.55 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.99 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.68 121.69 10.46 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.888 2.392 . . . . 0.0 112.219 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -60.57 -29.32 69.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.668 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 42' ' ' ARG . . . -61.11 -48.77 84.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.105 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.75 -40.1 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.371 . . . . 0.0 110.486 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 42' ' ' ARG . 82.0 mt -58.91 -40.42 84.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.729 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -69.14 -47.28 65.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.718 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 61.0 t -61.5 -38.04 79.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.761 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -62.73 -36.99 84.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.63 HH21 HD11 ' A' ' 9' ' ' LEU . 12.4 tpp180 -75.12 -18.74 60.18 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.522 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 13.9 m-85 -72.33 -28.04 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.142 0.496 . . . . 0.0 111.015 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.77 155.71 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.65 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -65.11 152.3 91.74 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.85 122.62 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.111 1.874 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -125.16 3.96 7.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.629 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.574 ' HB3' ' HD1' ' A' ' 78' ' ' PHE . 10.9 p90 -80.16 123.47 27.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.736 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -138.18 143.33 40.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.04 124.5 73.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 48.8 p90 -142.64 154.09 44.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 111.085 -175.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 16' ' ' LEU . 19.0 t -124.22 134.3 67.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 15.9 t70 -103.13 109.2 20.69 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.144 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 97.1 mt -133.4 29.86 3.91 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.486 0.66 . . . . 0.0 109.379 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -62.4 -24.69 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.19 3.44 55.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.035 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.97 141.04 33.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 25' ' ' TYR . . . -96.74 -129.14 6.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.232 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 35.4 mt-10 -83.78 154.96 23.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 111.641 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.69 168.26 31.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.651 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 40.6 t -82.14 143.14 31.66 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 66.3 m80 -127.89 121.42 29.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.467 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 90' ' ' MET . 7.1 m -112.02 116.99 31.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.345 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.13 167.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.34 136.95 34.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.48 128.3 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -170.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.74 150.64 22.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.335 173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.72 150.38 51.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.94 0.4 . . . . 0.0 111.692 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -136.29 156.0 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.44 -76.62 0.36 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.595 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 55' ' ' TYR . 23.1 p90 -80.02 143.63 57.66 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 152.07 25.34 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.445 2.097 . . . . 0.0 112.247 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.6 41.46 2.7 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.718 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.37 -33.28 22.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.512 0.672 . . . . 0.0 109.737 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.94 179.3 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.506 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -81.0 110.3 16.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.7 116.43 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.24 -173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.653 HG21 ' CE1' ' A' ' 116' ' ' HIS . 6.9 m -117.71 128.93 55.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.561 0.696 . . . . 0.0 110.445 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.23 116.35 32.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -127.02 92.49 44.2 Favored Pre-proline 0 N--CA 1.428 -1.565 0 C-N-CA 113.724 -3.19 . . . . 0.0 116.505 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' CG ' HG12 ' A' ' 34' ' ' VAL . 18.0 Cg_endo -111.67 126.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.62 0 C-N-CA 124.797 3.664 . . . . 0.0 104.228 102.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -86.19 -23.13 26.62 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.551 -1.259 . . . . 0.0 108.757 -169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 70' ' ' THR . 10.0 ttt -140.53 122.06 15.14 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.605 -1.634 . . . . 0.0 106.852 168.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.71 45.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.005 0.431 . . . . 0.0 110.956 -171.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 92' ' ' ARG . 10.4 ptp85 -107.77 134.7 50.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.132 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 60.0 t -125.48 121.36 60.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 64.4 tt0 -98.38 120.41 38.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' GLU . 98.7 mt -115.69 133.41 56.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.461 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -139.71 144.54 37.58 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.86 91.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.13 0.491 . . . . 0.0 110.163 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 21.6 tpp180 56.26 125.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.479 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.761 ' HG3' HG22 ' A' ' 28' ' ' VAL . 4.3 mm-40 -120.88 -80.06 0.62 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.81 -1.541 . . . . 0.0 107.874 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 9.4 t 171.23 76.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.017 0.823 . . . . 0.0 111.285 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.1 t -83.44 74.36 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 122.0 0.905 . . . . 0.0 108.783 169.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 p -112.84 6.91 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.954 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.76 132.61 21.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.01 131.71 26.13 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.351 2.034 . . . . 0.0 111.509 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.61 141.38 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.3 t -108.19 107.54 18.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.995 0.902 . . . . 0.0 109.496 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.9 96.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.448 -172.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.41 136.27 41.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.363 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -82.18 97.96 8.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.13 0.49 . . . . 0.0 110.945 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 11.1 pt -77.13 106.26 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.757 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -78.51 88.59 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.839 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.23 107.25 18.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.437 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.867 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.67 120.29 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 111.511 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -105.6 93.71 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.653 ' CE1' HG21 ' A' ' 85' ' ' THR . 1.4 t60 -73.13 155.37 39.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.704 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.525 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 6.1 t-80 75.4 102.6 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.751 0.657 . . . . 0.0 110.696 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -102.97 -18.37 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 110.459 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.941 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.781 0.324 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.57 135.04 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.163 2.575 . . . . 0.0 111.502 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -72.49 176.42 5.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -80.73 130.79 35.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.468 0.652 . . . . 0.0 111.542 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 31.0 t70 -117.42 87.61 2.74 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 5' ' ' ASP . 2.0 p-80 65.71 157.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 125.016 1.448 . . . . 0.0 110.112 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.16 163.69 15.49 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -120.36 148.86 43.21 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -147.73 125.89 12.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.549 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -98.04 116.43 30.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.041 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 36' ' ' VAL . 92.6 mt -71.41 -28.44 64.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 100.61 -145.9 17.35 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.241 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 5.0 pt-20 -104.54 106.71 17.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.302 0.572 . . . . 0.0 110.507 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.62 146.25 25.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -73.21 144.02 46.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.697 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 59' ' ' VAL . 41.1 tp -85.14 120.87 27.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 177.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 58' ' ' PHE . 28.5 m -88.93 118.39 28.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.057 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.8 114.73 45.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.182 0.515 . . . . 0.0 110.613 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 6.3 tt -93.0 118.01 30.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 61' ' ' LEU . 56.1 t80 -168.61 150.94 5.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.27 128.94 39.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.148 0.499 . . . . 0.0 111.248 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.16 5.44 5.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.141 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -83.92 -1.04 53.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -119.78 -79.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 18.1 m-85 -112.38 163.23 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -115.88 161.36 18.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -88.67 120.67 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.566 -170.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -85.49 -49.48 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.22 154.83 45.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 5.5 pm0 -154.65 161.57 41.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.239 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' HD22 ' A' ' 16' ' ' LEU . 32.0 m -73.65 107.81 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -61.9 2.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.262 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 p -139.97 147.52 40.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.56 157.17 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.203 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 52.7 tt0 -103.24 128.19 50.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.588 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.2 p -125.5 132.63 70.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.414 0.626 . . . . 0.0 110.452 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 15.6 t70 -125.0 140.31 53.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.491 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -116.3 140.43 49.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.983 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -137.22 136.26 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.816 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.93 -154.36 25.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.735 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 82' ' ' LEU . 76.8 Cg_exo -50.39 115.93 2.21 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.896 2.397 . . . . 0.0 112.219 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -61.14 -32.96 72.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.649 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.93 91.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.44 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.92 -46.84 95.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 110.049 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD21 HD13 ' A' ' 82' ' ' LEU . 94.4 mt -64.45 -32.74 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.723 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 m -65.37 -43.7 89.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.41 -39.95 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.0 -29.36 70.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.597 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 4.7 tmm_? -59.3 -31.78 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.311 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -76.59 -26.31 54.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.633 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.04 119.5 22.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.619 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.27 161.23 51.59 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.297 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -62.62 120.27 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.09 1.194 . . . . 0.0 113.558 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 m -126.05 3.81 7.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.038 166.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.498 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -104.34 113.24 26.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.281 -1.782 . . . . 0.0 109.101 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -125.37 151.04 46.63 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.184 0.516 . . . . 0.0 111.353 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 73' ' ' VAL . 16.0 t -104.31 123.18 58.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 43.9 p90 -142.26 151.23 41.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.581 0.705 . . . . 0.0 112.361 -170.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 16' ' ' LEU . 17.6 t -123.99 135.82 62.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.091 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . 9.2 p-10 -108.92 114.64 28.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.36 0.6 . . . . 0.0 109.787 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.457 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 41.4 mt -128.03 117.74 22.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.485 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.9 p -129.81 -39.73 1.41 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.071 0.462 . . . . 0.0 110.705 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.09 -35.03 14.84 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.278 0.561 . . . . 0.0 110.888 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.79 39.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.202 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -167.94 -35.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.952 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 142.82 50.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.52 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 -133.52 35.25 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.702 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -120.46 143.68 48.38 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -131.46 122.26 25.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 90' ' ' MET . 11.4 m -115.38 114.18 24.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.27 167.08 21.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.129 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.44 140.67 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 57' ' ' VAL . 12.0 t -104.36 133.76 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.053 0.454 . . . . 0.0 112.092 -170.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -87.58 146.61 25.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.781 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -131.84 149.45 52.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.61 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 76' ' ' ARG . 20.3 ttt180 -144.48 144.3 31.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.412 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 55' ' ' TYR . . . 133.52 -73.88 0.45 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -81.17 144.59 54.57 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 160.03 16.26 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.554 2.169 . . . . 0.0 112.941 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.51 21.15 5.48 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.975 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -71.33 -41.47 69.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.723 0.773 . . . . 0.0 109.679 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 HD21 ' A' ' 45' ' ' LEU . 49.4 mt -86.49 161.27 18.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.211 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.53 111.41 16.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.0 130.62 45.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 37' ' ' ASP . 20.1 m -118.27 139.1 51.83 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.1 t -131.88 145.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.009 0.433 . . . . 0.0 110.88 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 5.3 mm-40 -102.99 150.02 37.41 Favored Pre-proline 0 CA--C 1.502 -0.885 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 27.5 Cg_exo -10.75 128.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 124.973 3.782 . . . . 0.0 115.651 -138.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -90.98 -12.35 36.18 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.051 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB3' HG22 ' A' ' 70' ' ' THR . 80.0 mtp -106.5 132.73 52.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.254 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -118.46 141.52 48.48 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.05 0.452 . . . . 0.0 110.028 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' GLN . 37.3 ttm180 -108.05 125.68 51.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.397 -173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.308 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.89 121.13 41.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 62.7 mt -124.63 124.42 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.15 144.3 47.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.883 0.373 . . . . 0.0 110.308 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.16 140.13 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.327 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 98' ' ' ARG . 41.8 ttp180 -78.07 139.79 39.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.831 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -72.77 -46.58 52.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 p -89.77 79.27 6.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.924 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' SER . 43.0 t -64.21 -68.85 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.209 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 9.1 t 171.0 177.7 0.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.105 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.19 97.21 12.91 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.12 -165.66 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.061 2.508 . . . . 0.0 113.458 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG22 ' CG ' ' A' ' 113' ' ' GLU . 21.6 t 69.05 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.548 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -65.11 -53.9 38.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.239 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.25 127.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.914 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 108' ' ' GLU . 7.1 pt-20 -87.24 107.75 18.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.331 0.586 . . . . 0.0 110.327 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 38.6 ttm -170.48 -71.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.428 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -88.14 -21.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.492 173.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -114.52 127.48 55.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.198 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.0 97.89 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.451 ' CG ' HG22 ' A' ' 105' ' ' VAL . 6.2 tp10 -98.56 157.67 16.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.553 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -105.5 117.63 34.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.223 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.62 98.91 4.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -84.6 124.43 31.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.08 0.467 . . . . 0.0 110.411 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -165.78 108.69 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.76 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 119' ' ' HIS . 23.5 p-80 -115.57 132.38 56.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.506 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 118' ' ' HIS . 15.5 t-80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.676 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.852 0.358 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.83 139.35 39.74 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.553 2.168 . . . . 0.0 112.801 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.5 p 54.89 101.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 113.286 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -136.39 151.68 49.81 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.477 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 t0 64.26 90.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.47 ' NE2' ' HG2' ' A' ' 39' ' ' GLU . 18.5 t60 -161.5 110.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.47 -166.39 11.18 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -126.82 158.05 37.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.389 0.614 . . . . 0.0 111.388 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 45' ' ' LEU . 2.1 tm? -142.87 125.2 15.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.375 175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 m -105.81 133.26 50.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 111.439 -172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 14' ' ' LEU . 95.5 mt -88.91 -23.04 22.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.283 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' GLN . . . 83.46 -151.16 27.8 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.433 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.28 116.58 18.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 110.569 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 11' ' ' LEU . 88.4 mt -99.9 132.76 45.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.038 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.35 121.95 25.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.5 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.62 130.43 34.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.098 0.475 . . . . 0.0 110.512 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 23.4 m -93.93 131.61 39.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.795 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.64 118.81 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.856 0.36 . . . . 0.0 110.549 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.4 mt -96.9 118.35 33.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -150.4 163.39 38.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.539 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 62' ' ' THR . 19.6 t70 -80.18 99.96 8.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -76.45 -13.43 60.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -172.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.47 -47.46 73.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 30.5 ttt180 -95.58 -48.28 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 45.0 m-85 -101.91 144.94 29.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.02 0.438 . . . . 0.0 111.607 -170.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -133.05 157.84 44.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.2 mt -79.94 116.9 24.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.818 0.342 . . . . 0.0 111.296 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.28 -47.11 12.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 110.18 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.8 152.82 48.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -167.09 171.27 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.199 0.523 . . . . 0.0 112.047 -171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -95.65 136.53 35.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.005 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.82 -79.73 0.37 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 p -128.25 146.33 50.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 111.575 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.46 161.5 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.08 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 28.7 tt0 -105.14 131.06 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.955 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.98 130.71 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -130.22 139.18 50.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.397 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.92 131.3 56.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.8 tt0 -116.81 135.17 53.96 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 166.56 -169.58 40.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.708 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.95 144.19 96.17 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.05 2.5 . . . . 0.0 112.315 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -59.63 -30.55 68.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.691 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -57.24 -49.45 72.32 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.439 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.77 -38.82 80.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.23 0.538 . . . . 0.0 110.142 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 9' ' ' LEU . 90.3 mt -65.22 -42.76 93.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.303 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.4 m -67.9 -42.11 81.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.244 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -62.56 -38.97 82.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.8 -29.4 69.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -71.94 -25.52 61.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.17 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.17 -25.7 42.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 110.178 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.17 115.7 16.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.079 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.47 160.88 56.09 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.401 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.46 121.52 9.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.712 1.608 . . . . 0.0 112.509 -173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.4 m -145.31 14.2 1.44 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.886 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 12.3 p90 -102.37 137.65 40.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.884 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.57 147.87 41.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.8 t -125.79 121.86 60.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 17' ' ' THR . 41.8 p90 -149.71 155.96 41.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.186 0.517 . . . . 0.0 111.281 -171.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.95 134.18 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.23 101.99 14.27 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 109.931 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 95.5 mt -116.91 34.15 5.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.376 0.608 . . . . 0.0 109.976 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -60.09 -33.69 72.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.58 -37.35 23.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.739 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.78 -158.6 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.643 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.39 -129.86 1.42 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.46 142.59 35.88 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 53.15 -124.73 29.05 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.873 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 37.9 t -101.74 138.9 38.11 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.14 123.83 51.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.407 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 5.5 m -98.3 121.92 40.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.453 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.81 156.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.46 132.89 37.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 t -91.72 125.29 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.961 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.85 153.14 19.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.692 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -126.57 150.48 48.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.277 -170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 3.9 mmp_? -137.01 164.22 28.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.422 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 108.35 -65.34 0.25 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -86.55 143.84 36.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.52 134.02 31.81 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.679 2.253 . . . . 0.0 112.829 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.9 19.55 9.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.954 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.62 -20.2 50.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' A' ' 40' ' ' GLY . 80.2 mt -96.23 174.0 7.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.505 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . . . -83.1 109.66 17.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.4 t -94.28 127.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.578 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -111.11 130.58 55.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -130.11 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.142 0.496 . . . . 0.0 110.799 -174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 60.4 mm-40 -101.18 149.22 36.09 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 87' ' ' GLU . 21.6 Cg_exo -17.05 127.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.426 3.418 . . . . 0.0 115.269 -140.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -98.01 6.3 47.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.691 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.9 mmm -105.71 123.72 48.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.886 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 70' ' ' THR . . . -119.28 130.7 55.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 0.0 110.759 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 11.3 ptt-85 -108.12 129.93 55.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.262 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 66.8 t -137.6 128.22 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.91 0.386 . . . . 0.0 110.195 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 47.0 tt0 -102.41 120.7 40.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.957 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 97.2 mt -111.88 124.06 51.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -128.98 144.75 51.28 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 24' ' ' ARG . 38.9 mt-10 -50.1 125.3 11.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.619 0.574 . . . . 0.0 111.883 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.02 138.54 58.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.387 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' CD ' ' H ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -56.82 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -166.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.434 ' H ' ' HG2' ' A' ' 99' ' ' GLN . 3.6 m -147.63 9.54 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.764 0.792 . . . . 0.0 110.106 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.5 t -133.55 118.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.528 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -79.92 -168.85 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.319 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 105' ' ' VAL . 11.3 m -59.56 130.92 88.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.44 . . . . 0.0 111.051 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.12 25.61 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.109 2.539 . . . . 0.0 112.855 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 103' ' ' VAL . 47.3 t -59.51 100.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.944 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -83.65 133.57 34.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.606 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.84 137.13 21.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.721 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 71.7 -76.44 0.06 Allowed 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.954 0.784 . . . . 0.0 111.663 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.4 ttp -134.35 130.57 37.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.769 0.319 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.3 tp -60.03 132.08 25.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 17.5 t-20 -80.98 132.02 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.945 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.436 ' HG ' ' OD1' ' A' ' 111' ' ' ASN . 94.5 mt 63.99 -164.37 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.671 0.607 . . . . 0.0 110.812 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.18 127.08 52.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -115.13 108.94 17.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -86.1 93.71 9.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.198 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -137.16 94.87 3.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.633 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -128.51 140.99 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -142.39 115.34 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.906 0.384 . . . . 0.0 110.625 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.641 172.095 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.41 0.148 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.69 114.96 2.15 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.592 2.195 . . . . 0.0 110.938 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 140.82 29.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -99.4 134.35 42.39 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.11 84.56 0.06 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.708 0.63 . . . . 0.0 110.835 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 74.1 145.09 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.627 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.56 -173.63 14.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.209 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.75 156.92 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 0.0 110.211 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 45' ' ' LEU . 51.3 tp -150.84 128.78 11.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.58 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -100.34 128.57 46.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 110.971 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.93 -13.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 0.0 109.504 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.85 -154.39 24.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.264 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.31 109.18 21.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.29 153.94 17.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.421 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.8 139.77 30.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.573 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.72 HD11 HG23 ' A' ' 59' ' ' VAL . 35.2 tp -87.86 137.01 32.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.495 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 22.2 m -110.54 125.4 53.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.849 174.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 93' ' ' VAL . 48.3 t -107.28 130.49 59.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.201 -0.312 . . . . 0.0 110.934 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 88.4 mt -99.95 117.76 34.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.931 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 26.5 p90 -146.33 4.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 1.9 t70 60.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -124.52 24.98 7.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.988 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 21' ' ' ASP . 37.1 mt-10 -66.92 -73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.588 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.87 11.22 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 94.0 m-85 -128.66 151.12 49.86 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.604 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 43.9 t0 -143.67 162.16 36.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 18' ' ' VAL . 65.7 mt -80.38 118.49 28.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.043 0.449 . . . . 0.0 111.475 -173.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.1 t -89.56 -43.61 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.026 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 15.9 pt-20 -149.96 157.18 42.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.593 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' NE2' HG21 ' A' ' 27' ' ' ILE . 10.9 pt20 -161.16 -173.99 4.13 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.322 0.389 . . . . 0.0 110.243 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.438 HG23 HD22 ' A' ' 16' ' ' LEU . 6.7 t -111.06 90.7 3.41 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.65 -39.43 91.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.288 -167.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 p -129.18 145.82 51.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.558 . . . . 0.0 111.734 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 88' ' ' PRO . 11.2 m -133.91 148.03 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.844 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -96.5 128.81 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 86' ' ' VAL . 13.0 t -125.39 121.16 59.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.253 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.34 140.81 52.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.46 145.12 43.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.767 0.317 . . . . 0.0 111.154 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 33.4 mt-10 -121.82 155.75 34.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.33 -161.51 27.29 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.465 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 23.5 Cg_exo -63.86 122.07 9.99 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.149 2.566 . . . . 0.0 112.001 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 45' ' ' LEU . 70.0 mtm180 -60.86 -29.11 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -54.86 -48.97 63.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.068 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.67 -42.48 89.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.074 0.464 . . . . 0.0 110.057 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 42' ' ' ARG . 89.1 mt -56.51 -42.27 78.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.122 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -69.18 -45.44 69.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.31 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD2' ' A' ' 50' ' ' PHE . 99.3 t -60.61 -43.05 93.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -66.5 -35.4 80.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.192 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttp180 -65.8 -24.36 66.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.974 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HD2' ' HA ' ' A' ' 47' ' ' VAL . 27.1 m-85 -70.15 -31.3 68.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.635 0.255 . . . . 0.0 111.222 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.87 146.2 28.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.814 0.34 . . . . 0.0 110.429 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -68.24 154.03 94.66 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.18 121.98 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.035 2.49 . . . . 0.0 113.311 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -123.98 12.35 9.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.529 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.625 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 1.4 p90 -103.88 150.65 23.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.028 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.67 144.1 31.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.11 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.23 123.46 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 76' ' ' ARG . 37.8 p90 -151.86 155.14 37.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.014 0.435 . . . . 0.0 111.131 -176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.72 HG23 HD11 ' A' ' 16' ' ' LEU . 25.8 t -128.07 135.92 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 7.9 t70 -107.43 116.48 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.674 HD13 ' HD2' ' A' ' 69' ' ' HIS . 85.9 mt -140.28 35.79 1.89 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.343 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -60.93 -26.91 67.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.967 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.18 5.65 48.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.1 112.67 20.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.062 0.458 . . . . 0.0 111.198 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.78 89.9 0.45 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 67' ' ' GLY . 1.5 tm-20 -162.76 -167.91 1.66 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -80.02 -141.78 2.65 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 174.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.2 t -69.55 133.74 48.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.568 0.699 . . . . 0.0 109.291 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HD2' HD13 ' A' ' 61' ' ' LEU . 9.6 p-80 -133.59 137.17 45.35 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.758 -173.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 90' ' ' MET . 3.2 m -117.32 129.35 55.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.583 -175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 61' ' ' LEU . 31.4 m -137.64 167.78 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.29 0.567 . . . . 0.0 111.595 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.01 139.46 44.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.946 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.77 116.24 31.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.262 0.553 . . . . 0.0 111.545 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.82 152.14 20.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.134 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -133.0 150.72 52.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.318 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HB2' ' HE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -126.83 159.65 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 111.48 -86.06 0.42 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.142 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -78.2 143.89 65.96 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.9 164.33 11.78 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.727 2.285 . . . . 0.0 112.245 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.56 41.58 2.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.526 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.23 -37.67 37.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.703 . . . . 0.0 109.445 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.9 mt -96.21 174.66 6.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.413 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -80.63 113.06 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.97 115.74 33.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -115.71 122.77 46.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.492 0.663 . . . . 0.0 110.296 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.09 152.33 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.68 95.04 4.99 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 114.675 -2.81 . . . . 0.0 117.146 156.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 34' ' ' VAL . 41.1 Cg_endo -113.9 128.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 124.713 3.609 . . . . 0.0 105.333 106.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -89.49 -16.81 29.94 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 117.931 -1.508 . . . . 0.0 108.498 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.635 ' HG2' HG22 ' A' ' 70' ' ' THR . 13.3 ttt -153.83 125.78 7.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.747 169.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.39 144.36 46.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.382 0.611 . . . . 0.0 112.092 -169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.69 ' H ' ' HD2' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -108.13 145.68 33.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.4 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 18' ' ' VAL . 7.6 p -137.62 131.64 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tp60 -98.67 121.53 40.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 0.0 110.671 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' TYR . 92.7 mt -113.93 124.68 52.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.13 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.09 145.76 33.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.59 93.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.26 0.552 . . . . 0.0 109.692 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' HG3' ' H ' ' A' ' 99' ' ' GLN . 3.0 tpp180 -163.18 178.03 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 98' ' ' ARG . 44.2 tt0 -143.7 120.6 11.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -108.09 -167.29 1.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.083 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.55 94.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 0.0 109.954 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -76.51 111.85 12.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 58.3 t -97.64 115.46 65.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.374 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 103' ' ' VAL . 12.2 Cg_exo -70.62 104.3 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.893 2.395 . . . . 0.0 111.782 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.59 113.37 44.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.354 0.597 . . . . 0.0 110.078 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -163.61 147.81 10.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.198 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.5 m -135.47 144.3 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.037 174.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.3 115.41 27.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.685 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.9 mtt -99.75 104.23 15.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.184 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.7 tt -122.43 131.18 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.236 0.541 . . . . 0.0 110.44 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.62 132.75 13.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.311 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.3 -2.11 19.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HB3' ' H ' ' A' ' 114' ' ' HIS . 17.1 mm-40 54.58 -156.97 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 111.908 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.489 ' H ' ' HB3' ' A' ' 113' ' ' GLU . 52.3 m170 -103.82 135.62 45.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -67.64 150.33 48.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 74.68 6.11 4.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.933 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' HIS . 70.7 t60 -116.94 96.11 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.863 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -166.38 141.98 4.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.107 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.818 175.203 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.621 ' H2 ' ' HD2' ' A' ' 2' ' ' PRO . 1.3 mpt? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' HD2' ' H2 ' ' A' ' 1' ' ' MET . 9.9 Cg_endo -53.77 -68.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.205 1.937 . . . . 0.0 113.308 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 p 54.13 117.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.317 1.047 . . . . 0.0 113.188 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -57.16 124.05 17.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.587 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -85.36 55.65 3.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.576 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -141.31 123.14 15.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.86 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.11 -169.83 13.75 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.211 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 39' ' ' GLU . 10.9 m120 -132.01 152.66 51.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.7 tp -147.95 124.42 11.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.78 128.38 45.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -174.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.721 ' HB2' HG13 ' A' ' 36' ' ' VAL . 85.0 mt -84.95 -28.27 25.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.885 0.374 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -169.32 14.62 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.413 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -81.6 114.73 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 110.225 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 55' ' ' TYR . 57.0 mt -97.06 130.96 44.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.231 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.33 131.86 36.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.322 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 16' ' ' LEU . 1.5 tm? -83.19 116.16 22.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.163 0.506 . . . . 0.0 110.39 -170.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -89.11 122.69 32.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.548 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 93' ' ' VAL . 57.7 t -106.53 124.53 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 89.1 mt -88.81 117.86 28.1 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 26' ' ' ASP . 9.5 p90 -140.18 -5.26 1.28 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.36 . . . . 0.0 110.731 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t70 60.18 -156.52 0.34 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.453 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -116.7 32.0 6.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 21' ' ' ASP . 7.9 mm-40 -50.41 -71.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.339 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -168.83 10.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.88 162.25 31.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.181 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 28.2 t0 -138.53 161.53 36.82 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.01 106.39 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.085 0.469 . . . . 0.0 111.45 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.0 t -82.03 -47.38 19.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.893 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -133.69 153.52 51.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.641 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.57 -174.3 4.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.66 0.267 . . . . 0.0 110.43 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -97.56 110.8 23.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.98 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.27 -173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.21 150.32 45.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.64 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 m -124.26 148.85 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.049 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 58.6 tp60 -101.33 121.68 42.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 11' ' ' LEU . 3.5 p -118.74 125.8 74.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.444 0.64 . . . . 0.0 109.995 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -127.79 140.03 52.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.36 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -114.5 139.32 49.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.115 0.483 . . . . 0.0 111.755 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 43.7 mt-10 -122.07 167.7 12.83 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.163 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.61 -156.49 24.75 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.85 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 19.6 Cg_exo -66.26 128.33 19.21 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.301 2.667 . . . . 0.0 112.072 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.19 -33.06 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.818 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.09 -49.12 81.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.191 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.01 -42.88 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.451 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.672 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 96.5 mt -58.48 -36.68 74.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.005 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 24.9 m -66.68 -38.08 86.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.07 -38.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.201 0.524 . . . . 0.0 109.64 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -69.53 -28.72 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 93.1 mtt-85 -60.6 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -75.89 -31.85 59.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.321 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.93 118.16 20.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.239 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -61.54 153.88 67.73 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.659 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.49 124.58 13.52 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.474 2.783 . . . . 0.0 114.024 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -131.97 11.64 4.7 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.036 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 11.6 p90 -80.01 132.54 36.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -142.56 144.87 33.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG12 ' HB3' ' A' ' 75' ' ' HIS . 17.5 m -129.59 130.53 67.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.173 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -153.87 160.8 42.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.94 134.66 53.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.054 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 9.8 t70 -97.88 116.47 30.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 109.933 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 71' ' ' VAL . 76.7 mt -136.12 38.48 2.75 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.648 0.737 . . . . 0.0 109.891 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.9 p -64.5 -20.53 66.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.134 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -94.91 6.34 49.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.552 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 171.02 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.478 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.17 -111.42 2.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.273 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.39 151.48 22.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.27 177.95 34.4 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.881 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 22.7 t -95.61 140.65 30.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.237 0.542 . . . . 0.0 110.009 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -132.37 126.74 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.929 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 m -94.95 128.68 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 61' ' ' LEU . 16.8 m -131.8 166.92 27.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.537 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.16 139.3 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.61 116.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.15 151.09 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 57' ' ' VAL . 2.3 p80 -146.11 149.87 34.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.001 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -142.29 163.87 31.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.949 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 55' ' ' TYR . . . 123.75 -32.76 4.14 Favored Glycine 0 CA--C 1.51 -0.244 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 19.6 p90 -119.55 144.18 36.26 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 78' ' ' PHE . 3.2 Cg_exo -76.29 162.13 34.15 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.688 2.259 . . . . 0.0 112.296 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.92 11.92 19.43 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.376 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.12 -30.3 60.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.239 0.542 . . . . 0.0 110.128 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.29 160.53 15.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.678 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 39' ' ' GLU . . . -91.08 129.78 37.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.88 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.78 125.88 68.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.765 0.317 . . . . 0.0 111.849 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 m -102.28 136.29 42.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.28 133.31 67.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.193 0.521 . . . . 0.0 111.685 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 1.6 tt0 -104.52 150.92 39.04 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -5.77 129.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 125.226 3.95 . . . . 0.0 115.622 -138.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -101.85 -21.63 14.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.169 -164.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 88.3 mtp -113.5 135.99 53.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.966 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.21 131.4 55.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.03 0.443 . . . . 0.0 111.103 -172.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -106.3 128.78 54.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.024 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' SER . 10.8 p -123.52 138.54 53.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.404 174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 50.9 tt0 -102.2 120.17 40.02 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.3 mt -105.41 133.58 49.93 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ARG . 43.2 tt0 -131.57 144.77 51.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.99 36.14 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.654 0.74 . . . . 0.0 110.301 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLU . 41.5 ttp180 -142.11 142.67 32.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.968 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -97.52 132.26 43.37 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 101' ' ' VAL . 13.0 m -102.49 -74.46 0.63 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.245 0.545 . . . . 0.0 110.074 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 100' ' ' THR . 13.8 p 172.69 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.948 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -135.95 115.53 12.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.47 105.45 36.17 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 121.451 0.643 . . . . 0.0 111.279 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -93.37 104.82 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.416 2.744 . . . . 0.0 112.037 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.0 119.06 50.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.323 0.582 . . . . 0.0 110.018 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 46.5 m -85.71 106.1 16.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 0.0 110.804 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.85 140.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.689 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -86.85 124.72 33.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 0.0 110.727 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttt -105.1 116.35 31.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.014 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.2 pt -85.8 171.5 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.14 100.85 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.5 OUTLIER -102.22 -59.34 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' LEU . 44.2 tt0 70.84 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.674 0.75 . . . . 0.0 112.722 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -127.64 96.55 4.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.318 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -97.25 86.12 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.871 0.843 . . . . 0.0 110.36 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -84.84 -72.45 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.961 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -151.42 148.91 28.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -162.14 117.11 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.559 175.299 . . . . . . . . 0 0 . 1 stop_ save_